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Abstract
Hydrogels have emerged as an invaluable class of materials for biomedical applications, owing in part to their
utility as structural, bioinstructive, and cell-laden implants that mimic many aspects of native tissues. Despite
their many positive attributes, conventional hydrogels face numerous challenges toward translational
therapies, including difficulty in delivery (i.e., invasive implantation) as well as limited control over biophysical
properties (i.e., porosity, degradation, and strength). To address these challenges, the overall goal of this
dissertation was the development of a class of supramolecular hydrogels that can be implanted in vivo by
simple injection and that have tunable properties — either innate to the system or achieved through
additional modifications. Toward this, we developed guest-host (GH) hydrogels that undergo supramolecular
assembly through complexation of hyaluronic acid (HA) separately modified by adamantane (Ad-HA, guest)
and β-cyclodextrin (CD-HA, host).
Modular modifications were made to GH hydrogels to enable tuning of biophysical properties, including the
incorporation of matrix-metalloproteinase cleavable peptides between HA and Ad to form enzymatically
degradable assemblies. Additionally, dual-crosslinking (DC) of methacrylated CD-HA (CD-MeHA) and
thiolated Ad-HA (Ad-HA-SH) by Michael addition subsequent to GH assembly was explored to stiffen
hydrogels in vivo following injection. Finally, injectable and tough double network (DN) hydrogels were
fabricated, where GH hydrogels were formed in the presence of an interpenetrating covalent network
(methacrylated HA, MeHA) crosslinked by Michael addition with a dithiol under cytocompatible conditions.
Both GH and DC hydrogels were further explored in vivo, with application to attenuate the maladaptive left
ventricular (LV) remodeling that occurs following myocardial infarction (MI) that can result in heart failure.
DC hydrogels reduced stress within the infarct region, prevented early ventricular expansion and thereby
ameliorated progressive LV remodeling. Moreover, the preservation of myocardial geometry reduced
incidence and severity of ischemic mitral regurgitation — an undesirable and devastating consequence of LV
remodeling. Overall, the body of work represents a novel approach to engineer biomaterials with unique
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DEVELOPMENT OF SHEAR-THINNING AND SELF-HEALING HYDROGELS 
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APPLICATIONS  
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 Hydrogels have emerged as an invaluable class of materials for biomedical 
applications, owing in part to their utility as structural, bioinstructive, and cell-laden 
implants that mimic many aspects of native tissues. Despite their many positive 
attributes, conventional hydrogels face numerous challenges toward translational 
therapies, including difficulty in delivery (i.e., invasive implantation) as well as 
limited control over biophysical properties (i.e., porosity, degradation, and 
strength).  To address these challenges, the overall goal of this dissertation was 
the development of a class of supramolecular hydrogels that can be implanted in 
vivo by simple injection and that have tunable properties — either innate to the 
system or achieved through additional modifications. Toward this, we developed 
guest-host (GH) hydrogels that undergo supramolecular assembly through 
complexation of hyaluronic acid (HA) separately modified by adamantane (Ad-HA, 
guest) and β-cyclodextrin (CD-HA, host).  
Modular modifications were made to GH hydrogels to enable tuning of 
biophysical properties, including the incorporation of matrix-metalloproteinase 
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cleavable peptides between HA and Ad to form enzymatically degradable 
assemblies. Additionally, dual-crosslinking (DC) of methacrylated CD-HA (CD-
MeHA) and thiolated Ad-HA (Ad-HA-SH) by Michael addition subsequent to GH 
assembly was explored to stiffen hydrogels in vivo following injection. Finally, 
injectable and tough double network (DN) hydrogels were fabricated, where GH 
hydrogels were formed in the presence of an interpenetrating covalent network 
(methacrylated HA, MeHA) crosslinked by Michael addition with a dithiol under 
cytocompatible conditions.   
 Both GH and DC hydrogels were further explored in vivo, with application 
to attenuate the maladaptive left ventricular (LV) remodeling that occurs following 
myocardial infarction (MI) that can result in heart failure. DC hydrogels reduced 
stress within the infarct region, prevented early ventricular expansion and thereby 
ameliorated progressive LV remodeling. Moreover, the preservation of myocardial 
geometry reduced incidence and severity of ischemic mitral regurgitation — an 
undesirable and devastating consequence of LV remodeling. Overall, the body of 
work represents a novel approach to engineer biomaterials with unique properties 
toward biomedical therapies. 
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Introduction: Material Design for Biomedical Applications 
 
Adapted from: Rodell CB, Tibbett MW, Burdick JA, Anseth KS. Progress in Material 
Design for Biomedical Applications. Proceedings of the National Academy of 
Sciences (PNAS) 112, 14444-14451 (2015). 
 
1.1 Introduction 
Biomaterials have been used to augment tissue function and treat diseases 
and injuries for thousands of years – whether selecting coral or wood for dental 
implants or fabric for sutures, implant materials historically originated by evaluating 
potential materials in our surroundings that could be used for a specific biomedical 
application. Many times this selection process simply involved consideration of the 
mechanical properties of the material to restore basic function at the implant site; 
typically, the materials themselves were never originally designed to interface with 
living tissues. Today, this is no longer the case, as we now have an advanced 
toolbox of synthetic and processing techniques to rationally create, design, and 
process materials with specific properties in mind. These advancements have 
come hand in hand with the integration of theory with experiments, materials 
chemistry and biology with engineering, and basic science with application. As 
highlighted by the announcement of the Materials Genome Initiative1, biomaterial 
 2 
science is often the stealth technology that enables breakthroughs in medical 
devices that improve health care and save lives. 
In fact, the last few decades of research have led to the emergence of 
numerous biomaterial options, along with an increasing sophistication in the ability 
to tune and manipulate complex physical and biological properties. Such advances 
in biomaterial science have not only driven and enabled new medical products, but 
have served as new tools for investigation of important biological questions. The 
modern biomaterial evolution initiated with the design of materials – including hard 
materials like metals and ceramics – that focused on outcomes such as 
mechanical properties and biocompatibility. This approach led to the clinical 
implementation of numerous materials for biomedical applications, such as joint 
replacement, pacemakers, and orthodontics. The contemporary age of 
biomaterials has advanced with a further focus on functionality, where materials 
are now smarter and responsive to their environment; they incorporate bioactive 
signals, and they have multifunctional design. These strategies are leading to 
progress and improvements in fields ranging from medical devices, to drug 
delivery, to regenerative medicine. 
As one example, vascular stents have been widely used to open blocked 
vessels and restore blood flow to ischemic tissues, and the design of these stents 
has significantly evolved with time. With the development of Nitinol®, a metal alloy 
of nickel and titanium with unique shape memory and superelastic properties, stent 
design has improved to be implanted with simpler, minimally-invasive procedures 
and to maintain function for longer periods of time. Next generation stents 
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transitioned from passive mechanical devices to those that actively regulate the 
biological interface by integrating biodegradable polymer coatings that locally elute 
drugs to limit restenosis and resulting stent failure. These advances enhanced both 
the functionality and efficacy of stent technology for clinical use. Similarly, the 
coating of traditional metal orthopaedic implants with bioactive ceramics improved 
clinical outcomes by facilitating osseointegration with bony tissue, and after the 
discovery of bone morphogenetic proteins and their recombinant production, 
spinal fusion surgeries benefited from material delivery systems that enabled their 
local presentation (e.g., INFUSE®). Collectively, these examples demonstrate how 
material design can be used to present biological signals that result in new medical 
devices and implants with superior clinical performance. In fact, a recent report 
estimated the 2012 global biomaterial market at $44.0 billion and forecasted a 15% 
compounded annual growth rate between 2012-2017, reaching $88.4 billion by 
20172. 
This perspective focuses primarily on recent developments in polymers and 
soft materials, due to the large technological growth in these systems since the 
1990s. This review is organized to highlight some of the major advances and 
modern thinking in biomaterial design, such as the ability to manipulate and control 
biomaterial properties at multiple length-scales, introduce dynamic behavior into 
biomaterials, and capture biocomplexity and additive functionalities. We then 
conclude with a forward-looking perspective about the current challenges and 
future directions for designing the next generation of biomaterials. 
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1.2 From Molecular to Macroscopic  
Biomaterials fabrication has evolved across all size scales—from molecular to 
macroscopic—to impart biochemical and biophysical cues into cell culture 
platforms for regenerative medicine, to achieve optimal outcomes in drug delivery 
systems, and to improve in vivo success of medical implants. Our increased 
understanding of native tissue architecture and cell-material interactions, as well 
as the development of processing methods and chemical syntheses has driven the 
design of new materials. This section will highlight advances that have been made 
in the development of a toolbox of synthetic approaches and fabrication techniques 
that impart defined structures over a range of biologically relevant length scales.  
 
1.2.1 From Molecular Organization to Nanostructure 
An increased understanding of biological structures, with a focus on their 
biochemical composition and organization, has provided insight into the manner 
by which molecular structure and chemistry impart properties into biological 
systems. Covalent bonds endow stability (e.g., peptide bonds) while secondary 
structures confer material resilience (e.g., resilin3, elastin4). Peptide coupling, 
recombinant protein synthesis, and evolution via phage display have become 
invaluable tools to recapitulate similar functionalities in synthetic biomaterial 
analogues. Likewise, synthetic approaches (e.g., bio-orthogonal chemistry) have 
evolved to enable the fabrication and functionalization of biomaterials (e.g., 
hydrogels) that capture aspects of native biological structures5. Collectively, these 
techniques have allowed the production of biomaterials with unique capacity, 
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including post-modification of cell culture matrices and to crosslink implantable 
materials. 
 
Figure 1.1. The biomaterials toolbox. The toolbox of biomaterials processing techniques 
that enable formation of highly controlled structures with biochemical and biomechanical 
features that vary across many size scales, as well as levels of complexity. These include 
nanoscale molecular self-assembly6, photolithography7,8, electrospinning9,10, geometric 
self-assembly11,12, and 3D bioprinting13. 
 
Covalent chemistries have dominated the biomaterials field since its 
conception. However, the emergence of supramolecular chemistry has begun to 
enhance our understanding of biology and capacity for creating precise, 
physiologically structured materials. Nobel Laureate Jean-Marie Lehn insightfully 
described supramolecular interactions as “chemistry beyond the molecule,” 14 
since they enable dynamic macromolecular interactions, as well as the self-
organization necessary to form higher order structure in proteins and tissues15. In 
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the body, supramolecular presentation of bio-signals is exemplified by native 
extracellular matrix (ECM) interactions, including receptor-ECM interactions and 
heparin-binding proteins. As such, biomolecule presentation through 
supramolecular interactions has emerged as a means of controllable delivery16, 
including through cyclodextrin-mediated sequestration of small molecules17 or 
biomimetic electrostatic protein-matrix interactions18. Beyond the capacity for 
single molecule-matrix interactions, the general ECM structure itself is largely the 
result of self-assembly (e.g., fibrillar structure of collagen) and can be 
recapitulated, in part, by well-designed synthetic analogues. These higher order 
motifs are exemplified by self-assembling nanostructures from peptide 
amphiphiles6 (Figure 1.1, top left), though many alternative means of biologically 
inspired supramolecular materials have been explored and their implications 
toward cell behavior recently reviewed19. 
 
1.2.2 Building at the Mesoscale 
While self-assembly processes based on molecular design have achieved vast 
success in recapitulating certain aspects of the biological nanostructure, they face 
notable challenges. Among these is relative homogeneity at larger scales 
(resulting from thermodynamically controlled assembly) and physiologically low 
mechanical properties (owing to the underlying weak intermolecular forces). In 
order to address these aspects at the nano and mesoscale, more active 
processing methods have been utilized to impart defined structure. Notably, 
electrospinning (Figure 1.1, center) of naturally derived or synthetic materials has 
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become a dominant technique to mimic the nanofibrous nature of ECM20. The 
functional importance of such microstructural organization cannot be discounted, 
as it enables mechanical anisotropy21 and therefore holds great promise for 
formation of biomedical implants including vascular grafts22 and orthopedic 
connective tissues23. Toward formation of porous architectures, other processes 
such as phase separation, leaching, and directional freezing have also emerged 
as versatile methods to process biomaterials that permit cell and tissue 
infiltration24,25. 
The aforementioned methods allow realization of bi-continuous structures at 
the nano- and micro-scale, yet they often display limited capacity toward 
generating complex topographical, mechanical, or biomolecular presentation. For 
modulation of these aspects, post-processing of larger scaffolds, such as by light-
mediated reactions (Figure 1.1, bottom left), has become instrumental toward 
spatiotemporal control of biochemical signals on hydrogel surfaces26 or within 3D 
hydrogels through either focused single photon7 or multiphoton27 irradiation 
methods. Building on these advances, selective photopolymerization28, addition 
reactions29, and degradation mechanisms30,31 have enabled extension of 
photopatterning methodologies toward 2D and 3D presentation of spatially or 
temporally varying mechanical properties. 
 
1.2.3 Macroscopic Materials and their Sub-Assemblies  
Ultimately, material design for biomedical applications must achieve the 
capacity for preparation at the tissue-scale with both structure and mechanical 
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properties suitable for in vivo implantation, preferably with necessary tissue 
interfacing to achieve functionality. Methods reminiscent of industrial processes, 
such as injection molding, have been employed to achieve macrostructure control 
in biomaterials. These approaches have enabled recreation of complex structures 
at the macroscale with utility toward application in craniofacial32 and meniscal33 
implants. In some cases, the biological interaction with these materials has been 
mediated by biomolecule presentation within the scaffold, such as sequestration 
of heparin and, correspondingly, endogenous BMP-2 to enhance bone formation34. 
Toward their utility in tissue engineering applications, material assemblies often 
require advanced structural flexibility in order to recapitulate the inhomogeneity of 
tissue structures (e.g., spatiotemporal presentation of cells and matrix). To achieve 
this, appropriate molecular-, nano-, and meso-scale signals may be engineered 
into macroscale structures through either modification of bulk hydrogels (top-
down) or directed component assembly (bottom-up) approaches. A powerful 
means of achieving controlled signal presentation within a homogenous scaffold is 
photolithography (vide supra), which embodies the top-down methodology. 
Alternatively, two primary means of bottom-up approaches have emerged to 
create tissue-scale structures with non-homogenous cell and material 
compositions. First, pioneering work by the Whitesides group12 has demonstrated 
means by which materials may be pre-cast into microgel components with the 
desired composition and allowed to passively self-assemble (Figure 1.1, top right) 
through hydrophobic or capillary forces35. Owing to the thermodynamic control of 
assembly in these systems, repeatable geometric structures may be achieved over 
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large length scales. Toward increasing the complexity of allowed structures, such 
tools as field-driven input and direct serial manipulation have also been 
employed11. As an alternative to this self-assembled approach, techniques like 3D 
printing (Figure 1.1, bottom right)—the direct spatially controlled deposition of 
materials, with or without included cells or signals — have emerged to introduce 
material structure at the macro-scale. Within only the past few years, these 
methods have been extended to include processes such as: sacrificial printing to 
enable perfusion and viability within a secondarily cast hydrogel36, layer-by-layer 
printing of pluronics or other thermogels37, and methods to directly write complex 
structures in 3D13. Looking forward, it is expected that further inclusion of smaller 
scale sub-assemblies, such as nanostructured materials and microscale 
patterning will aid in furthering success of these approaches.  
 
1.3 From Static to Dynamic 
Beyond control of material structure from the molecular to the macro-scale, 
biomaterials are also evolving from a traditional, pre-engineered static design to 
those that have dynamic properties. Historically, biomaterials were intended to 
provide consistent functions, such as mechanical support (e.g., orthopaedic 
implants) or optical properties (e.g., contact lenses). This approach has led to the 
successful design of numerous clinically-used biomaterials; yet, advances in 
material design and polymer chemistry have recently allowed us to incorporate 
dynamic features into biomaterials. This approach ranges from the design of 
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materials that are degradable, to eliminate permanent implantation or a second 
surgery for implant retrieval, to those that have stimuli-responsive properties, 
where various chemical and biological signals can trigger changes in biomaterial 
properties or release drugs on-demand. 
 
Figure 1.2. Dynamic and responsive materials. Dynamic biomaterials based on 
polymer degradation38, stimuli-responsive properties (e.g., local changes in temperature 
or pH) for the release of therapeutics, or temperature induced shape-memory changes 
(e.g., self-tying suture)39. 
 
1.3.1 Incorporating Degradation into Biomaterials 
Biodegradable materials are those that transition from an initial, stable structure 












of such system have been around for numerous years, with biodegradable sutures 
perhaps being the most common40. Original resorbable sutures consisted of 
materials such as catgut that degraded via inherent biological mechanisms, but 
these were later engineered from synthetic and hydrolytically degradable polymers 
(e.g., poly(α-hydroxy esters)). Other examples of biodegradable materials used in 
the clinic include biodegradable films that limit undesired adhesions after surgical 
procedures and degradable fixation devices (e.g., screws and plates) in 
orthopaedics41. Important considerations in the design of biodegradable materials 
are the rate of degradation and ensuring that the degradation products are non-
toxic when released. 
Biodegradable materials have been applied widely to biomedical applications 
to provide temporal control over material presentation, including towards the 
engineering of tissues or the release of drugs and growth factors42. For tissue 
engineering, the material may temporarily provide a 3D structure or ‘scaffold’ for 
the growing tissue, whereas degradable materials for drug delivery are engineered 
to protect and then release molecules at desired rates. Hydrogels are one such 
class of biomaterials that have been designed with degradable linkers, for example 
through the introduction of hydrolytically or enzymatically cleavable bonds into the 
crosslinks. Degradable hydrogels have been synthesized from a range of 
materials, including synthetic polymers (e.g., poly(ethylene glycol)43, poly(vinyl 
alcohol)44, and poly(propylene fumarates)45) and biologically-derived polymers 
(e.g., hyaluronic acid46) (Figure 1.2). Towards tissue engineering or wound healing 
applications, it is important that the hydrogel remains intact long enough for 
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delivered or recruited cells to secrete their extracellular matrix, but not persist too 
long so as to impede tissue formation. For example, hydrogels have been 
optimized for cartilage tissue engineering by tuning the degradation rate to control 
matrix production and distribution by encapsulated chondrocytes47. Likewise, for 
delivery of entrapped biomolecules, hydrogel degradation is primarily used to alter 
the diffusion and kinetics of molecule release, which subsequently controls their 
spatiotemporal presentation to local cells and tissues48. Often times, these 
biological signals are designed to act as morphogens and influence tissue 
formation and healing49. 
As a complement to hydrolysis, which often occurs at pre-engineered rates 
throughout the bulk of a material, biomaterials have also been engineered to 
degrade via proteases, more similar to how tissues are remodeled in the body. In 
pioneering studies by Hubbell and colleagues, peptides were incorporated into 
hydrogel crosslinks that cleave through cell-produced proteases50,51, such as 
matrix metalloproteinases (MMPs), elastases, and plasmin52-54. With this protease-
mediated degradation and the addition of cell-adhesive signals, these biomimetic 
hydrogels were remodeled by cells55 and could be tuned for specific applications, 
such as the regeneration of bone and vascular structures50,54,56,57. In some 
examples, only growth factors were embedded into the matrices and their release 
occurred in a “cell-demanded” fashion58. This approach can also be harnessed to 
control the delivery of molecules to treat diseases where protease activity is 
altered, such as rheumatoid arthritis59, cancer60, and after myocardial infarction61; 
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here, the drug release rate and dose are controlled through a feedback mechanism 
(i.e., elevated protease activity releases more drug more quickly). 
Although these examples have focused on hydrogels, there are many other 
instances where degradation is used to control the dynamic properties of 
biomaterials. As one highlight, drug delivery reservoirs have been incorporated 
into synthetic devices, where they are covered by a thin biomaterial film (e.g., 
poly(lactic-co-glycolic acid) (PLGA))62. Subsequent drug release is mediated 
through degradation of the films, where the timing is dependent on the 
biodegradable polymer design. Release profiles can be pulsatile, and efficacy has 
been shown for the delivery of chemotherapeutics from device for targeting 
tumors63. Furthermore, stents have been designed to incorporate various drugs 
through biodegradable coatings and reservoirs (vide supra), where drugs (e.g., 
paclitaxel) are released through polymer degradation at concentrations and rates 
that can locally influence tissue response (e.g., suppress unwanted scarring or 
restenosis)64.  
 
1.3.2 Stimuli-Responsive Biomaterials 
Beyond degradation, biomaterials have been designed to respond to a range 
of environmental stimuli that may involve signals such as changes in temperature, 
ionic strength, light exposure, mechanical stress, magnetic fields, or pH65. These 
stimuli may initiate from the local biomaterial environment (e.g., after implantation) 
or be introduced as an external “trigger” (i.e., active systems) (Figure 1.2). 
Biologically responsive mechanisms include enzyme catalysis66, competitive 
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ligand-receptor binding67, and nanometer-scale protein motions68, where material 
properties and therapeutic release are altered based on the biological 
environment. Important examples in this area are the release of insulin in response 
to glucose catalysis69 or biochemically-triggered growth factor release70, where the 
disease stimuli controls drug delivery. Materials are also designed so that the 
presence of specific proteins can disassemble nanoparticles, opening up disease-
triggered therapeutics and diagnostics71. Hydrogels with pH responsive swelling 
changes provide advantages for the oral delivery of therapeutics, where 
biomaterials are stable in the stomach and then release drugs in the intestines72. 
As active systems, biomaterials are being designed with dynamic properties 
that introduce temporal signals to cells, towards the engineering of tissues, the 
expansion of stem cells, or to understand complex cellular processes. One 
common dynamic hydrogel system includes those fabricated from poly(N-isopropyl 
acrylamide), which transition from a swollen to a collapsed hydrogel when 
processed through its lower critical solution temperature (LCST). Changes in 
volume, mechanics, and optical transparency occur when the material transitions 
through its LCST, and these changes have been exploited to release cells and cell 
sheets for tissue engineering73. Another stimulus of particular interest is light, due 
to the allowed spatiotemporal control. Anseth and colleagues introduced light as a 
trigger for the cleavage of crosslinks (e.g., containing o-nitro benzyl groups) in 
hydrogels30 for the release of tethered signals or to probe how dynamic mechanical 
properties influence the phenotype of valvular interstitial cells74. Light has also 
been used to stiffen materials, where light introduces new crosslinks that can alter 
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material mechanics at a user-defined time75. Beyond light, dynamic properties may 
be introduced in ionically crosslinked gels, by the addition of multivalent cations76 
or in physically associated DNA-based gels through the introduction of 
complementary DNA77. All of these systems have been used to probe cell behavior 
in response to dynamic environments. 
Actively controlling biomaterials once implanted in the body is more 
challenging, particularly to introduce the stimuli to materials that are implanted 
deep within tissues. Light penetration can be attenuated at many depths and 
wavelengths; however, there are numerous examples where light has been used 
to either form materials78 or alter their properties when implanted79. Ultrasound is 
another trigger that can be introduced to disrupt polymer structure and release 
therapeutics80,81. As described with the biodegradable reservoirs above, a similar 
system has been developed with electrochemically activated microchips with 
release through the dissolution of a gold membrane82. While this system is non-
polymeric, it constitutes an important example of stimuli-responsive properties for 
controlled release in implanted materials.  
As a sub-set of responsive biomaterials, shape-memory materials exhibit 
changes in geometry based on triggers such as temperature or light83,84.  In brief, 
these materials are fixed into a temporary shape (usually under stress) and then 
transition into a relaxed permanent shape following an external or environmental 
trigger. (Figure 1.2) Such a dynamic process may lead to the next generation of 
minimally-invasive implantable constructs, capable of altering their geometry once 
implanted39. As mentioned above, shape memory alloys (e.g., Nitinol®) were 
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developed many years ago and have found commercial application, but the last 
few decades have led to an increase in the number of polymeric systems available 
for biomedical applications, along with those that under multiple transitions that 
allow for sequential geometric changes. These polymers can be processed from a 
range of covalently and physically crosslinked polymers and copolymers, including 
from biodegradable polymers83,84, and have the potential to be designed for 
degradation, elution of drugs, or even signaling to local cells for improved wound 
healing. 
 
1.4 From Bioinert to Biocomplex 
Building upon advances in dynamic and responsive biomaterials, another 
recent direction in soft biomaterials is the design of systems that engage with, 
respond to, and integrate into the biological landscape. Such systems extend 
beyond passive biological function (bioinert), and researchers seek to engineer 
materials that actively interface with biologically complex environments 
(biocomplex). Discoveries in the biological sciences have revealed how 
information is processed and exchanged in the body, exposing new routes toward 
engineering material-tissue interactions. For example, the language of the genetic 
code presents novel therapeutics; the critical role of the ECM informs tissue 
engineering and regenerative medicine; the genetic basis of many diseases (e.g., 
cancer, Marfan syndrome) transforms the way patients are treated; the 
communication networks of the immune system inform vaccinations and cancer 
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therapy; and the discovery of the microbiome restructures the way we think about 
bacteria. 
Toward fueling advances in medicine, these basic scientific discoveries are 
essential in the design of future biomaterials. For example, biocomplex materials 
have the potential to perceive malignant dysfunction and respond by releasing 
therapeutics to restore homeostasis; alternative systems could mimic critical 
aspects of the ECM to direct tissue morphogenesis ex vivo. Often, the biggest 
challenge is reducing the biological complexity into essential elements (e.g., rate 
limiting steps, critical signaling factors) that enable a synthetic material to perform 
a desired task. In this manner, biomaterials scientists are leveraging biologic 
understanding to design materials that are structurally simple, yet functionally 
complex in order to communicate with, react to, and synergize with biology to 
address clinical needs. This section articulates the concept of biocomplex 




Figure 1.3. Biologically complex materials. Biocomplex biomaterials interact with and 
direct cells both internally and externally. For example, advanced drug delivery vehicles 
introduce exogenous nucleic acid content to up- or down-regulate protein expression by 
transporting sensitive biomolecules through the circulation, actively targeting specific 
cells, and releasing the therapeutics into the cytoplasm. In addition, biocomplex materials 
are designed to present external signals to cells, either those that are delivered with the 
matrix or those that are recruited exogenously. These biomaterial niches can be loaded 
with multiple cues, presented in concert or sequentially, to communicate, recruit or signal 
to cells locally. For example, immune activating materials cooperate with native biological 
signaling to recruit naïve immune cells to a site in the body, activate them with target 
antigens, and equip them to target specific cells or tissues, such as malignant tumor cells. 
 
1.4.1 Materials to Deliver Therapeutics 
Bioinert micro- and nanocarriers that achieve long circulation times in the blood 
have transformed parenteral administration of small-molecule drugs 85,86. Potent 
macromolecular biotherapeutics (e.g., antibodies, recombinant proteins, and 
nucleic acids) have been identified that treat a variety of diseases at the molecular 
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scale; however, because of their nature, they present unique challenges for 
delivery. For example, translation of these therapeutics requires carriers that not 
only circulate for extended periods of time, but also shield the sensitive molecular 
cargo from degradation in the bloodstream, target specific cells or tissues, and 
release cargo at the appropriate site of action. Additionally, the design of 
biocomplex nanocarriers that address these challenges must be balanced by the 
need for structural simplicity that enables reproducible manufacturing. 
Some of the most clinically relevant biotherapeutics, whose efficacy hinges on 
the design of biocomplex delivery systems, are nucleic acids (NAs). NA-based 
therapies, such as ribonucleic acid (RNA) interference (e.g., microRNA (miRNA) 
or short interfering RNA (siRNA)) draw inspiration from native mechanisms and 
regulation in the transcription and translation of genetic material into protein. RNA 
interference is a native avenue for post-transcriptional silencing of gene 
expression, whereby miRNA or siRNA selectively prevent protein synthesis87. In 
addition, exogenous messenger RNA (mRNA) can induce the production of 
specific proteins to upregulate protein expression 88. Since NA-based therapies 
alter intracellular machinery, their efficiency relies on cytoplasmic delivery. 
Moreover, these biomolecules are particularly sensitive to in vivo conditions, 
exhibiting very short half-lives before biochemical decomposition is observed. 
Therefore, successful translation requires a delivery vehicle that offers protection 
from clearance or nuclease degradation, site-specific targeting, passage across 
the cellular membrane, and endosomal or lysosomal escape89,90. 
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Toward this end, biocomplex polymeric and lipid-based nanoparticle 
formulations have been developed to deliver NAs intravenously, some of which 
have progressed to clinical trials (Figure 1.3)91. Specific advances have focused 
on stable nucleic-acid lipid particles (SNALPs) and ionizable lipids that package 
NAs and increase transport across the cell membrane89,90. The majority of NA 
nanocarriers unintentionally accumulate in the liver, and to overcome this issue, 
lipid structures have been recently developed that allow for selective passive 
targeting of heart, lung, and vascular endothelial tissues92. Targeting to tumor cells 
has been achieved by functionalizing the surface of delivery vehicles with ligands 
that bind specifically to proteins that are selectively expressed on the surface of 
tumor cells 93. A major challenge that remains in the clinical use of NA therapeutics 
is their escape from endosome or lysosomes into the cytoplasm. To address this 
issue, Sahay et al. identified NPC1 as a critical protein in the trafficking of lipid 
nanoparticles that can be exploited in the design of materials that better escape 
the endosome94. 
 
1.4.2 Materials to Present Matrix Cues 
The fields of tissue engineering and regenerative medicine rely on the 
proliferation and maintenance of human cells outside of the body. Seminal culture 
scaffolds have been designed to permit cell survival and proliferation, but are 
inherently passive. While these bioinert scaffolds provided a route to maintain and 
culture cells, recent improvements in scaffold design integrate biofunctional 
aspects of the native signaling landscape 95. In vivo, cells integrate a complex array 
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of signals from the extracellular environment that synergize with the genetic code 
to instruct cell function, such as proliferation, phenotype, and differentiation. As 
discussed, ECM cues include both biophysical and biochemical signals that vary 
on multiple length and time scales. Additional signals are introduced by 
neighboring cells via cell-cell contacts or secreted cytokines and growth factors. 
Biocomplex 3D culture matrices seek to recapitulate critical ECM cues and cell-
cell signaling events through spatiotemporal control over matrix mechanics and 
ligand presentation 96. Toward this goal, both static and temporally controlled 
presentation of adhesive ligands has been exploited to bias chondrogenic 
differentiation of hMSCs30,97. In addition, dynamic control over substrate modulus 
has been leveraged to reveal new mechanism of ‘mechanical memory’, bias 
differentiation of mesenchymal stem cells, and mature cardiomyocytes28,98-100. 
In another approach to communicate with cells, researchers have developed 
biocomplex materials that exploit the language of the immune system to treat and 
detect disease (Figure 1.3). These strategies utilize an understanding of how the 
immune systems senses a foreign substance, arms itself for attack, and carries 
out the attack. Mooney and coworkers demonstrated implantable devices that 
interact with the immune system to suppress tumor growth101; specifically, 
chemotactic factors were released locally to recruit dendritic cells, that were then 
activated by local presentation of tumor antigens, which then instructed the 
immune system to target cancer cells. An alternative approach employs implanted 
materials to cooperate with the immune system to prime a pre-metastatic niche for 
the recruitment of metastatic cells, preventing distal metastases and enabling early 
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detection of cancer. Further, a suite of synthetic vaccines have been developed 
similarly that communicate with immune cells to increase immunogenicity and, 
ultimately, vaccine efficacy102. 
 
1.4.3 Materials for Tissue Integration 
Beyond intracellular and extracellular signaling, biocomplex materials have 
been designed to orchestrate multicellular events. For example, Miller et al. used 
3D printing of sacrificial sugar networks embedded within hydrogels to fabricate 
vascularized neo-tissues36. Culver et al. employed laser writing of adhesive 
peptides to instruct multicellular organization for the fabrication of vascular 
networks within hydrogels103. Further, gradient biomaterials that present 
biochemical ligands in a spatially defined fashion have been used to recapitulate 
osteochondral and osteotendinous interfaces104,105. 
Despite these in vitro advances, a major hurdle in the clinical utility of 
implantable biomaterials (including joint replacements, smart drug delivery 
materials, and cell carriers) is non-specific protein adsorption and the 
accompanying foreign body response (FBR)106. No implanted material is truly 
bioinert; proteins rapidly adsorb to the surface of biomaterials in the body with 
random orientations and configurations106,107. Early, this proteinaceous layer 
facilitates neutrophil adhesion and activation106,107. With time, macrophages fuse 
to form foreign body giant cells that attack the implant surface while recruiting 
fibroblasts, which deposit ECM and form a dense, fibrotic capsule that isolates the 
implant from the surrounding tissue108. As a more clear picture of implant rejection 
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has developed, the community has begun to present an array of biocomplex 
materials that mitigate the FBR and assist integration with resident tissue. For 
example, Jiang and colleagues developed Zwitterionic hydrogels that demonstrate 
ultra-low protein fouling109, and the surface chemistry and nanotopography of 
implant surfaces has been designed to limit macrophage activation106. Ratner and 
colleagues further showed that implant porosity can be exploited to tune the FBR 
and tissue integration110. While these advances demonstrate that biocomplex 
materials can assist in the organization of multiscale tissues, clinical translation 
remains hindered by an incomplete understanding of which critical signals to 
present and integrate within biocomplex scaffolds. 
 
1.5 Moving into the Future 
There are thousands of different types of medical devices, diagnostic kits, and 
pharmaceutical formulations that exist today as a result of advances in biomaterial 
science and engineering. The polymers and soft biomaterials employed are 
diverse in their origin, classification, and properties, and many products integrate 
multiple components that are carefully selected for their performance and function. 
Yet, as we look towards the future, the design of soft biomaterials is unifying 
around concepts that include: hierarchy, complexity, dynamics and adaptation, as 
well as healing111, and to realize this potential, better experimental methods 
and modeling tools are needed so that we can understand how to synthesize and 
engineer advanced biomaterials systems. While modern chemistry allows the 
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synthesis of polymers with controlled molecular weights, defined sequences, and 
integrated biological functionality, biomaterial systems depend on how these 
structural elements assemble and interact at complex biological interfaces, as 
this hierarchy ultimately dictates performance and function. 
The biomaterials that are native to our body (e.g., the ECM) are profound in 
their ability to remodel, adapt, and store and retrieve information; this is critical 
during processes such as development, growth, and wound healing. While 
biomaterials do not need to mimic all aspects of the complexities of a living 
organism112, understanding the fundamentals of these processes unlocks future 
opportunities in rational design of biomaterials. Contemporary research topics 
include the development of healable materials, drug delivery systems that interact 
with and deliver their contents in response to signals from cells, active materials 
that promote healing of tissues that could not otherwise occur, medical devices 
that integrate seamlessly with tissues at the implant site, and stealth nanosystems 
that serve as sentinels to monitor and treat disease. Many of these developments 
occur and will continue to revolve around multidisciplinary institutes and 
environments that eliminate barriers and bring together chemists, biologists, 
engineers, and clinicians, that bridge the academic-industrial divide, and engage 
researchers on a global scale. 
Key to all of these advances will be synthetic tools that allow control of 
biomaterials from the molecular to the macro, for patterning and dynamically 
revealing biological functionalities, and for engineering biocomplex materials with 
enhanced properties, desired stability, and loaded with the biological signals 
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delivered in the right context, locality, and time. Importantly, all of this must be 
achieved in a manner that allows manufacturing at large scales and that 
overcomes any regulatory challenges with the translation of new materials. 
Biological complexity demands better tools to characterize changes in material 
properties in situ, from molecular level features of degradation to structural 
changes and functional properties. The body is a dynamic environment, so 
biomaterials constantly experience changes that alter performance, and this 
highlights the profound need for methods to allow tracking of biomaterials in 
physiologically complex niches and/or improved in vitro assays that allow better 
prediction of in vivo performance. Finally, to facilitate the discovery process, 
methods to screen and model the broad and diverse experimental space is critical. 
Clearly, rational material design will remain an important and leading approach of 
the community, but combinatorial and high-throughput strategies that are 
complemented by biological assays will allow mining of huge data sets to evolve 
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Specific Aims and Research Overview 
 
2.1 Introduction and Specific Aims 
The medical importance of soft biomaterials has motivated the development of 
innumerable materials systems, many of which have been introduced in the 
preceding introduction. Despite these advances, injectable hydrogels have been 
confined largely to thermoresponsive and covalently crosslinked systems, placing 
constraints upon the delivery methods allowed as well as the tunability of the 
material properties relevant to both in vitro and in vivo applications.1-3 While 
covalently crosslinked hydrogels have the potential to achieve greater moduli 
(>250 kPa) than physically crosslinked materials, suitability toward percutaneous 
delivery (i.e., syringe or catheter injection) for clinical translation remains 
challenging, in part due to crosslinking kinetics. Rapid crosslinking results in 
delivery failure, while slow crosslinking limits material retention at the injection 
site.4,5  
In contrast, physically crosslinked hydrogels have the potential for formation of 
solid hydrogels (i.e., in a syringe) that can be subsequently injected through shear-
thinning of the hydrogel into a liquid state (within the needle) and then self-heal 
(i.e, re-form a solid gel) for localization within the tissue.6-9 Despite the great 
potential of shear-thinning hydrogel systems as injectable therapeutic systems, 
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such materials typically exhibit low mechanical strength (moduli <1kPa), slow 
healing, and stochastically controlled degradation on the order of hours to days.9,10  
With these challenges in mind, the goal of this dissertation was the 
development and characterization of a shear-thinning and self-healing hydrogel 
system capable of injection. Hydrogels were designed to harness guest-host (GH) 
interactions to form supramolecular assemblies through complexation of 
hyaluronic acid (HA) separately modified by adamantane (Ad-HA, guest) and β-
cyclodextrin (CD-HA, host). Importantly, the system is synthetically tractable, 
enabling scalable synthesis and tunability of material properties.  
To bolster the therapeutic utility of these materials, the physical properties were 
tuned through various modifications of the guest-host hydrogel system, including: 
(i) introduction of protease-degradable peptides between the HA and guest 
molecule, (ii) dual-crosslinking (DC) of methacrylated CD-HA (CD-MeHA) and 
thiolated Ad-HA (Ad-HA-SH) by Michael addition subsequent to GH assembly, and 
(iii) formation of double network (DN) hydrogels through assembly of GH hydrogels 
in the presence of an interpenetrating covalent network (methacrylated HA, 
MeHA). Application of these supramolecular guest-host (GH) and dual-
crosslinking (DC) hydrogel systems was further investigated towards treatment of 
myocardial infarction (MI), demonstrating their potential in an application where the 
precise delivery of hydrogels with tunable properties is desired. To systematically 
address the development, characterization, and employment of these materials 
systems, the following aims were developed.  
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Specific Aim 1: Develop and characterize guest-host (GH) hydrogels capable 
of injection. 
Hypothesis: Complementary macromers with physically associating chemical pairs 
will enable formation of injectable supramolecular hydrogels with tunable 
properties. 
HA was separately modified by adamantane (Ad-HA, guest) and β-cyclodextrin 
(CD-HA, host), enabling non-covalent GH hydrogel assembly by simple mixing of 
the two polymer solutions in water. The tunability of GH hydrogel properties was 
investigated by rheological, degradation, and biomolecule release studies. 
Characterization of the GH hydrogel microstructure was further examined in the 
hydrated state by fluorescence microscopy and micromechanical characterization, 
elucidating the heterogeneity of supramolecular assembling materials that may 
evolve temporally. Finally, bioactive degradation of GH hydrogels was achieved by 
introducing an enzymatically-degradable peptide sequence to link Ad to HA, and 
both in vitro and in vivo hydrogel erosion was monitored in comparison to non-
degradable peptide controls. These investigations develop the GH hydrogel 
system and a base understanding of its tunable biophysical properties.  
 
Specific Aim 2: Develop dual-crosslinking (DC) hydrogels capable of both 
guest-host assembly and secondary covalent crosslinking in situ on 
clinically relevant timescales. 
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Hypothesis: Properties of guest-host hydrogels can be modulated by tandem 
covalent crosslinking in situ via Michael addition. 
Dual-crosslinking (DC) hydrogels were developed to address the low moduli 
and rapid erosion typical of supramolecularly assembled hydrogels. Here, 
thiolation of Ad-HA and methacrylation of CD-HA allowed a secondary covalent 
crosslinking tostiffen the hydrogel in situ. To allow for sufficient time for injection, 
reactions kinetics were tuned through choice of the Michael acceptor and reaction 
conditions. Properties of the DC hydrogels were evaluated, relative to GH 
hydrogels, through mechanical characterization, degradation analysis, and in vitro 
tissue injection. A rodent model of MI was used to establish the potential for 
therapeutic use, which is expanded upon in Aim 3.  
 
Specific Aim 3: Assess the therapeutic potential of guest-host and dual-
crosslinking hydrogels to attenuate LV remodeling in an ovine infarct model. 
Hypothesis: GH hydrogels will enable facile percutaneous delivery, and 
subsequent dual-crosslinking will mitigate post-MI remodeling through mechanical 
stabilization of the infarct. 
The overall goal of this Aim was to develop a preventative therapy for heart 
failure, through attenuation of adverse LV remodeling post-MI by targeting 
abnormal stress distributions in the myocardium that are known to result in 
myocardial thinning and infarct expansion. To accomplish this, direct epicardial 
injection of the GH and DC systems was employed in an ovine model of 
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posterolateral MI, with evaluation relative to saline injection controls. 
Computational modeling was performed to predict the ability of hydrogel injections 
to alter myocardial stress, and the efficacy of the therapy toward attenuating LV 
remodeling was assessed through longitudinal measurement of ventricular 
geometry and function. The prevention of mitral regurgitation, a direct result of 
ventricular dilation, was investigated by echocardiographic and MRI methods. 
Additionally, percutaneous endocardial injection of the hydrogels was performed 
with guidance by fluoroscopy and intracardiac echocardiography. 
 
Specific Aim 4: Develop injectable, cytocompatible, and tough 
supramolecular double network (DN) hydrogels through tandem guest-host 
and covalent crosslinking reactions. 
Hypothesis: Interpenetration of supramolecular and covalent networks will enable 
formation of tough cytocompatible double networks. 
To expand the attainable mechanical properties of DC hydrogels, the tandem 
supramolecular-covalent crosslinking approach was explored in the context of 
double networks. GH hydrogels were formed with an interpenetrating network of 
methacrylated HA (MeHA) covalently crosslinked by dithiothreitol. Additionally, 
partial methacrylation of the GH hydrogels was performed to explore tethering of 
the two polymer networks. The bulk properties of the double network hydrogels 
were examined by a combination of shear, compressive, and tensile mechanical 
testing, including moduli, failure stress, toughness, and self-healing capacity. 
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Methods for cytocompatible hydrogel crosslinking were developed, based upon a 
highly efficient phosphine catalyst, and long-term viability of encapsulated 
mesenchymal stem cells (MSCs) was assessed in vitro. 
 
2.2. Research Overview 
Chapter 1 has provided perspective on recent developments in polymeric and 
soft materials that have occurred in recent decades, including modern thinking in 
biomaterial design and therapeutic applications. Building upon this general 
background, Chapter 3 provides an in depth review of supramolecular hydrogels 
— specifically, those formed through guest-host macrocycle interactions. 
Particular attention has been given to the hydrogel structure, formation, properties, 
and applications relevant to recent progress and remaining challenges in the field.  
Chapter 4 outlines the development and characterization of a synthetically 
tractable and easily scalable supramolecular hydrogel, based on the guest-host 
interaction of hyaluronic acid (HA) modified by coupling of 1-adamantane acetic 
acid (Ad-HA, guest) or aminated β-cyclodextrin (CD-HA, host). This guest-host 
(GH) hydrogel serves as the base material system that is explored throughout the 
dissertation. Specifically, while Chapter 4 develops an understanding of self-
assembly at the molecular scale, Chapter 5 furthers develops understanding of the 
microscale heterogeneity of these GH hydrogels with dependence on time and 
hydrogel composition. While GH hydrogels undergo passive stochastic erosion, 
Chapter 6 introduces a responsive hydrogel degradation mechanism through 
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inclusion of peptide linkers susceptible to proteolysis, relevant to applications in 
drug delivery. Chapter 7 then further develops GH hydrogels where mechanical 
stiffness and degradation behavior are easily modulated in vivo by addition of 
secondary covalent crosslinking (i.e., dual-crosslinking, DC). Applications toward 
treatment of MI are explored in a rodent model, establishing the utility of the GH 
and DC hydrogel systems.  
Application of GH and DC hydrogels as a preventative therapy for heart failure 
following myocardial infarct is further explored in Chapters 8, with application to a 
large animal MI model. Specifically, the percutaneous delivery of GH hydrogels via 
catheter-based intramyocardial injection is demonstrated, and metrics of left-
ventricular (LV) remodeling, such as thinning and dilation associated and resultant 
decline in myocardial function are assessed. Additionally, the work explores the 
role of these hydrogels in prevention of ischemic mitral regurgitation (MR), which 
is a devastating secondary consequence of LV remodeling.  
Toward further harnessing of the unique crosslinking within this system, the 
dual-crosslinking is further explored in Chapter 9 in the context of interpenetrating 
networks. Characterization of hydrogel toughness, self-healing, injectability, and 
cytocompatibility are performed. Finally, Chapter 10 provides a summary of the 
work presented, illuminating the overall impact of the GH hydrogel system upon 
the materials science and biomaterials fields. Limitations of these material systems 
are discussed, and potential future directions are proposed that may further 
expand the use of these supramolecular hydrogels, including toward clinical 
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3.1 Introduction 
While chemists have traditionally focused on methods of assembling atoms and 
molecules through the formation and rearrangement of covalent bonds, it has been 
elegantly noted that this strategy pales in comparison to the array of possible 
interactions utilized in nature to develop large, complex molecular structures 
through non-covalent bonds.1 These interactions are encompassed within the field 
of supramolecular chemistry, which includes electrostatics, hydrogen bonding, van 
der Waals forces, п-п interactions, and hydrophobic or hydrophilic attraction for 
molecular assembly.2 While such interactions have long been known, the field has 
continued to rapidly expand since the 1987 Nobel Prize was awarded to 
Pedersen,3 Cram,4 and Lehn5 for their pioneering work in formalizing synthetic 
methods in this area.  
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Lehn described the concept of supramolecular assembly as “chemistry beyond 
the molecule.” 5 This is because the non-covalent nature of supramolecular bonds 
renders them inherently weaker than covalent bonds and they may therefore 
exhibit thermodynamic or forcefully induced rearrangement. As a result, 
supramolecular bonds display a capacity for directed assembly at length scales far 
exceeding that of single atoms or molecules, such as with the formation of higher 
order structures in biological proteins and tissues. The capacity for spontaneous 
and reversible binding between molecular species is likewise a driving force in the 
development of structured,6-8 dynamic,9 and self-healing10 materials, as well as in 
pharmaceutical applications11-13 and directed cell-material interactions which will 
be discussed herein. 
One particular subset of supramolecular chemistry, namely guest-host 
interactions, is of particular interest toward the biomedical community. These 
bonds are based on the transient association of a molecule containing a cavity (i.e. 
a cavitand) with suitable molecular guests. The family of cavitands includes both 
naturally-derived (e.g. cyclodextrin) and synthetic (e.g. cucurbit[n]urils, 
calix[n]arenes, and pillar[n]arenes) macrocycles.12,14-16 The criteria for a guest-host 
pair involves complementary size of the host cavity and guest molecule, as well as 
their specific interactions (predominantly through hydrophobic attraction).17,18 
These broad criteria lend themselves to the pairing of macrocycles with numerous 
potential guests, which may be inert or stimuli-responsive molecules, 
pharmaceuticals, biomolecules (i.e. peptides, proteins), polymers, or other 
chemical species. Owing to the array of guest and host molecules and their 
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synthetic flexibility, incorporation of these groups into polymeric materials may be 
easily achieved for a diverse range of biomedical applications. Despite recent 
developments in polymeric guest-host materials, there remains a tremendous 
capacity for growth in the biomaterial utilization of these unique chemistries. 
Toward elucidating these future directions, this review will highlight recent 
advances in both our understanding and application of materials and interactions 
mediated by guest-host macrocycle assembly.  
 
3.2 The Structure of Self-Assembly 
3.2.1 Direct Molecular Recognition 
Supramolecular assembly may be ambiguous, with non-specific interactions 
between numerous groups. Examples of such interactions in material assembly 
include the formation of hydrophobic crystalline domains or charge-based 
assembly of polyelectrolyte or polyampholyte polymers. These interactions may 
be preferable in some cases, such as to facilitate incorporation of hydrophobic19,20 
or charged drugs21,22. However, such assembly processes involve development of 
long-range order over relatively long timescales, which may hamper rapid 
formation and recovery. Moreover, the prevalence of competitive binding groups 
(i.e. any non-charged molecule, salts) may disrupt bond formation and material 
assembly. Thus, it is important to define supramolecular interactions that have 
more specific associations to fabricate robust materials for biomedical interactions. 
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Toward this, direct associating systems are based on specific molecular 
recognition of a guest by its corresponding host molecule upon mixing (Figure 3.1). 
Such direct interactions do not require long-range order and therefore occur 
rapidly, with timescales governed by the association constant (ka), enabling rapid 
initial material formation and self-healing upon rupture. Numerous molecular 
structures have been identified and designed to form guest-host pairs. These 
include the relatively weak association of crown ethers, cryptands, and related 
molecules;23,24 though, such associations are generally more suited for ionic 
sequestration and not molecular recognition. Alternatively, an array of transient 
peptide and/or protein interactions have been devised,25-29 which often display 
greater affinity and specificity, but at the cost of increasing complexity and 
laborious synthesis. Finally, the guest-host macrocycles combine rapid, high 
affinity molecular recognition with ease and scalability of synthesis.  
Of the guest macrocycles, cyclodextrin (CD) is the most prevalent due to its 
relatively high water solubility, low toxicity, and extensive history of use. The first 
reference to CD was that of Villiers, in 1891, who isolated a crystalline substance 
following bacterial digestion of cellulose.30 While research continued on the 
formation and characterization of these crystalline dextrans, nearly half a century 
passed before their cyclic structure was proposed (D-glucose units arranged in a 
toroidal fashion through α-1,4 glycosidic bonds) and isolation of homogenous 
fractions of α, β, and γ cyclodextrin (which contain 6, 7, or 8 repeat units, 
respectively) was accomplished.14 Importantly, improvements toward these 
synthesis and purification processes have proceeded to industrial scale, as have 
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many strategies for their synthetic modification, resulting in a relatively cheap and 
abundant material source.14,31 Enabled by the scalability of synthesis, CD 
molecules are used in a variety of industrial, commercial, and pharmaceutical 
applications and have been categorized by the Food and Drug Administration as 
“generally recognized as safe” (GRAS).32-34 Moreover, the cavity sizes of CDs 
allow them to include a range of guest hydrophobic molecules in its interior. Of 
these potential guest molecules, adamantane (Ad) is widely regarded as having 
one of the greatest affinities (Keq ≈ 105 M-1) due to its complementary size for βCD 
and high hydrophobicity.35 Alternatively, responsive guest-host interactions have 
emerged as a means of regulating these intramolecular interactions. These include 
azobenzene and ferrocene, which are known to interact with numerous species of 
CD and are responsive to light36 and redox conditions,37,38 respectively. This 
behavior renders them particularly useful toward the development of responsive 
delivery vehicles,39 actuating materials,40,41 and dynamically assembling 
systems.42-44  
More recently, alternate cavitands have emerged and demonstrated relevance 
toward biomedical applications. This second generation of cavitands includes 
cucurbit[n]urils (CBs), pillar[n]arenes, and calix[n]arenes. While CBs were first 
prepared in 1905,45 investigation of their structure was not performed until 1981,46 
and numerous CBs (typically 5-10 repeat units) have since been explored. Recent 
examination has revealed mild in vitro toxicity of these groups, though only at 
doses far exceeding those typical in vivo, supporting their continued 
pharmaceutical used.47 Binding affinities for CBs are often greater than that of 
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other cavitands and can reach values as high as Keq ≈ 1015 M-1.48 This may be 
attributed, in part, to the binding of guest molecules through a combination of 
hydrophobic and cation-dipole interactions.48-50 Moreover, the unique geometry of 
CB[8]s allows for multivalent binding of guest molecules (such as naphthalene and 
methyl viologen), which enables reinforcement of binding affinity by cooperation 
between п-п stacking or charge-transfer interactions for guest-host complex 
formation.51 Recently, the use of the cup-shaped calix[n]arenes and pillar-shaped 
pillar[n]arenes toward biomedical applications has begun.12 Their translation to this 
field has been previously hampered both by lower guest-host affinity and water 
solubility when compared to their CD and CB counterparts; though, recent work 
has sought to improve the affinity and water solubility of these macrocycles such 
as through repeated and efficient modification by solubilizing functional groups,52 
resulting in macrocycles with improved utility in aqueous environments.  
 
Figure 3.1. Molecular guest-host assembly. (A) Generalized schematic of host (red) 
interaction with its corresponding guest (blue) to form a guest-host complex (purple), with 
bonding equilibrium governed by the association (ka) and dissociation (kd) constants. (B) 
Schematic representation of cavitand host species, represented by pillar[5]arene, 
calix[4]arene, cyclodextrin, and cucurbit[n]uril.  
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3.2.2 Polymeric Assembly 
Guest-host molecular recognition is particularly useful for the formation of 
supramolecular structures (i.e. guest-host hydrogels). Toward hydrogel formation, 
pioneering work by Harada demonstrated that poly(ethylene oxide) (PEO) could 
be threaded within multiple αCD moieties, yielding a rotaxane structure.53 Pursuit 
of such systems further illustrated the formation of pseudopolyrotaxanes and a sol-
gel transition upon simple mixing of PEO and αCD through crystallization of CD 
domains (Figure 3.2A).54 These and similarly formed pseudopolyrotaxanes, such 
as through pendant polymer modification with PEO or similar polymers (Figure 
3.2B), have since become a basis for supramolecular assembled hydrogels which 
have been separately reviewed.55 Such systems may be limited in therapeutic use, 
due to long recovery times after injection,56 which may hinder injection site 
retention, and the inaccessibility of CD in the network to interact with surrounding 
molecules.  
Alternatively, modification of polymers with guest and host groups (either as 
end-groups or pendant modification) has become the primary method for 
fabrication of supramolecular networks from guest-host interactions. For example, 
the end-modification of mono- and bifunctional polymers has been examined 
(Figure 3.2C), where potential applications may include the self-sorting of linear 
supramolecular polymers or assembly of block copolymers with utility toward such 
materials as responsive micelle assembly.57-59 In extension of this methodology, 
multiarm PEO has been modified with either βCD or cholesterol (the guest 
molecule) and van de Manakker and colleagues demonstrated formation of 
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supramolecular hydrogels by mixing these precursors with controllable rheological, 
erosion, and cargo release profiles. 60,61 Similarly, Charlot et al. extensively 
explored the rheological behavior of binary associating systems by conjugating 
βCD and Ad to chitosan, hyaluronic acid (HA), and other polymers as pendant 
groups (Figure 3.2D). While low modification resulted in weak supramolecular 
networks (typical G’ < 100Pa), their results demonstrated the importance of 
polymer concentration, charge, and competitive binding on network assembly.62 
Moreover, theoretical and experimental approaches have been combined to 
illustrate the importance of multivalent and inter-polymer interaction to generate 
high avidity and network stability.63,64 Toward harnessing this understanding, our 
group has demonstrated that higher degrees of modification of HA with these same 
guest-host groups enables formation of more robust supramolecular hydrogels (G’ 
= 10 kPa possible) through generation of larger net avidity between polymers 
which may be enhanced by multifold polymer junctions.65  
CB macrocycles have also been explored to produce robust supramolecular 
hydrogels. This work has been pioneered by the Scherman group, where polymers 
were modified with pendant methyl viologen or napthoxy derivatives that form 
ternary complexes with soluble CB[8] with high affinity (Ka ≥ 1011 M-2, Figure 3.2E). 
Such materials resulted in good network mechanical properties (typical G’ > 
500Pa) even at low polymer modification (5-10% of repeats).66,67 For further 
information regarding polymer architecture and molecular organization in guest-
host hydrogels and their influence on bulk hydrogel properties, the reader is 
referred to extensive reviews that cover these topics.2,68 
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Figure 3.2. Schematic representation of guest-host polymeric assemblies. (A, B) 
CD-PEO pseudopolyrotaxanes; (C) supramolecular polymers from heterobifunctional (i), 
homobifunctional (ii), and monobifunctional (iii) gelators; (D) separate, pendant 
modification by βCD and adamantane; and (E) separate, pendant modification of polymers 
by methyl viologen or napthoxy derivatives with crosslinking by ternary complexes with 
soluble CB[8]. 
 
Beyond the ability to assemble into networks, supramolecular guest-host 
interactions may be used to introduce structure at the nano- and micro-scales. 
Indeed, the organization of many natural structures is driven by supramolecular 
interactions, such as native extracellular matrix (e.g., fibrillar structure of collagen) 
and the DNA superstructure. Such aspects may be recapitulated by synthetic 
analogues.69,70 Observations of such behavior have been noted in numerous self-
assembling systems including peptide amphiphiles71, DNA-based hydrogels72, 
dendritic materials8, and PEG-based supramolecular systems73. In recent years, 
there have been numerous reports indicating that similar hierarchical structures 
are possible in guest-host hydrogels, though most include only observation of dried 
samples by electron microscopy. Recent reports have shown the formation of 
nanoparticles with well controlled size through synthesis of diblock copolymers 
 53 
containing βCD.74 Moving this structure into two-dimensional assembly, semi-rigid 
four-arm macromolecules have been modified by methyl viologen and 2,6-
dihydroxynaphthalene which assemble into two-dimensional films upon mixing 
with CB[8] in water. Both TEM and AFM confirmed a nanofibrillar structure, and 
SAXS estimated the spacing of these features to be well approximated by the 
theoretical pore size.75 In an interesting example of three-dimensional structure, 
aggregation of N-isopropylacrylamide (NIPAAM) thermogels has been controlled 
by introducing CB[7] as polypseudorotaxane side chains. Such inclusion results in 
semi-rigid polymer segments that induce transition from a globular to porous 
morphology that could be observed by optical microscopy in a hydrated state.76 
Control of physical structure on these length scales holds great promise for the cell 
biology and biomaterials fields, as dynamic self-assembly of these structures may 
best recapitulate the natural processes that drive cell behavior. Though, systematic 
studies including the effects of polymer architecture, bond affinity, and other 
variables are still lacking.  
 
3.3 Diverse Biomedical Applications 
3.3.1 Injectable Hydrogels 
Injectable materials have become important in the biomaterials community as 
they can be introduced in a minimally invasive manner through direct injection into 
a tissue or via catheters. Many methodologies exist for formation of injectable 
materials, including in situ gelling via initiated or autonomous polymerization, 
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addition crosslinking, or thermogelation; however, there are numerous limitations 
to such systems based on gelation kinetics (i.e. too fast leads to clogging of 
delivery device, too slow leads to material dispersion upon injection). Alternatively, 
guest-host hydrogels may be formed prior to injection (Figure 3.3A, i) and extruded 
via shear-induced flow. Such shear-thinning properties are of interest for numerous 
supramolecular hydrogels,77 due to their dynamic bonds that can be broken and 
then reformed. Many practical requirements should be considered when designing 
guest-host hydrogels as deliverable materials, such as the injection process (i.e., 
ease of injection and capacity for retention), as well as the subsequent physical 
properties after injection (i.e., suitable moduli and degradation times).  
 
Figure 3.3. Guest-host hydrogel injection. (A) Hydrogels are pre-formed within the 
syringe through guest-host bonds (i) which are broken by shear stress (τ) within the needle 
(ii). Following extrusion, bonds rapidly re-form (iii) to enable retention within the tissue. 
Subsequent disassembly of the hydrogel in vivo occurs through spontaneous dissociation 
of the dynamic bonds and resultant surface erosion of the polymer (iv). (B) Representative 
oscillatory time sweep demonstrating initial hydrogel mechanics (i), yielding to enable flow 
under high strain (ii), and rapid recovery (iii) such as that proposed for injection. Adapted 
from (Rodell et al, 2013) with necessary permissions.   
 
For shear-thinning materials, the injection process is governed by the material 
response to shear stress; ideally, the material is pre-formed and then exhibits a 
decrease in viscosity (i.e., shear-thinning) during injection that permits flow. 
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Indeed, this is the case for the majority of supramolecular materials, as the physical 
bonds that permit assembly are temporarily broken (Figure 3.3A, ii). The kinetics 
of bond formation, though, are of key interest to the shear response of hydrogels. 
Craig and coworkers extensively studied the relationship of bond kinetics and 
polymer relaxation timescales, demonstrating that disadvantageous shear-
thickening behavior arises if polymer relaxation occurs more rapidly than 
reconnection of broken crosslinks.78,79 As such, the decreased polymer relaxation 
may be accomplished through formation of multifold junctions in highly modified 
guest-host hydrogels to enforce shear-thinning behavior and ease of injection.80 
The physical chemistry underlying the flow process, as well as other fundamental 
behaviors of supramolecular networks have been recently reviewed.9 Beyond 
regulating flow properties, the binding kinetics are also essential toward material 
formation following injection (Figure 3.3A, iii), as rapid bond reformation is 
essential for material retention. In recent work, we demonstrated that rapidly self-
healing guest-host hydrogels are well retained (>98% of initial hydrogel volume) 
upon injection into myocardial tissue, whereas slowly crosslinking covalent 
controls were not retained as gelation was too slow.81 This high material retention 
is essential, including toward successful implementation of injectable materials as 
tissue supplements, drug reservoirs, or cell delivery vehicles as discussed in 
subsequent sections. 
Also critical to the success of injected biomaterials are the final properties in 
vivo, following injection. In many cases, material degradation may be desired to 
eliminate the need for implant removal or permanent implantation. Guest-host 
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assembled materials are of great utility toward this, as they undergo natural 
disassembly due to their dynamic bonds (Figure 3.3A, iv). Thus, their rate of 
degradation can be controlled through features such as material concentration, 
guest-host affinity, and number of guest-host bonds.61,80 Additionally, the 
degradation rate of such materials may be altered by inclusion of conventional 
degradation mechanisms, including hydrolysis or enzymatic degradation. Toward 
such control of degradation, Tian et al utilized a hydrolytically degradable 
poly(organophosphazine) backbone grafted with PEO of differing molecular 
weights. In the presence of soluble αCD, hydrogels were formed which exhibited 
controlled release of bovine serum albumin (BSA) over a period of 2-12 days, with 
concurrent and prolonged hydrogel degradation.82 More recently, bioactive 
degradation mechanisms have been demonstrated; in one embodiment, micelles 
and hydrogels were formed through inclusion of glutathione in the micelle core to 
enable bioreduction of the polymeric structures which effected release of 
doxorubicin.83 Additionally, pendant Ad modification of HA has included a peptide 
linker susceptible to cleavage by matrix metalloproteinases (MMPs) that are 
naturally produced in remodeling of the extracellular matrix. When combined with 
pendant modified βCD-HA, hydrogels were formed which exhibited enhanced 
degradation in the presence of mammalian MMP-2.84 These means of degradation 
are of interest to the biomedical community to ensure clearance of the eroded 
materials (e.g. failed renal clearance of high molecular weight PEO may limit 
applicability of αCD-PEO hydrogels without inclusion of such hydrolysis 
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mechanisms) and because bioresponsive degradation perpetuates such 
applications as on-demand drug release and tissue-material integration. 
As an alternative to enhanced degradation, prolonged material presence may 
be desirable. Many supramolecularly assembled materials degrade in the course 
of days, which may be too rapid for numerous applications in cell delivery or tissue 
repair. One approach to achieve improved degradation lifetimes is the use of 
higher affinity interactions, such as CB[8] with an electron transfer pair, which has 
enabled sustained release of biomolecules (BSA and lysozyme) for up to 160 days 
in vitro.85 Interaction of CB[6] and polyamine modified HA has also been used, but 
implantation was achieved not by shear-thinning injection but instead by sequential 
subcutaneous injection of the two components, with supramolecular assembly in 
vivo. Inclusion of fluorescently labeled CB[6] in the hydrogel demonstrated 
presence as long as 11 days, whereas the free fluorophore was released within 24 
hours as examined by in vivo fluorescence imaging.86 These approaches 
demonstrate the capacity for high affinity guest-host pairs to provide prolonged 
delivery of biomolecules by diffusion or through modular modification with the host 
molecule, though such high affinity guest-host interactions may limit shear-thinning 
properties, hindering their use as injectable materials.87 
Alternatively, the use of secondary stabilization chemistries, subsequent to 
supramolecular bonding, has been achieved to enhance mechanical stability 
without affecting injectability. Such processes have been accomplished in protein-
based supramolecular assembly using photopolymerization or thermogelation as 
secondary gelation mechanisms.28,88 To allow for in vivo crosslinking and long-
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term mechanical stability, we have recently introduced secondary crosslinking in 
vivo through autonomous Michael addition, enabling covalent crosslinking on 
clinically relevant timescales. Application in a rodent model of myocardial infarct 
(MI) demonstrated a capacity for mechanical stabilization of the injured tissue, 
tending to improve geometrical and functional outcomes relative to untreated MI 
or guest-host material controls without secondary crosslinking.81 Though, care 
should be taken in these approaches, as rapid covalent crosslinking may result in 
delivery failure. 
 
3.3.2 Therapeutic Delivery 
In addition to formation of injectable materials by guest-host mediated self-
assembly, these unique interactions have significant applications in drug delivery 
strategies. The most widely used materials in this field have been the CD 
macrocycles, as they have been used in many pharmacological drug formulations 
including Sporanox©, Yaz©, and Abilify© among others.89 CDs form inclusion 
complexes with various drugs, which improves the drug bioavailability by 
increasing drug solubility and protecting them from degradation, which has been 
reviewed extensively elsewhere.13,89,90 Guest-host interactions have also been 
used recently to develop materials as drug delivery systems, providing novel 
biofunctionality through non-covalent conjugation of bioactive pendant groups, as 
well as the development of bulk materials to provide the controlled release of 
growth factors, genetic material, and small molecule therapeutics. 
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While improving the physiochemical properties of drugs has prevailed in the 
translational application of guest-host complexes, more advanced nanoparticle 
systems are also being developed. These systems leverage the formation of 
guest-host complexes as a conjugation strategy to provide stealth or targeting, or 
to allow nanoparticles to carry hydrophobic payloads (Figure 3.4A). Work from the 
Davis group provides an excellent example of exploiting guest-host complexes in 
delivery systems that have translated to clinical trials.91 They developed CD 
functionalized polymer backbones that form polyplexes with siRNA payloads, with 
surfaces that may be decorated with Ad coupled macromolecules such as PEG or 
transferrin.92-94 This type of conjugation allows for rapid and modular modification 
of particle systems with a variety of ligands. Similar non-covalent conjugation 
strategies have been employed using other guest-host pairs such as CB[6] with 
polyamines to provide targeted delivery of nanocapsules.95,96 In addition to 
strategies for noncovalent surface modification, macrocycles have been 
incorporated into nanoparticles to act as molecular “docking” sites that can 
facilitate drug loading (Figure 3.4B). This carrier functionality has been exploited 
using amphiphilic CD nanocapsules to entrap tamoxifen, ionic βCD nanoparticles 
as doxorubicin carriers, and CB[6] particles to carry paclitaxel.96-98 Furthermore, 
macrocycle interactions have provided an avenue for direct, noncovalent 
conjugation of biofunctional groups to drug molecules (Figure 3.4C). As examples, 
βCD functionalized with lactoferrin and saccharide ligands has been used to 
complex and target drugs to lactoferrin and mannose receptors, respectively.99,100  
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In addition to nanoparticle strategies, guest-host systems have been leveraged 
in bulk hydrogels to provide controlled release of therapeutic payloads. Many 
groups have employed guest-host assembly to drive the formation of hydrogels 
that can provide sustained release of biomolecule payloads such as proteins and 
growth factors (Figure 3.4D). These systems provide diffusive release kinetics that 
may be tuned through network properties such as porosity, mesh size, and 
degradation, which may in part be mediated by dynamic supramolecular 
interactions. For example, Liu et al used polyrotaxane assembly between αCD and 
tri-block copolymers to form gels that display tunable sustained release of dextran 
molecules as a model for release.101 Furthermore, the Scherman group developed 
systems based on CB[8] assembly that provide tunable release of bioactive 
proteins over sustained periods in vitro, as previously discussed.85 Finally, work 
from the Hennink group as well as our own have shown tunable protein release 
from βCD-based hydrogels, where crosslink density was used to control release 
for up to 60 days.65,102 These applications have recently been extended in vivo, 
where the guest-host hydrogel was used as an injectable material for diffusive local 
delivery of multiple biomolecules (interleukin-10 and anti-transforming growth 
factor β) to treat chronic kidney injury.103 Similarly, hydrogels composed of αCD 
pseudopolyrotaxanes with PEO terminated block copolymers have been used as 
an injectable reservoir for delivery of erythropoietin (EPO) in a rodent model of MI. 
The therapy resulted in a tendency toward increased vascular density as well as a 
significant decline in apoptosis and increase in myocardial function (fractional 
shortening) as compared to saline, hydrogel alone, and soluble EPO injection. 
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These examples demonstrate the multifaceted use of such material systems as an 
easily prepared injectable material to generate diffusively controlled drug delivery 
reservoirs in vivo.  
A last mechanism by which guest-host interactions can control release of 
molecules is through inclusion effects of therapeutics with macrocycles anchored 
to a polymer backbone (Figure 3.4E). Several groups have investigated covalently 
crosslinked hydrogels containing CD pendant groups to provide sustained release 
of small molecules.104-109 In one example, the von Recum group developed 
polyurethane gels containing CD as device coatings for the controlled release of 
numerous antibiotics.110 Work from our own group has also explored CD retentive 
effects for controlled release of small molecules including doxorubicin, 
doxycycline, and peptides containing tryptophan residues, from guest-host 
assembled networks, leveraging these interactions to provide a material with 
simultaneous injectable and sustained release properties.109 These systems 
provide tunable small molecule release through the engineering of host content, 
as well as the guest affinity for the host included in the network.  
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Figure 3.4. Guest-host interactions in drug delivery systems. Guest-host chemistry 
may be used for direct, non-covalent modification of drug molecules with targeting ligands 
(A), to provide non-covalent modification of nanoparticle drug carriers with targeting or 
stealth ligands (B), and to impart molecular carrier functionality to nanoparticles (C). 
Furthermore, in hydrogel systems, guest-host chemistry may be used to tune crosslinks 
in hydrogels for the diffusive release of biomacromolecular therapeutics (D) or to promote 
retention of small molecule therapeutics within the hydrogel (E).  
 
3.3.3 Cell-Material Interactions  
While the above applications have targeted material implantation and 
therapeutic delivery through guest-host mediated assembly, still others have 
sought to develop methods for the direct modification of cell-material interactions 
using guest-host chemistry. These approaches to modulate cell-material 
interactions have primarily taken two forms: modification of material surfaces and 
the pursuit of material-assisted cell delivery.  
Surface modification strategies are useful to introduce various biophysical and 
biochemical signals to cells, and guest-host interactions provide an opportunity to 
introduce dynamic signals that can alter cell behavior. Stupp and colleagues 
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utilized the guest-host complexation of guest-bound adhesive peptide sequences 
to alginate-βCD surfaces to dynamically control biomolecule display.111 
Specifically, they utilized the fibronectin derived cell-adhesion sequence RGD 
bound to the guest molecule Ad or naphthalene, suspended in culture medium, to 
impart cell adhesion and spreading on the material surface. Importantly, spreading 
was observed to be dependent on the affinity of the guest for βCD and was 
reversible when napthyl-RGD was removed by competitive binding with the higher 
affinity non-cell adhesive sequence Ad-RGES. In concurrent work, the Cooper-
White group used supramolecular interactions to display RGD in nanopatterned 
topographies produced by the segregation of Ad terminated polystyrene-co-PEO 
block copolymers (PS-PEO-Ad).112 Such topographies are known to influence cell 
behaviors, including adhesion, spreading, and differentiation.113-115 The ratio of 
PS-PEO/PS-PEO-Ad used to control the concentration of βCD-RGD bound within 
the nanodomains influenced cell adhesion and area. Interestingly, the facile 
conjugation process enabled the concurrent addition of RGD and the laminin 
derived sequence IKVAV in set molar ratios, demonstrating similar adhesion 
across all ratios with spreading and stress fiber organization dependent on RGD 
concentration alone.  
These methods of dynamic surface modification have demonstrated promise 
toward influencing cell adhesion and spreading; however, little work has been 
performed to directly demonstrate influence over cell differentiation. There is a 
growing interest in the field to understand the effects of substrate properties on 
differentiation, as indicated by the recent use of covalently or ionically crosslinked 
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hydrogels with tunable viscous behaviors (i.e., creep and viscoelasticity) to study 
differentiation.116-118 Toward understanding differentiation in response to 
mechanically dynamic substrates, αCD-PEO polyrotaxane coated surfaces have 
recently been explored. Here, the mobility of αCD was modulated by 
methacrylation—thus varying its affinity for PEO. Subsequent coating of this 
polyrotaxane surface by fibronectin produced a cell-adhesive surface which 
demonstrated enhanced osteogenic differentiation in response to molecular 
mobility. Though, results are complicated by a lack of standardization in fibronectin 
density between groups.119  
Cell delivery for therapeutic applications is often problematic, as cells have 
limited retention at injection sites; however, hydrogels can be used to enhance cell 
retention, particularly with rapidly re-assembling hydrogels.88,120 Toward such a 
delivery approach, Kimoon Kim and colleagues have developed an in situ forming 
supramolecular hydrogel (Figure 3.5) based on the interaction of hyaluronic acid 
modified by CB[6] and alkylammonium ions 1,6-diaminohexane (DAH) or spermine 
(SPM). Initial studies demonstrated the rapid formation of a hydrogel upon mixing 
of CB[6]-HA with either DAH-HA or SPM-HA, though SPM-HA hydrogels exhibited 
significant toxicity toward fibroblasts in culture. In contrast, DAH-HA hydrogels 
exhibited good cytocompatibility and fibroblast proliferation was observed when 
hydrogels included the cell adhesive RGD sequence which was modularly included 
by guest-host interaction through preparation and addition of c(RGDyK)-CB[6].86 
Building upon this work, they utilized the materials as a platform for the delivery of 
engineered mesenchymal stem cells (eMSCs) for suppression of tumor growth.121 
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The authors engineered MSCs to produce interleukin-12 (IL-12) through 
adenoviral transfection and demonstrated increased IL-12 production by hydrogel 
inclusion of retinoic acid (RA, hydrolytically bound to HA) and CB[6] conjugated 
dexamethasone (Dexa-CB[6], guest-host bound). Assessment of enhanced green 
fluorescent protein (EGFP) expression in a subcutaneous injection model 
demonstrated cell retention and continued protein expression beyond 60 days, 
greater than three-fold longer than control hydrogels. Delivery of IL-12 producing 
eMSCs in a subcutaneous murine melanoma model was successful in retarding 
tumor growth and enhancing survival outcomes. Importantly, this effect was 
enriched by inclusion of Dexa-CB[6] and RA, demonstrating the utility of 
supramolecular drug inclusion. 
 
Figure 3.5. In situ hydrogel formation. Schematic representation of in situ 
supramolecular hydrogel formation including cell encapsulation (A), through mixing of 
cucurbit[6]uril-conjugated hyaluronic acid (CB[6]-HA) and polyamine-conjugated HA (PA-
HA) and subsequent modular modification with various CB[6] bound tags. The chemical 
structures (B) of CB[6] and PAs of diaminohexane (DAH) and spermine (SPM). Adapted 
from (86) with necessary permissions. 
 
While these studies by the Kim group have utilized sequential injection of the 
hydrogel precursors and in situ hydrogel formation, such approaches may be 
enhanced by a priori hydrogel formation in the presence of cells and subsequent 
shear-thinning delivery. Indeed, numerous shear-thinning hydrogel systems have 
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increased delivery efficiency both by increasing cell viability and retention at the 
target site. Toward these efforts, the use of shear-thinning hydrogels based on CD-
HA and Ad-HA, previously discussed, have been used to encapsulate and deliver 
endothelial progenitor cells (EPCs) to myocardial infarct tissue in rodents. Results 
demonstrated enhanced engraftment of the EPCs with hydrogel delivery (via 
constitutive GFP expression) at 1 week post-injection when compared to injection 
of suspended EPC controls. The cell-hydrogel therapy likewise resulted in 
enhanced vasculogenesis and contractile function when compared to controls of 
saline, EPC suspension, and hydrogel alone injections.122 While results from such 
studies are promising, there is still much work to be done to optimize injection 
conditions of guest-host systems to make certain that viable cells are being 
delivered. However, it is known that guest-host type hydrogels exhibit 
characteristic shear-thinning and shear-banding, similar to other supramolecular 
hydrogels where such studies have been performed. For example, in alternative 
supramolecular systems such as in β-hairpin peptide hydrogels, shear-thinning 
behavior resulted in plug-flow through cylindrical channels (mimicking injection 
through a needle or catheter), which reduced exposure of encapsulated cells to 
shear stresses and increased viability.123 Continuation of this work in loosely 
crosslinked alginate hydrogels has highlighted the importance of extensional flow, 
such as near entrance to the syringe needle, as a primary cause of acute cell 
death.124 Extension of these studies toward direct assembling guest-host 
hydrogels is essential toward understanding cell viability with respect to clinical 
applications of cell delivery. 
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3.4 Conclusions and Future Directions 
Supramolecular guest-host chemistry has made great strides over the past 
decades since formalization of synthetic methods for their production and 
subsequent polymer modifications. Particularly in the field of bioengineering, these 
unique chemistries have shown great potential toward numerous applications. 
Arguably, the most advanced of these is therapeutic delivery, where the use of 
cavitands (cyclodextrin in particular) to enhance solubility and bioavailability of 
pharmaceutical drugs has become common practice. However, the capacity to 
harness these interactions for drug delivery systems (i.e. nanotherapeutics, drug-
eluting coatings, and bioresponsive materials) currently remains primarily limited 
to basic research. Similar to alternative methods of now conventional delivery, 
such as liposomal formulation of chemotherapeutics, these methods hold promise 
as a means to revolutionize the pharmaceutical industry; though, their 
development to industrial scale and market approval remains a challenge.  
At a more basic level, the use of guest-host materials as injectable therapeutics 
is of great interest to the medical community. Such material systems perpetuate 
numerous applications, including the local delivery of biomolecular therapeutics 
via diffusion and the supramolecularly controlled delivery of small molecules or 
suitably modified biomolecules. The use of such materials may also be of interest 
in tissue bulking applications (e.g., dermal fillers, regenerative scaffolds) and 
therapeutic cell delivery. However, the investigation of these important material 
systems and applications is mainly limited to in vitro investigation, with exceedingly 
few examples demonstrating in vivo efficacy. Further investigation of the in vivo 
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material properties is needed to develop an understanding of material degradation, 
mechanics, and therapeutic elution. Similarly, the biological response to guest-
host materials, including macrophage recruitment and long-term fibrotic 
encapsulation remains almost wholly unexamined. Further understanding of these 
systems in a functional, biological setting is a needed priority in the field.  
Finally, with respect to basic biological understanding—guest-host assembly 
offers a unique platform for investigation of cell behavior in response to substrates 
that mimic aspects of the dynamic ECM. This is embodied in the capacity to 
dynamically alter cell culture substrates, including to mimic features such as 
adhesion ligand mobility and substrate viscoelasticity in an attempt to represent 
more biomimetic cellular environments. Toward the applications discussed herein, 
understanding of the underlying chemical processes and polymer physics are of 
utmost importance, as they ultimately control the bulk material properties to enable 
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Rational Design of Network Properties in Guest-Host Assembled 
and Shear-Thinning Hyaluronic Acid Hydrogels 
 
Adapted from: Rodell CB, Kaminski AL, Burdick JA. Rational Design of Network 
Properties in Guest-Host Assembled and Shear-Thinning Hyaluronic Acid 
Hydrogels. Biomacromolecules 14, 4125-4134 (2013). 
 
4.1 Introduction 
Injectable hydrogels continue to gain interest as scaffolds for biomolecule 
delivery and tissue engineering due to their potential for minimally invasive delivery 
and tunability in properties.1-3 Many injectable systems have been designed which 
undergo chemical crosslinking in situ, ranging from transdermally photoinitiated 
systems to autonomous redox reactions or Michael-addition crosslinking. 
However, in situ polymerizing systems may be limited by initial diffusion of the 
polymer from the injection site4 and the potential for premature gelation and 
resulting delivery failure.5 Additionally, many of these systems are based on radical 
initiation and potential issues such as cytocompatibility6,7 and protein bioactivity8-
10 must be considered. 
In contrast to hydrogels that form in situ with covalent crosslinking, hydrogels 
based on physical crosslinking mechanisms (e.g., ionic and hydrophobic 
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interactions, chain entanglement) have also been developed. While physical 
crosslinking naturally leads to less mechanically robust hydrogels, this may be 
beneficial as the physical associations are also the basis for advantageous shear-
thinning and self-healing behavior.11,12 In these systems, the application of shear 
force breaks the physical crosslinks and creates fluid-like flow, allowing easy 
injection of the material through a syringe or catheter, including with cells and 
therapeutics as cargo. Upon cessation of shear, the hydrogel is able to 
autonomously reassemble at the target site through these same crosslinking 
mechanisms.  
Numerous systems exhibiting shear-thinning properties have been reported.11 
Typically, these systems rely on weak interactions to drive assembly of a global 
architecture, including formation of entangled β-sheets or microcrystalline 
domains.13-16 As a result of the required macrostructural assembly, these 
hydrogels often exhibit recovery times on the order of minutes to hours when shear 
is removed.11,17,18 These long times may limit their application as injectable 
hydrogels, since the material components or therapeutic cargo may diffuse from 
the injection site prior to reassembly. In contrast, systems based on the direct 
interaction of complementary binding motifs have shown improved recovery times 
and even near-immediate recovery of initial mechanics in some cases.19-22 One 
example of complementary binding is embodied by guest-host chemical 
interactions, which are composed of two or more chemical species which interact 
through non-covalent bonds to drive molecular complexation in a defined structural 
arrangement. Specifically, host macrocycles such as cyclodextrins have 
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hydrophobic interior cavities which have high affinity for specific hydrophobic guest 
moieties.23 Several systems employing guest macrocycles for supramolecular 
assembly have been reported and reviewed.12,23-27 To date, such systems focused 
largely on the development of nano and microparticulate drug carriers, 
viscosupplements, triggerable interactions (e.g., light or heat), or the development 
of applicable network theory to describe rheological behaviors. While there are 
some examples on the development of supramolecular hydrogels, these structures 
have been relatively weak mechanically, exhibited rapid erosion and biomolecule 
release, or have not exhibited tunable network properties. 
For many applications of injectable hydrogels, matching the physical properties 
of the hydrogel and implant site is desirable. Recent studies have highlighted this, 
as soft injectable materials resulted in reduced mechanical damage as compared 
to analogous tougher hydrogels when injected for intrarenal drug delivery.28 
Beyond the delivery mechanism, the final hydrogel properties are also important 
as diffusive properties and hydrogel erosion control biomolecule release20,29 and 
the physical properties may influence encapsulated cell behavior with respect to 
cellular migration,30,31 proliferation,32-35 and differentiation.36-39 Thus, it is important 
to design systems where biophysical properties may be tailored for specific 
applications and optimal outcomes.  
Here, we report the synthesis and characterization of self-assembling 
hyaluronic acid (HA) hydrogels based on the guest-host interactions of 
adamantane-modified HA (guest macromer; Ad-HA) and β-cyclodextrin-modified 
HA (host macromer; CD-HA). HA was chosen as the backbone polymer since it is 
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found abundantly in tissues and has already been used extensively in biomedical 
applications.40 The HA derivatives are therefore expected to provide a highly 
biocompatible material as adamantane derivatives are widely used in the 
pharmaceutical industry41 and cyclodextrins have attained FDA GRAS approval 
and are readily included in pharmaceutical, cosmetic, and food products.42,43 
Moreover, the specific guest-host pair was chosen because it has been widely 
investigated and is known to have a relatively high association constant on the 
order of 1x105 M-1.23 As a result of this high affinity, mixing of the two macromer 
components in aqueous solution resulted in hydrogels composed of non-covalent 
bonds. The goal of this study was to investigate the tunability in network properties 
and structure, as well as features such as molecule release and erosion. 
 
4.2 Methods 
4.2.1 General Materials.  
Sodium hyaluronic acid (HA, 74kDa) was purchased from Lifecore (Chaska, 
MN). All other chemicals were purchased from Sigma-Aldrich unless otherwise 
indicated.  
 
4.2.2 HA-TBA Preparation.  
The sodium salt of HA was dissolved in DI water at 2 wt%, exchanged against 
Dowex-100 resin, neutralized by tetrabutylammonium hydroxide, and then frozen 
and lyophilized.44 
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4.2.3 Ad-HA Synthesis.  
Various functionalizations of Ad-HA were prepared by coupling 1-adamantane 
acetic acid (Acros Organics) to HA-TBA via esterification. A round bottom flask 
was charged with HA-TBA (3.0 g, 4.20 mmol repeat units, 1 eq), 1-adamantane 
acetic acid (2.45 g, 12.59 mmol, 3 eq), and 4-dimethylaminopyridine (0.38 g, 3.15 
mmol, 0.75 eq). The vessel was purged by nitrogen, and anhydrous DMSO added 
via cannulation to afford an approximately 2wt% solution. Once fully dissolved, di-
tert-butyl dicarbonate (BOC2O) was added via syringe (quantity adjusted to afford 
the desired final adamantane functionalization: 20%: 0.41 eq, 30%: 0.54 eq, 40%: 
0.81 eq, 50%: 1.15 eq) and the reaction carried out at 45○C for 24 hours. 
Purification was performed by dialysis for 3 days against DI water, precipitation in 
acetone, and further dialysis. The solutions were frozen and lyophilized to afford 
the final products. Adamantane functionalization of the macromers was quantified 
by 1H-NMR (Bruker 360MHz) and determined from integration of the ethyl multiplet 
of adamantane (δ=1.50-1.85, 12 H) relative to the HA backbone (δ=3.20-4.20, 10 
H). The percent of HA repeat units modified were varied from 20%-50% as denoted 
by the component subscript. 
 
4.2.4 β-CD-HDA Synthesis.  
Synthesis of 6-(6-aminohexyl)amino-6-deoxy-β-cyclodextrin (β-CD-HDA) was 
performed by adaptation of similar reported syntheses.45-47 β-cyclodextrin (20 g, 
17.62 mmol, 1 eq) was suspended in water (125 mL) and cooled to 0°C. p-
toluenesulfonyl chloride (TosCl; 4.2 g, 22 mmol, 1.25 eq) was dissolved in minimal 
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acetonitrile (~10 mL) and added dropwise. The reaction was stirred at room 
temperature for 2 hours. Sodium hydroxide (2.18 g, 53.6 mmol, 3.1 eq) was 
dissolved in water and added dropwise. The reaction was stirred at room 
temperature for 30 minutes before the pH was adjusted to 8.5 by addition of solid 
ammonium chloride. The solution was cooled on ice and the precipitate collected. 
The crude product was re-precipitated from cold water (3x200mL), washed by 
acetone (3x50mL) and dried under vacuum to afford the intermediate 6-o-
monotosyl-6-deoxy-β-cyclodextrin (5.12 g, 23%) as a white powder. 1H-NMR 
(DMSO-d6) δ = 2.42 (s, 3 H), 3.12-3.80 (m, overlaps with HOD), 4.12-4.40 (m, 6 
H), 4.77 (s, 2 H), 4.83 (s, 5 H), 5.60-6.05 (br s, 14 H), 7.43 (d, 2 H), 7.75 (d, 2 H). 
A round bottom flask was charged with 6-o-monotosyl-6-deoxy-β-cyclodextrin (5 
g, 3.88 mmol, 1 eq), 1,6-hexanediamine (HDA; 20 g, 172.24 mmol, 45 eq), and 
DMF (25 mL). The reaction was carried out under nitrogen at 80○C for 18 hours. 
The product was precipitated from cold acetone (5x500mL), washed by cold diethyl 
ether (2x100mL) and dried under vacuum to afford the final product (3.26 g, 68%) 
as a white powder. 1H-NMR (DMSO-d6) δ = 1.14-1.61 (m, 12 H), 3.12-3.45 (m, 
overlaps with HOD), 3.48-3.78 (m, 28 H), 4.28-4.56 (br s, 6 H), 4.83 (s, 7 H), 5.59-
5.88 (br s, 14 H). 
 
4.2.5 CD-HA Synthesis.  
CD-HA was prepared by coupling β-CD-HDA to HA-TBA via amidation.39 A 
round bottom flask was charged with HA-TBA (2.5 g, 3.43 mmol repeat units, 1 eq) 
and β-CD-HDA (2.96 g, 4.86 mmol, 0.5 eq). The vessel was purged by nitrogen 
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and anhydrous DMSO added via cannulation to afford an approximately 2wt% 
solution. Once fully dissolved, (benzotriazol-1-
yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP; 1.06 g,4.86 
mmol, 0.5 eq) was dissolved in minimal DMSO and added via syringe. The reaction 
was carried out at room temperature for 2 hours. Purification was performed by 
extensive dialysis against DI water and filtration to remove insoluble byproducts 
from the reaction. The solution was frozen and lyophilized to afford the final 
product. Functionalization was determined from integration of the hexane linker 
(δ=1.35-1.85, 12 H) relative to the methyl singlet of HA (δ=2.1, 3 H).The percent 
of HA repeat units modified was ~20% as denoted by the component subscript. 
 
4.2.6 Determination of Apparent Binding Affinity.  
To achieve the required solubility, 1-adamantane acetic acid was converted to 
the sodium salt by neutralization with sodium hydroxide. Either the resulting 1-
adamantane acetate sodium salt or Ad20-HA was dissolved at approximately 
2.5mM in DI water and titrated by either β-cyclodextrin or CD-HA. Samples were 
frozen, lyophilized, and reconstituted in D2O for 1H-NMR spectroscopy. The ethyl 
chemical shift of adamantane (CH2, 6H, δ0=1.61) was used to monitor guest-host 
complex formation. The apparent binding affinity (Ka) was determined by fitting the 
change in this shift (Δδ) and total β-cyclodextrin concentration [H]0 to the Benesi-











       eq. (4.1) 
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where Δδmax is the maximum possible change in this NMR shift occurring with a 
large excess of β-cyclodextrin, extrapolated from the curve fit. Linear models for 
each case were fit in R and compared by ANOVA.  
 
4.2.6 Hydrogel Formation.  
For all characterization studies, hydrogels were prepared from stock solutions 
of the individual macromers in PBS at the desired concentration. For hydrogel 
formation by the guest-host assembly mechanism, the two component solutions 
were combined and mixed by manually stirring to ensure a homogenous hydrogel 
which was then briefly centrifuged to remove entrapped air. Unless otherwise 
stated, adamantane and β-cyclodextrin were present in stoichiometric balance, 
and the concentration refers to the overall weight percent of combined macromers. 
 
4.2.7 Rheological Characterization.  
All characterization was performed using an AR2000 stress-controlled 
rheometer (TA Instruments) fitted with a 20 mm diameter cone and plate geometry, 
59 min 42 s (0.995º) cone angle, and 27 μm gap. Rheological properties were 
examined at 25ºC by oscillatory frequency sweeps (0.01-100 Hz; 1% strain), 
oscillatory time sweeps at various frequencies (0.01, 1.0, 10, or 100 Hz; 1% strain), 
oscillatory strain sweeps (0.01-500% strain 10Hz), and continuous flow 
experiments with the shear rate linearly ramped from 0-0.5 s-1 or 0-5.0 s-1 and 
returned. For shear recovery experiments, shear-thinning was performed at 250% 
strain with recovery at 0.5% strain, each at 10 Hz. Frequency and time sweeps 
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were performed on a minimum of 3 different samples and comparisons of moduli, 
loss tangent, and bulk relaxation times between groups were performed by an 
unpaired Student’s t-test. Comparison within groups at varying frequency was 
performed by a paired Student’s t-test.  
 
4.2.8 Fluorescent Labeling.  
For erosion studies, Adx-HA products were fluorescently labeled to allow direct 
quantification of polymer concentrations in solution. Following adamantane 
modification, products were again converted to their corresponding 
tetrabutylammonium salts. Alexa Fluor 350 hydrazide was then coupled by BOP 
mediated coupling in DMSO and purification was performed by extensive dialysis. 
 
4.2.9 Hydrogel Erosion and BSA Release.  
Custom fabricated molds of cast acrylic plastic (McMaster-Carr) were used to 
contain the hydrogels within a 5 mm diameter 6 mm high depression exposed 
directly to an overlying reservoir of buffer. The hydrogels were either fluorescently 
labeled for erosion or loaded with 0.1 wt% fluorescein isothiocyanate conjugated 
bovine serum albumin (FITC-BSA) as a model biomolecule to monitor release 
behavior. Hydrogels were prepared as above, loaded into a 0.5cc syringe, and 20 
μL of the desired hydrogel was injected into the depression. The mold was briefly 
centrifuged to level the hydrogel surface. Hydrogels were covered with 1 mL PBS 
and allowed to erode for up to 60 days statically at 25°C. At specified time points, 
the buffer was removed from the well and replaced with fresh buffer. Macromer 
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and BSA release were quantified calorimetrically relative to standard curves, and 
data points represent the mean and standard deviation of three gels for each 
composition.   
 
4.3 Results and Discussion 
4.3.1 Chemical Modification of HA.  
The controlled esterification of HA with carboxylic acid containing groups has 
been previously demonstrated to be a powerful means of reproducibly controlling 
HA functionalization.48 Similar methodology was utilized here (Figure 4.1A,B) to 
couple adamantane to HA, where 1-adamantane acetic acid was present in excess 
and the final HA functionalization was controlled simply by altering the molar ratio 
of BOC2O to HA repeat units. The chemical structure of Ad-HA was confirmed by 
1H-NMR spectra (Figure 4.1C), and functionalizations of 21.0, 29.1, 39.2, and 
49.8% were produced as confirmed by integration of the ethyl multiplet of 
adamantane (δ=1.50-1.85, 12 H) relative to the HA polymer backbone (δ=3.20-
4.20, 10 H). 
Various methods of producing CD grafted HA have been previously reported, 
including the use of the Mitsunobu reaction and coupling through reductive 
amination.49,50 Here, we utilized the amine coupling of β-CD-HDA to HA (Figure 
4.1A), as the methodology allows for homogenous reaction conditions, controlled 
final functionalizations, formation of a stable amide linkage, and requires a 
monofunctionalized derivative of β-cyclodextrin which is easily prepared (Figure 
4.1B). The chemical structure of CD-HA was confirmed by 1H NMR (Figure 4.1D) 
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and a functionalization of 20.6% was determined by integration of the hexane linker 
(δ=1.35-1.85, 12 H) relative to the methyl singlet of HA (δ=2.1, 3 H). 
 
Figure 4.1. Synthesis of guest (Adx-HA) and host (CD20-HA) macromers. (A). (i) 3.0 
equiv Ad-COOH, DMAP/BOC2O, DMSO, 45ºC, 24 h. (ii) 0.5 equiv β-CD-HAD, 0.5 equiv 
BOP, DMSO, room temp, 2 h. (B). (i) 1.25 equiv TosCl, NaOH, H2O, room temp, 30 min. 




4.3.2 Inclusion Ability of Guest and Host Macromers.  
The hydrogel crosslinking scheme used here is based on the specific and direct 
interaction of two complementary binding motifs, namely the guest-host 
complexation of adamantane and β-cyclodextrin. As discussed in a recent review, 
others have reported inhibition of the CD complex formation with guest compounds 
having a low molecular weight or molar volume when the guest is attached to a 
polymer chain.43 It is therefore essential to the molecular design that the binding 
of the guest and host motifs is not impeded, such as by steric hindrance of the 
proximal bulky HA polymer backbone.  
The apparent binding affinity of the native guest-host complex and the 
synthesized macromers was examined, as depicted in Figure 4.2. For each case, 
the guest component was dissolved and titrated by the corresponding host 
component. As a result of the hydrophobic interaction within the guest-host 
complex, a pronounced down-field shift and broadening of the ethyl peak was 
observed in the 1H-NMR spectra of adamantane (Figure 4.2B). This shift was 
monitored throughout the titration and utilized to construct mole ratio plots of the 
chemical shifts due to this interaction. All groups show a strong linear correlation 
between the chemical shift and mole fraction (R2>0.98, Figure 4.2C), indicative of 
the known one-to-one association of adamantane with β-cyclodextrin.  
The apparent binding affinity was determined for each system by fit to the 
Benesi-Hildebrand equation. While large error estimates in the maximum shift 
make it difficult to directly compare the association constants reliably,51 no 
significant increase in slope for the linear models (i.e. decrease in binding affinity) 
 92 
was observed for the grafted guest and host molecules relative to the native 
complex (p>0.054). The association constants are similar for all cases examined, 
ranging from 503 to 536 M-1 and on the order of those determined by similar 
spectrographic methods.52 The results confirm that the chosen macromer design 
follows the expected one-to-one guest-host complexation and that tethering of 
either the guest or host molecule to HA does not impede the binding of these 
components with their complement.  
 
Figure 4.2. Binding affinity determination. Confirmation of guest-host complexation for 
modified macromers by titration of the guest (adamantane, Ad) by the host (β-cyclodextrin, 
CD). (A) Schematic of Ad and CD interactions examined, either alone or when either Ad 
or CD are coupled to HA (illustrated as black line). (B) Corresponding 1H NMR spectra of 
Ad monitored throughout the titrations. (C) Mole ratio plots showing the ethyl chemical 
shift of Ad with various molar ratios of CD/Ad investigated. 
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4.3.3 Hydrogel Formation.  
When HA macromers modified with either adamantane or cyclodextrin were 
mixed in solution, near-immediate formation of a pseudoplastic hydrogel occurred 
through the complexation of reversible guest-host moieties on complementary 
macromers (Figure 4.3A). Specifically, while the individual macromer solutions 
were flowable liquids, the formed hydrogel was stable to a qualitative inversion test 
(Figure 4.3B). Oscillatory rheology confirmed that individual macromers were both 
viscous solutions and that an increase in moduli of several orders of magnitude 
occurred following mixing (Figure 4.3C).  
 
Figure 4.3. Overview of hydrogel formation. (A) Schematic of dynamic crosslink 
formation utilizing guest-host complexation. (B) Qualitative inversion test; Ad20HA 5wt% 
(blue, left), CD20HA 5wt% (red, middle), CD20HA + Ad20HA 5wt% (purple, right). (C) 
Oscillatory time sweeps of individual macromers and hydrogel formed at 5wt%; storage 
modulus (G’, filled symbols) and loss modulus (G’’, empty symbols) at 10 Hz, 1.0% strain.  
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The utility of spectroscopic methods previously discussed are limited to 
solutions, as hydrogel formation results in freezing of the NMR signal. Thus, the 
interaction of the Ad-HA and CD-HA in a one-to-one fashion was confirmed by 
oscillatory rheology of hydrogels (7.5 wt%) consisting of either excess Ad20-HA or 
CD20-HA. Representative frequency sweeps (Figure 4.4A) demonstrate a 
decrease in relaxation times and moduli for hydrogels containing excess Ad20-HA. 
Further quantification (Figure 4.4B) of the storage and loss moduli at various 
stoichiometries shows a clear convergence on maximal properties when the guest 
and host are present in a one-to-one ratio, confirming that balanced stoichiometry 
affords the most robust hydrogel. As highlighted in Table 4.1, this condition also 
coincides with the maximum theoretical crosslink density as may be expected for 
such self-assembling systems.  
 
Figure 4.4. Moduli dependence on guest-host mole fraction. Rheological confirmation 
of optimal guest-host mole fraction. (A) Representative oscillatory frequency sweeps 
showing storage modulus (G’, filled symbols) and loss modulus (G’’, open symbols) of 
hydrogels containing excess adamantane in the given ratio with cyclodextrin. (B) 
Quantification of moduli from time-sweeps performed at 10Hz, 1% strain and values 




Table 4.1. Hydrogel compositions examined. Parameters investigated and hydrogel 
formulations used for each case are provided. Crosslink density reflects the maximum 
theoretical density of guest-host pairs.  
 
 
4.3.4 Control of Network Properties.  
The crosslink density and architecture may be varied by the concentration of 
the individual macromers and the extent of functionalization of the macromers with 
either the guest or host molecules, as well as the ratio of guest to host components. 
It has been previously proposed that two primary junction points exist within binary 
associating systems similar to those developed here, as depicted in Figure 4.5A. 
These include both weak network junctions composed of few guest-host 
complexes and multifold junctions where multiple polymer chains entangle and are 
joined by several guest-host complexes.53 Multifold junctions contribute largely to 
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the properties of the hydrogels, as the sum of many guest-host interactions results 
in an avidity greater than the affinity of a single guest-host bond. While both of 
these junction point architectures may contribute to the moduli, the multifold 
junctions dominate the slow dynamic properties of the hydrogel as stress 
relaxation at these junctions requires the simultaneous slipping of multiple guest-
host bonds. For any binary associating system, these two types of junction points 
must exist in a thermodynamic equilibrium which governs the time-dependent 
properties of the network.27 
 
Figure 4.5. Representative frequency dependence. Example frequency dependence of 
material behavior. Schematic representation of a weak network junction (top) and a 
multifold junction (bottom) that are proposed to constitute the network junction points (A). 
Representative oscillatory frequency sweeps showing storage modulus (G’, filled 
symbols) and loss modulus (G’’, open symbols) of hydrogels composed of different 
macromer concentrations (B) or Adx-HA modifications (C) as indicated.  
 
In order to control the properties of assembled hydrogels, we altered the 
crosslink density and junction point architecture through both the macromer 
concentration and the guest macromer modification. First, an increase in the 
macromer concentration (2.5 to 10 wt%) was utilized to increase the theoretical 
crosslink density from 4.87 to 21.13 mM. At concentrations of 2.5 wt% and below, 
hydrogels were observed to assemble and exclude excess solvent, which 
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prevented consistent rheological measurement; at concentrations greater than 10 
wt%, solutions were highly viscous and homogenous mixing was difficult. 
Separately, the guest macromer modification was increased from 20 to 50% while 
maintaining a macromer concentration of 7.5 wt%. Although this resulted in a 
minimal change in the theoretical crosslink density (15.42 to 19.97 mM), the 
proportion of effective multifold junctions is expected to increase as formation of 
guest-host complexes requires the coordination of multiple polymer chains. The 
frequency response of the materials illustrates the changes in network structure 
for these separate conditions. Specifically, while an increase in the macromer 
concentration resulted in an increase in moduli as well as a moderate reduction in 
crossover frequency (Figure 4.5B), an increase in the guest macromer modification 
resulted in drastic changes in the crossover frequency with little change in the 
moduli across groups (Figure 4.5C).  
Quantification of these observations across the frequency range demonstrated 
the hypothesized phenomena. Notably, the storage modulus increased with both 
macromer concentration and frequency according to a power law (Figure 4.6A, 
4.7A). Similar relationships were observed for the loss moduli (Figure 4.7A), 
though a more rigid solid was formed with increasing macromer concentration as 
indicated by the decrease in the loss tangent (tan(δ), Figure 4.6C, 4.8A). However, 
the moduli of hydrogels composed of varying guest macromer modifications did 
not scale similarly with frequency. Rather, a moderate increase in moduli was 
observed across groups, which was significant only at low frequencies (Figure 
4.6B, 4.7B). A great reduction in the loss tangent (Figure 4.6D, 4.8B) at high 
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modifications and low frequencies suggests the change in properties is a result of 
the network junction architecture. In particular, a disproportionate increase in the 
proportion of multifold junctions must limit network relaxation and thereby increase 
moduli at low frequency. 
 
Figure 4.6. Frequency dependence of material properties. Storage modulus (G’) of 
hydrogels composed of different macromer concentrations (A) or Adx-HA modifications 
(B). Loss tangent (tan(δ)) of hydrogels composed of different macromer concentrations 
(C) or Adx-HA modifications (D). Values represent the mean measurement of 3 different 
hydrogels. Please note the directional change in frequency magnitude between the 
storage modulus and loss tangent plots. For two-dimensional representation, including 




Figure 4.7. Statistical comparisons of frequency dependence. Storage modulus (G’, 
blue) and loss modulus (G’’, red) of hydrogels composed of different macromer 
concentrations (A) or Adx-HA modifications (B). Values represent the mean ± standard 
deviation of 3 different hydrogels. For (A) and (B), all differences across frequency are 
significant. Within each frequency, insignificant differences are indicated (*) and pertain to 
differences between groups for both G’ and G’’.  
 
 
Figure 4.8. Statistical comparison of loss tangent. Loss tangent. Loss tangent of 
hydrogels composed of different macromer concentrations (A) or Adx-HA modifications 
(B). Values represent the mean ± standard deviation of 3 different hydrogels. For (A) and 
(B), all differences across frequency are significant. Within each frequency, insignificant 
differences are indicated (*).  
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To corroborate these observations, the bulk relaxation time was examined. The 
relaxation time is the characteristic timescale over which an applied stress is 
dissipated by viscous behavior of the pseudoplastic hydrogel (i.e. bond re-
organization to eliminate internal shear stress) and is directly determined from the 
loss tangent as a function of frequency (tan(δ)=1; Figure 4.9). Guest macromer 
modification was found to exhibit a greater influence over the bulk relaxation time 
than macromer concentration (Figure 4.10A,B). For instance, an increase in 
polymer concentration from 7.5 to 10 wt% resulted in a four-fold increase in the 
bulk relaxation time; whereas, a similar increase in the theoretical crosslink density 
by increasing macromer modification from 20 to 50% resulted in a nearly ninety-
fold increase in the bulk relaxation time. These results support the notion that an 
increase in the proportion of multi-fold junctions is produced by a mismatch of the 
guest and host macromer modifications, and the effects on hydrogel behavior are 
visually demonstrated in long-term flow experiments (Figure 4.10C). It was 
observed that hydrogels having relatively short bulk relaxation times flow to allow 
relaxation of internal shear stresses. However, hydrogels consisting of guest 
macromers with high modifications exhibited negligible flow over the course of one 
week. Taken together, the results demonstrate a methodology to independently 
control the moduli and relaxation behavior of binary associating systems. 
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Figure 4.9. Representative loss tangent and determination of relaxation time. 
Representative oscillatory frequency sweeps showing loss tangent of hydrogels 
composed of different macromer concentrations (A) or Adx-HA modifications (B). The 
point at which the loss tangent is equal to one represents the crossover frequency where 
the storage modulus (G’) is equal to loss modulus (G’’). The inverse of the crossover 
frequency affords the bulk relaxation time.  
 
 
Figure 4.10. Bulk relaxation behavior of hydrogels. Relaxation times with varied 
macromer concentration (A) or Adx-HA modification (B). Values were quantified from the 
frequency sweeps of three independent hydrogels and represent the mean ± standard 
deviation of a minimum of 3 samples. All groups are significantly different with the 
exception of 40 to 50% Adx-HA modification. (C) Images of hydrogels of varied 
composition that were formed in the bottom of glass vials and the vials were placed on 
their sides for up to one week.  
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4.3.5 Shear-thinning and Recovery.  
Since the guest-host assembly mechanism is based on reversible dynamic 
bonds, formed hydrogels exhibited flow and recovery characteristics. To 
demonstrate the desired shear-thinning ability required for injectable delivery 
systems, hydrogels were subject to continuous flow experiments. Here, the shear 
rate was linearly ramped from 0-0.5s-1 to investigate the effect of flow rate on 
viscosity and resultant shear stress. In this regime of simulated slow flow 
conditions, hydrogels that were formed from various macromer concentrations 
(Figure 4.11A) or extent of guest macromer modification (Figure 4.11B) show the 
desired shear-thinning behavior where viscosity decreases with shear rate. 
Consequently, the shear stress approached a maximum. The terminal viscosity 
and shear stress magnitudes were observed to increase with both macromer 
concentration and modification of the guest macromer, while the profiles of shear 
stress and viscosity changes with increased shear rate were similar across all 
systems investigated.  
While this behavior demonstrates the shear-thinning ability of this hydrogel 
system, the shear rate experienced within a syringe may be far greater than those 
explored here.54 Upon exploring higher shear-rates (up to 5s-1), trends in shear-
thinning behavior were not observed to change for increases in macromer 
concentration; however, an increase in the guest macromer modification resulted 
in a pronounced decline in shear-stress at high shear-rates (Figure 4.12). Similar 
trends have been examined in various supramolecular networks, and shown to be 
a consequence of network rearrangement during shear-induced flow.12,27,55,56 
Specifically, if the chain relaxation time is slower than the reconnection of 
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unassociated crosslinks, then a regime of drastic shear-thinning may be induced 
above a critical shear rate. From these observations and previously discussed bulk 
relaxation behavior, it is reasonable to conclude that the increased local stability 
of multifold junctions decreases the chain relaxation time, resulting in pronounced 
shear-thinning behavior when the extent of guest macromer modification is 
increased. For biomedical applications, such drastic shear-thinning behavior may 
be advantageous as it increases the materials ability to flow through a catheter or 
narrow gauge syringe, which reduces the necessary force for injection. 
To examine the timescale of material recovery, such as following injection, 
hydrogels were subjected to cycles of large amplitude oscillatory stain followed by 
low amplitude oscillatory strain. First, a strain sweep (Figure 4.11C) was used to 
determine the yield stress for the hydrogel examined (~60% strain at yield), from 
which a low (0.5%) and high (250%) strain were determined for recovery 
experiments. Under cyclic deformation, materials demonstrated a clear decline in 
moduli and concurrent gel-sol transition at the onset of high strain conditions 
(Figure 4.11D). At the transition from high to low strain conditions, rapid recovery 
to initial mechanics was observed. Even at a sampling rate of 0.75Hz, the transition 
could not be observed as greater than 80% of the initial moduli were recovered in 
this time and complete recovery was observed within 30 s. Similar recovery 
characteristics were observed regardless of the number of cycles performed or the 
composition of the hydrogel. These results indicate that the materials are capable 
of near-immediate recovery following shear-thinning delivery, allowing optimal 




Figure 4.11. Guest-host hydrogel flow and recovery characteristics. Continuous flow 
experiments showing the shear stress (closed symbols) and viscosity (open symbols) of 
hydrogels composed of different macromer concentrations (A) or Adx-HA modifications 
(B) as indicated by adjacent labels. Storage modulus (G’, red dotted line), loss modulus 
(G’’, blue dashed line), and loss tangent (tan (δ), black solid line) of a hydrogel undergoing 
a strain sweep at (C) or cyclic deformation (D) of 0.5% (low, unshaded areas) and 250% 




Figure 4.12. Continuous flow at increased shear rate. Continuous flow experiments 
at increased shear rate showing the shear stress (closed symbols) and viscosity (open 
symbols) of hydrogels composed of different macromer concentrations (A, labels on 
outside of plot) or Adx-HA modifications (B).  
 
 
4.3.6 Hydrogel Erosion and Biomolecule Release.  
Hydrogel erosion and the sustained delivery of therapeutic biomolecules are 
required for many applications and the desired degradation and release kinetics 
are dependent on the specific application. Although this study is not targeted 
towards a single application, we investigated the tunability of hydrogel erosion and 
concurrent biomolecule release through changes in crosslink density and network 
architecture. Hydrogels investigated were contained within the depression of 
custom fabricated erosion cells and exposed directly to buffer. For controls 
comprised of individual macromer components, near immediate dissolution into 
the buffer was observed. For all hydrogels investigated, initial high erosion rates 
were followed by a slower phase of nearly linear erosion (Figure 4.13A,B). The 
initial release of macromer is likely related to macromers that are not well 
incorporated to the bulk system and can be released rapidly as the dynamic guest-
host interactions become limited. Increasing the crosslink density through the 
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macromer concentration resulted in a clear trend of decreased erosion rates 
(Figure 4.13A). This is expected as the disassembly of gels is related to the number 
of guest-host interactions in the network. Interestingly, increases in the guest 
macromer modification were found to increase the rate of erosion, particularly in 
the later near linear phase (Figure 4.13B). These results are counterintuitive 
considering the erosion of dynamically bonded hydrogels are known to be 
dependent on valency of the associating groups, as erosion of a macromer 
requires the simultaneous dissociation of all binding groups.20 In this case, erosion 
likely proceeds by surface erosion of small clusters of the macromers which are 
no longer linked to the bulk hydrogel, suggesting network homogeneity plays an 
important role in long-term stability.  
As cyclodextrins are known to interact strongly with a great variety of small 
organic molecules, primarily through hydrophobic interactions, they have been 
extensively employed in the pharmaceutical industry. Particularly, cyclodextrins 
have been investigated for their ability to complex with and control the release of 
small organic molecules,24,26 and their interaction with proteins has also been 
investigated for pharmaceutical applications as discussed in recent reviews.43 
While such small molecule interactions have proven efficacy, the utilization of 
supramolecular network structure to control biomolecule release has rarely been 
examined.57 In order to perform a generalizable examination of this behavior, we 
utilize bovine serum albumin (BSA) as it is a moderately sized biomolecule (66.5 
kDa) with globular structure. Some proteins may contain phenylalanine or tyrosine 
residues on the surface, enabling binding of cyclodextrins to the protein and 
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resulting in interference with release. It is known that no such significant interaction 
exists between β-cyclodextrin and BSA58 and the utilization of FITC-BSA has 
previously been scrutinized in release from β-cyclodextrin based materials and no 
interaction with fluorescein was observed.59 
In this general study, we observed sustained release that was dependent on 
both the macromer concentration and guest macromer modification. For all 
hydrogels examined, release beyond 60 days was observed, which extends the 
release capabilities beyond what has been achieved in hydrogels based on similar 
supramolecular crosslinking. Importantly, release rates were readily tailorable 
according to the macromer concentration (Figure 4.13C). Specifically, the time until 
90% cumulative release was increased from approximately 21 to 53 days between 
2.5 and 10 wt% hydrogels. While trends in protein release followed those of the 
erosion profiles, protein release occurred faster than erosion, indicating that a 
combination of diffusion and surface erosion likely contributes to release. This is 
in contrast to similar reported systems employing high polymer concentrations 
(>20 wt%) that showed zero-order release consistent with primarily surface 
erosion.59 The effect of surface erosion is apparent in the release from hydrogels 
of various guest macromer modifications. Here, a tendency towards increased 
release rates with guest macromer modifications was observed, despite a 
moderate increase in crosslink density (Figure 4.13D). These observations are 
consistent with the previously described increase in erosion for these hydrogels. 
The influence of this erosion based release mechanism minimally affected release, 
with the time to 90% cumulative release occurring between 39 and 46 days for all 
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hydrogels within this group. The observations herein provide a strong basis of 
understanding the design parameters controlling hydrogel erosion and 
biomolecule release for the guest-host hydrogels developed, perpetuating their 
use in future applications.  
 
Figure 4.13. Erosion and molecule release characteristics. Cumulative guest-host 
hydrogel erosion profiles for various macromer concentrations (A) or Adx-HA modifications 
(B). Model biomolecule (FITC-BSA) release from hydrogels composed of different 
macromer concentrations (C) or Adx-HA modifications (D). Values represent the mean ± 





Self-assembling HA hydrogels based on a guest-host assembly mechanism 
were developed. The reactions chosen for modification of HA with the host 
cyclodextrin and guest adamantane were simple, direct, and resulted in the desired 
products with controlled functionalization and potential for scalable synthesis. The 
resulting guest and host macromers were found to have a binding capacity which 
was unhindered by the molecular structure. Formation of a hydrogel by simple 
mixing of the two macromer components in aqueous solutions was demonstrated, 
and the properties of the resulting hydrogel was dependent on crosslink density 
and network architecture which were separately controlled by macromer 
concentration and guest macromer modification. Importantly, all hydrogel 
formulations examined were capable of shear-thinning behavior to enable ease of 
injection as well as rapid recovery to localize the hydrogel and its potential 
therapeutic cargo at the site of injection. Erosion and model biomolecule release 
demonstrated a remarkable stability and tunability based on hydrogel design. In 
short, the hydrogel system developed shows great potential as a minimally-
invasive injectable material platform due to its demonstrated tunable mechanical 
properties, near-ideal flow and recovery characteristics, and remarkable stability 
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Evolution of Hierarchical Porous Structures in Supramolecular 
Guest-Host Hydrogels 
 
Adapted from: C.B. Rodell, C.B. Highley, M.H. Chen, N.N. Dusaj, C. Wang, L. 
Han, J.A. Burdick. Evolution of Hierarchical Porous Structures in Supramolecular 
Hydrogels. (In Preparation). 
 
5.1 Introduction 
Material heterogeneity arises naturally from supramolecular self-assembly 
processes, leading to complex structures that are adaptive and temporally 
evolving.1 Indeed, natural materials such as the extracellular matrix are formed via 
supramolecular self-assembly (e.g., the fibrillar structure of collagen). The 
formation of such structures has been mimicked with synthetic analogues, 
including with peptide-based assemblies2-6 that recapitulate many aspects of the 
native extracellular matrix such as its fibrillar structure.7-9 Similar principles have 
been exploited to form highly ordered and even porous materials through block 
copolymer assembly,10,11 hydrogen bonding,12,13 and with DNA-based materials.14 
Though, the utility of such methods is limited largely to the fabrication of structures 
at the nanoscale.15 
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Alternatively, bulk physical hydrogels have been formed through 
supramolecular assembly of modified polymers.16-18 Prominent among these 
physical hydrogels is the utilization of cyclodextrins, cucurbit[n]urils, and other host 
macrocycles that form dynamic physical associations with an array of 
corresponding guest molecules. Through polymer conjugation, these macrocycles 
have bridged the gap between simple supramolecular bonding and complex 
macromolecular self-assembly processed, enabling formation of precise nano- 
and micro-particulates, as well as bulk hydrogels.18,19 Within these bulk hydrogel 
systems, the polymer structure has been generally regarded as highly disordered 
and homogenous. However, theoretical exploration has predicted well-ordered 
states, such as polymer alignment, are thermodynamically preferred.20 Such states 
are proposed to arise from the dynamic rearrangement of supramolecular bonds, 
which enables the polymers to self-sort into their lowest energy state — the 
configuration in which the number of guest-host complexations is maximized. 
Monte Carlo simulations of polyelectrolytes have demonstrated such phenomena, 
including polyelectrolyte collapse into dense heterogeneous structures through 
introduction of divalent counterions.21 Experimentally, recent reports have 
indicated the potential of bulk physical hydrogels, including those formed through 
macrocyclic assembly, to form heterogeneous structures.22-26 Despite the depth of 
theoretical works, there remains a lack of experimental observation bridging the 
gap between directed polymeric self-assembly and supramolecular microstructure. 
Towards the development of these physical hydrogels, a better understanding 
of the underlying phenomena is needed, in conjunction with experimental 
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examination of the hydrogel microstructure and ways to control its features.  
Hydrogels from supramolecular assemblies are finding widespread use in 
biomedical applications, including as injectable hydrogels for the delivery of 
therapeutics and cells.27-31  In this case, heterogeneity may influence outcomes 
such as drug release profiles and cellular interactions, where the scale at which 
biochemical and biophysical signals are presented to cells may be important.32,33 
The control of microstructural evolution in supramolecular assemblies may add to 
techniques such as particle leaching, gas foaming, freeze-drying, and 
electrospinning34 which are currently used to introduce structural heterogeneity.  
Herein, we investigated the evolution of heterogeneity in supramolecular 
hydrogels formed through guest-host association of β-cyclodextrin (CD) and 
adamantane (Ad) when separately conjugated to hyaluronic acid (HA). 
Investigation was performed via confocal microscopy in the hydrated state to 
elucidate hierarchical assembly via guest-host induced polymer condensation. The 
temporal evolution and influence of hydrogel composition on porosity were 
explored via quantitative image analysis. Further, multiple modalities of 
micromechanical analysis were used to explore the extent of polymer segregation. 
The work represents a systematic study of hierarchical microporous assembly in 
supramolecular hydrogels, offering insights into mechanisms of formation and 






5.2 Experimental Methods and Materials 
5.2.1 Materials Synthesis.  
Reagents were purchased from Sigma-Aldrich, unless otherwise indicated. 
Hyaluronic acid (HA, 90kDa; Lifecore Biomedical) was methacrylated (MeHA) via 
esterification with methacrylic anhydride (pH 8.25-8.5, 3 hrs, 30% modification)35 
and subsequently converted to the tetrabutylammonium salt (MeHA-TBA) by ion 
exchange against Dowex 50Wx8 hydrogen form and neutralization by aqueous 
tetrabutylammonium hydroxide (0.4M, Fisher Scientific).36 MeHA-TBA was 
modified by 1-adamantane acetic acid (Acros Organics) to form Ad-MeHA or 6-O-
monotosyl-6-deoxy-β-cyclodextrin to form CD-MeHA by anhydrous reaction in 
DMSO according to our previously published methods.37 Briefly, coupling of 
cyclodextrin (0.6 eq) and HA (1.0 eq disaccharides) was accomplished by reaction 
in the presence of (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium 
hexafluorophosphate (BOP, 0.6 eq), yielding 25% of disaccharides modified. 
Esterification of adamantane (3.0 eq) and HA (1.0 eq disaccharides) proceeded by 
reaction with di-tertbutyl dicarbonate (BOC2O) and 4-dimethylaminopyridine 
(DMAP, 1.5 eq) where the amount of BOC2O was varied to alter HA modification: 
25% (0.47 eq) and 50% (1.13 eq). For all HA derivatives, purification was 
performed by exhaustive dialysis, filtration to remove insoluble byproducts where 
necessary, and lyophilization. 1H NMR spectra were acquired in deuterated water 
(360 MHz, Bruker) and determination of HA modifications performed as previously 
described.37,38   
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In order to fluorescently label the hydrogels, the peptide GCKKG was prepared 
by solid phase peptide synthesis (PS3, Protein Technologies) from FMOC 
protected amino acids and glycinol 2-chlorotrityl resin (Novabiochem) and 
terminated with either 5(6)-carboxyfluorescein (GCKKG-Fluor) or rhodamine B 
(GCKKG-Rho). Molecular weight was confirmed by MALDI-tof mass spectrometry 
(Applied Biosystems Voyager 6030; GCKKG-Fluor: m/z = 893.3, expected 893.5 
Da and GCKKG-Rho: m/z = 959.5, expected 959.5 Da).  
Ad-MeHA and CD-MeHA were labeled by the fluorescent peptides to form Ad-
MeHA-Fluor and CD-MeHA-Rho, respectively. The desired peptides were 
dissolved in deionized water (0.015 eq) and added dropwise to a solution of the 
methacrylated polymer (220 mmol disaccharides, 1.0 eq) dissolved in 
triethanolamine buffer (0.2 M TEOA in PBS, 10 mL, pH 10). Following reaction at 
room temperature for two hours, purification was performed by exhaustive dialysis 
and products recovered by lyophilization.  
 
5.2.2 Hydrogel Formation.  
Adamantane and β-cyclodextrin were maintained in a one-to-one ratio, and Ad-
MeHA of 25% modification was used for all samples, except where indicated. The 
concentration (1.25-10.0 wt%) denotes the combined weight percent of both guest 
and host polymers. Hydrogels were prepared from separate solutions of the guest 
and host polymers in PBS containing 5.0 mM lithium phenyl-2,4,6-
trimethylbenxoylphosphonate (LAP, photoinitiator). The two component solutions 
were combined, manually mixed, and centrifuged to remove entrapped air.  
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5.2.3 Microscopic Characterization.  
For analysis of polymer co-localization, separately labeled guest (Ad-MeHA-Fluor) 
and host (CD-MeHA-Rho) polymers were utilized. Hydrogels were formed as 
described, cast in cylindrical molds (8 mm diameter, 75 µL hydrogel), covered in 
PBS, and incubated for the prescribed period. Prior to confocal imaging (Leica TCS 
SP5, 20 µm z-spacing, 20x immersion lens), buffer was changed to PBS 
supplemented with 5.0 mM LAP (2 hr incubation) and photocrosslinked (EXFO 
OmniCure Series 1000, 320-390 nm filter, 10 mW/cm2, 3 min) to stabilize the 
structures.  
Examination of hydrogel porosity was similarly performed, with hydrogels 
consisting of Ad-MeHA and CD-MeHA. For imaging and quantification, GCKKG-
Fluor was included (5.0 mM) in the buffer at the time hydrogels were dissolved as 
well as during LAP incubation prior to photocrosslinking. Samples were repeatedly 
washed by PBS prior to image acquisition, which was performed as described. For 
quantification (ImageJ) of hydrogel void fraction, images were thresholded and 
converted to binary (n = 4 hydrogels/group, 10 slices/hydrogel). The pore diameter 
(n = 4 hydrogels/group, > 3pores/hydrogel) was determined as the maximum 
diameter for the observed pore. Data is reported as mean ± standard deviation. 
 
5.2.4 Atomic Force Microscopy.  
Hydrogels were formed as described and cast into ~ 200 µm thick layers between 
two glass slides. To aid in sample recovery, one slide was hydrophobically treated 
(Rain-X). Following incubation for 3 days, samples were incubated with 5.0 mM 
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LAP (2 hrs) and photocrosslinked (10 mW/cm2, 3 min). The top surface was 
exposed by removal of the treated slide and then subject to atomic force 
microscopy (AFM)-based nanoindentation. Nanoindentation was performed on the 
top surface and pore center (n ≥ 2 locations/sample, 3 repeats/location) at 10 µm/s 
indentation depth rate using a borosilicate microspherical tip (R = 12.5 µm, nominal 
spring constant k= 0.03 N/m) and a Dimension Icon AFM (BrukerNano). The 
effective indentation modulus, Eind, was calculated by fitting the loading portion of 








           eq. (5.1) 
where R is the tip radius and ν is Poisson’s ratio (0.49 for highly swollen 
hydrogels).39 Data are reported as mean ± standard error and comparison was 
performed by a two-tailed Student’s t-test with significance determined at P < 0.05. 
 
5.2.5 Diffusive Microparticle Tracking.  
Hydrogels were cast in thin layers, as described for AFM characterization, with 
hydrogels containing 0.2 µm fluorescent carboxylate-modified polystyrene beads 
(Fisher, 6.7x10-3 wt%). Following swelling at 37○C for 7 days, a concentrated 
solution of microbeads (< 5 µL, 0.04 wt%) was introduced into the aqueous phase 
via a microinjector and beads were allowed to passively diffuse throughout the 
construct. Controls included suspension of microbeads (6.7x10-3 wt%) in PBS 
containing soluble unmodified HA (0, 2.5, 5.0, and 10.0 wt%) as well as beads 
adhered to a glass surface (fixed, non-diffusive control). Fluorescent beads were 
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imaged for 30 seconds at 62.5 fps (Basler acA640-90uc) at 40x magnification 
(Olympus BX51).  
For analysis, images were corrected via background subtraction and 
sharpening (ImageJ). Corrected images were analyzed (Trackpy) to determine the 
trajectory and mean squared displacement (MSD) of individual particles; drift 
correction was used as necessary to account for non-diffusive motion. Data was 
analyzed (MATLAB) by assessment of MSD during the first second of recorded 
motion, where data for each particle was approximated by a power law: 
𝑀𝑆𝐷 = 𝐷𝜏𝛼                eq. (5.2) 
where D represents the diffusion coefficient and the power, α, describes the 
diffusivity law of the sample (i.e., superdiffusive, diffusive, or subdiffusive). Data 
for MSD (n = 3 sample/group, >25 particles/sample) and fit parameters are 
reported as mean ± standard error. Fit parameters were determined by least-
squares regression in MATLAB (Mathworks) and comparisons performed by 
ANOVA with post hoc Tukey’s HSD; significance was determined at P < 0.05.   
 
5.3 Results and Discussion 
5.3.1 Material Preparation and Polymer Co-Localization.   
Macrocyclic guest-host assembly has been used to form hydrogels with diverse 
polymeric structures and guest-host pairs.18 Here, we utilized hyaluronic acid (HA) 
modified (Figure 5.1A) by 1-adamantane acetic acid (Ad-HA) and aminated β-
cyclodextrin (CD-HA) as previously described.37 Upon aqueous dissolution and 
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combination of Ad-HA and CD-HA polymers, hierarchical assembly (Figure 5.1B) 
is initiated at the molecular scale through guest-host (GH) complexation. At the 
macromolecular level, it has been proposed that binary associations between 
polymers with such structure (i.e., linear and pendantly modified) 
thermodynamically favor the formation of specifically structured polymer pairs, 
including lateral assembly in a “railway” type complex to minimize free energy,20 
resulting in GH polymer condensation. Extrapolating this conception to a dense 
combination of guest and host polymers, we hypothesized that the initially 
homogenous mixture would not represent the thermodynamically favored state. 
Rather, stochastic rearrangement of bonding pairs was expected to result in 
polymer condensation at the microscale. 
 
Figure 5.1. Polymer structure and self-assembly. (A) Chemical structure of the 
component polymers, including hyaluronic acid (HA, black) modified by 1-adamantane 
acetic acid (Ad, green) or β-cyclodextrin (CD, red). (B) Schematic of guest-host (GH) 
hydrogel hierarchical organization at the molecular, polymeric, and microscales.  
 
Indeed, macromolecular self-assembly has resulted in ordered structures, 
including in porous network assembly by crown ethers26 as well as in thin film and 
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bulk hydrogel assemblies by cucurbit[8]uril.24,25 Though, such observations have 
primarily been made by scanning electron microscopy (SEM) of dried samples, 
where freeze-drying may induce porosity via ice crystal formation as an artifact of 
the methodology. Such artifacts have been observed in cucurbit[8]uril hydrogels 
by examination via small-angle neutron scattering (SANS) which revealed no 
change in nanostructure with increased crosslink density, despite observation of 
porous structure by SEM.40  
Given these prior observations, direct visualization of hydrogels in the hydrated 
state was deemed essential. To enable microscale imaging in aqueous conditions, 
guest and host polymers were methacrylated to allow fluorescent labeling via 
Michael addition reactions—where Ad-MeHA and CD-MeHA were labeled by 
thiolated fluorescein (Fluor) and rhodamine (Rho) to yield Ad-MeHA-Fluor and CD-
MeHA-Rho, respectively. Additionally, methacrylate functionalization was utilized 
to stabilize the supramolecular hydrogels via photopolymerization41 in the 
presence of lithium phenyl-2,4,6-trimethylbenxoylphosphonate (LAP) to prevent 
disruption of the structures, which may occur due to physical agitation or thermally 
induced GH complex dissociation. 
Solutions of Ad-MeHA-Fluor (0.95 wt%), CD-MeHA-Rho (1.55 wt%), and their 
corresponding GH hydrogel (2.5 wt%: 0.95 wt% Ad-MeHA-Fluor + 1.55 wt% CD-
MeHA-Rho) were incubated for three days prior to photopolymerization and 
examination. Photopolymerized Ad-MeHA-Fluor and CD-MeHA-Rho controls 
remained translucent at the macroscale (Figure 5.2A); whereas, GH hydrogels 
were translucent upon formation but then turbid by day 3, indicative of light 
diffraction by microstructural inhomogeneity. When identical samples were 
examined with confocal microscopy and quantified with intensity profiles (Figure 
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5.2B), the CD-MeHA-Rho or Ad-MeHA-Fluor hydrogels were homogeneous, 
whereas the GH hydrogel assumed a heterogeneous and highly porous 
architecture. This microscale polymeric condensation has been previously 
unobserved for GH hydrogels in the hydrated state. Controls did not develop 
structural arrangement, including after identical incubation and 
photopolymerization. The observed GH hydrogel structure is therefore the direct 
result of hierarchical assembly and not an artifact of hydrophobic polymer 
association or polymerization-induced aggregation.    
 
Figure 5.2. Binary associations and heterogeneity in guest-host hydrogels. (A) 
Micrograph of CD-MeHA-Rho (left, 1.55 wt%), Ad-MeHA-Fluor (middle, 0.95 wt%), and 
corresponding GH hydrogel (2.5 wt%: 0.95 wt% Ad-MeHA-Fluor + 1.55 wt% CD-MeHA-
Rho) polymerized at day 3 following incubation. Scale bar: 5.0 mm. (B) Fluorescent 
confocal images (top) and normalized intensity profiles (bottom, path indicated by yellow 
dotted line) of separate guest-host hydrogel components and the corresponding GH 




In order to probe the initial state and evolution of porous structure, GH hydrogels were formed 
(2.5 wt%) and imaged over time to evaluate temporal changes in structure (Figure 5.3). Initially 
(day 0), the guest and host polymers were uniformly distributed, as confirmed by their 
corresponding intensity profiles. Over time, porous structures developed throughout the hydrogels 
(day 1 and day 3). Intensity profiles further demonstrated a high degree of spatial co-localization 
between the fluorescein and rhodamine signals, indicating co-localization of the modified polymers. 
Likewise, examination of three-dimensional (3D) reconstructions (Figure 5.4) demonstrated co-
localization of the separate polymers throughout space with relative heterogeneity of pore size 
throughout the depth (400 µm) examined. Such co-localization is requisite for the hierarchical 
assembly mechanism proposed, as both guest and host polymers are required to achieve GH 
polymer condensation.  
 
Figure 5.3. Temporal evolution of hydrogel porosity and component co-localization. 
(A) Representative fluorescent confocal microscopy images of GH hydrogels (2.5 wt%) at 
day 0 (top), day 1 (middle) and day 3 (bottom), where components were separately labeled 
for imaging: Ad-MeHA-Fluor (green) and CD-MeHA-Rho (red). Scale bar: 100µm. (B) 
Corresponding normalized intensity profiles along the path indicated (yellow dotted line), 





Figure 5.4. Three-dimensional representation of structure. Orthogonal view of three-
dimensional (3D) reconstructions (A) and maximum projection (B) of the guest-host 
hydrogels (Day 0-3; 2.5 wt%). Stacks are merged channels from confocal Z-stacks at day 
0 (left), day 1 (middle) and day 3 (right). Scale bar: 100 µm.  
 
5.3.2 Control of Heterogeneity.  
In various self-assembled systems, the resulting superstructure is dependent upon 
the material composition, including component topology and concentration.2,12,13,42 
These factors govern the configurations in which macromolecules may assemble 
and the influence of secondary interactions (i.e., entanglement, additional 
hydrogen bonding, and electrostatic repulsion), respectively. Additionally, the 
formation of supramolecular structure is temporally dependent, as macromolecular 
re-arrangement is required.12 Accordingly, both temporal dependence and 
hydrogel composition were systematically investigated by microscopy methods, 
where hydrogels were allowed to evolve to the determined time point prior to 
photocrosslinking in the presence of thiolated fluorescein (5 mM). Inclusion of the 
fluorophore during the crosslinking process enabled improved contrast for 
quantification of pore features, including void fraction and pore diameter.  
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Heterogeneity rapidly developed in these systems, with void fractions of 
67.8±4.2% observed within 6 hours that slowly increased to 93.3±2.4% by day 7. 
Results were indicative of relatively rapid GH polymer condensation to achieve 
thermodynamic equilibrium. During this timeframe, the pore size steadily increased 
from 58.3±3.5 µm at 6 hr to 1025.4±209.4 µm at day 7. The drastic growth in pore 
size despite reduced relative changes in void fraction imply that pore growth may 
have resulted from microscopic restructuring, such as the merger of adjacent pores 
due to wall thinning (Figure 5.5A, indicated). 
To evaluate how hydrogel composition influenced porosity, samples were 
evaluated at day 3. Both void fraction (90.9±2.6% to 44.1±6.8%) and pore diameter 
(418.8±1.5 µm to 31.5±9.8 µm) were inversely proportional to polymer 
concentration (1.25-10 wt%). Increased modification of the guest polymer (50% 
modified Ad-HA) and varied polymer concentration demonstrated that pore size 
was controlled independent of polymer concentration. Void fractions (86.6±1.7% 
to 8.5±0.9%) were similar to those of 25% modified Ad-HA with drastic reductions 
in pore size (122.4±19.4 µm to 2.1 ± 0.5 µm). Taken together, these results indicate 
that polymer concentration alone is a governing factor in controlling the void 
fraction. Secondary polymeric interactions, including polymer solvation and 
electrostatic repulsion of HA are therefore implicated in suppression of void 
formation as they prevent polymer condensation. Independent of these 
mechanisms, increased Ad modification (i.e., increased multivalence) is known to 
drastically reduce dynamic rearrangement of guest-host hydrogels as a result of 
increased polymer avidity and formation of multifold junctions, as examined 
through prior characterization of bulk relaxation behaviors.37,43 Here, reduction in 
macromolecular dynamics due to increased avidity translated to reduced 
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microstructural rearrangement and hence reduced pore size. Due to the influence 
of macromolecular dynamics on the observed porosity, it is notable that the feature 
size and evolution timescale may also be drastically altered through selection of 
the supramolecular binding pairs, as the timescale for the transient associations is 
related to the equilibrium association constant (Keq) which varies by orders of 
magnitude.18,44  
 
Figure 5.5. Control over hydrogel porosity. (A) Representative confocal images (left) 
and corresponding quantification (right) of hydrogel void fraction and pore diameter over 
time (Day 0-7; 2.5 wt%; 25% modified Ad-HA). Wall thinning and pore merger, proposed 
to contribute to restructuring, is indicated (▼). Pore features were dependent on polymer 
concentration (B; Day 3; 1.25-10.0 wt%; 25% modified Ad-HA), including with change in 
Ad-HA modification (C; Day 3; 1.25-10 wt%; 50% modified Ad-HA).  
5.3.3 Micromechanical Characterization.  
Imaging in the hydrated state allowed discrete quantification of hydrogel 
heterogeneity. However, the composition of the solid and solute phases within the 
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hydrogel cannot be determined by optical methods, due to light diffraction which 
produces a non-zero intensity throughout the sample. In order to confirm phase 
segregation, both atomic force microscopy (AFM) and diffusive microparticle 
tracking analysis were performed.  
To probe heterogeneous structures via AFM, hydrogels (2.5 wt%) were cast in 
thin layers (~200 µm thick) and allowed to evolve for three days prior to 
photocrosslinking. The top surface was exposed and subject to indentation testing 
(Figure 5.6) at the hydrogel surface (i), where an indentation modulus of 0.41±0.07 
kPa was observed. The probe was re-located to the pore center (ii) at height 
identical to (i), where indentation yielded no measurable modulus. Assisted by the 
z-step motor of AFM (resolution = 0.1 µm), the indenter tip was lowered for ≈ 50 
µm until the pore surface (iii) was located. Throughout this process, 
nanoindentation measurements were repeated (approximately every 10 µm). At 
location (iii), nanoindentation yielded a modulus of 0.47±0.13 kPa. The inability of 
nanoindentation in step (ii) indicates that the pore phase indeed contained no 
crosslinked solid phase material, as no resistance to indentation was observed 
throughout the pore region. Moreover, the moduli of the gel phase were similar (p 
= 0.77) at both the top surface (i) and bottom of the pore region (iii), indicating 
homogeneity throughout the gel phase. It should be noted that these moduli are 
representative of the GH hydrogel only after the introduction of covalent crosslinks 




Figure 5.6. Examination of guest-host hydrogel heterogeneity via atomic force 
microscopy (AFM). (A) Schematic illustration of testing (side view), where moduli of the 
hydrogel (Day 3; 2.5 wt%) were determined at the top surface (i), in the pore center (ii, 
same z position as (i)) and at increments of approximately 10 µm until the bottom surface 
of the pore region (iii) was located. (B) Bright field image, approximate location of testing 
indicated. Scale bar: 100 µm. (C) Indentation moduli at the locations tested. (mean ± SE; 
n ≥ 6; p = 0.77). 
 
While AFM nanoindentation is useful to illustrate varied hydrogel moduli in 
space, it is unable to account for changes in viscoelastic behavior of the material 
or solute viscosity which may occur due to un-crosslinked polymer in solution. 
Toward investigation of viscosity and viscoelasticity, microparticle tracking has 
become a standard methodology, including in its active (i.e., traction force 
microscopy and driven microbead rheology) and passive (i.e., diffusive microbead 
rheology) forms. Moreover, these techniques have recently enabled investigation 
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of micro-heterogeneous environments, including in the intracellular and pericellular 
space.45,46 Thus, diffusive microbead rheology was explored herein, as it enables 
facile investigation and precision suit able to discern changes in viscosity resulting 
from small changes in HA concentrations.47,48 
 
Figure 5.7. Microrheological examination of guest-host hydrogels. (A) 
Representative epifluorescent image of microbeads (0.2 µm diameter) entrapped within 
the hydrogel (I, Day 7; 2.5 wt%) or diffusing throughout the pores (ii). Scale bar: 50µm. 
(B) Trajectories of particle motion within the x-y plane over a 30 second period for a 
microbead engrafted within the hydrogel (Gel, orange) or diffusing throughout a pore 
(Pore, blue). (C-D) Mean squared distance (MSD) traces of particle motion as a function 
of time for representative subpopulations (n=20 particles/group shown) within the hydrogel 
(C) and for solutions consisting of PBS or soluble hyaluronic acid (2.5, 5.0, 10.0 wt% HA 
in PBS) and fixed (non-diffusive) controls (D). (E) Diffusion coefficients, determined by fit 
to eq. (5.2) (mean ± SE; n > 25; *p < 0.05). 
 
To assess properties via microrheology, samples were prepared in thin layers 
with inclusion of 0.2 µm fluorescent beads without photocrosslinking. As included 
microbeads are entrapped within the polymer mesh during structural evolution, 
diffusive beads were not initially observed within the pores and were thus 
introduced by microinjection of concentrated suspensions and allowed to diffuse 
throughout the constructs prior to image acquisition. Particle motion and 
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trajectories within the hydrogels (Figure 5.7A,B) indicated two discrete 
populations—a population of diffusive particles grossly similar to those in buffer 
(PBS) and a separate population with constrained trajectories. Examination of 
mean-squared distance (MSD, Figure 5.7C,D) and fitting of diffusion parameters 
(eq. 5.2) confirmed diffusive, unconstrained motion (α = 1.04 ± 0.013) and 
subdiffusive motion (α = 0.76 ± 0.049) of particles within the pore and gel phases, 
respectively. Between the two populations, diffusion coefficients differed (Figure 
5.7E, Tukey p < 0.0001). Significant differences were also noted relative to 
measurement in buffer alone (PBS) and particles fixed to a glass surface, 
indicating some viscosity of the pore phase and some motion in the gel phase.  
To further validate sensitivity of the method toward viscosity changes, particle 
motion was examined in HA solutions of varying concentration (Figure 5.7D). 
Drastic changes in gross particle motion and diffusion coefficients (Tukey p < 
0.001) were observed with varied concentration. Exponential fits were performed 
to diffusion coefficients (D) as a function of HA concentration ([HA] mg/ml), (𝐷 =
2.70𝑒−0.54[𝐻𝐴];  𝑅2 > 0.98), from which the HA concentration within pores was 
approximated to be 0.16 wt%. Low concentrations of unbound polymer within the 
pore were likely a result of stochastic dissociation of guest or host polymers from 






Supramolecular interactions were utilized to produce physical hydrogels that 
evolved through hierarchical assembly to produce highly porous microstructures 
over time. Assembly resulted from macromolecular condensation, driven by 
dynamic molecular guest-host complexation. Micromechanical analysis indicated 
that the pores were indeed devoid of solid hydrogel—containing only low 
concentrations of dissociated polymer from stochastic erosion. Furthermore, the 
porosity evolved temporally to increase both void fraction and pore diameter. 
Owing to polymer solvation and electrostatic repulsion, component concentration 
was primarily responsible for suppression of the void fraction. Reduction in network 
dynamics (i.e., increased polymer modification) influenced the timescale of 
macromolecular rearrangement, altering pore diameter. Through these 
mechanisms, pore diameters spanning three orders of magnitude were achieved 
and void fractions as great as 93.3±2.4% were observed. These studies begin to 
close the gap in knowledge which exists between directed polymeric assembly and 
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CHAPTER 6 
 
Selective Proteolytic Degradation of Guest-Host Assembled, 
Injectable Hyaluronic Acid Hydrogels 
 
Adapted from: Rodell CB, Wade RW, Purcell BP, Dusaj NN, Burdick JA. Selective 
Proteolytic Degradation of Guest-Host Assembled, Injectable Hyaluronic Acid 
Hydrogels. ACS Biomaterials Science & Engineering 1, 227-237 (2015). 
 
6.1 Introduction 
Hydrogels are well suited for a range of biomedical applications, particularly 
due to their biophysical and biochemical properties. While synthetic hydrogels are 
not typically bioactive, they may be regarded as a blank slate, where desirable 
signals (e.g., topography, adhesion, mode of degradation) can be introduced. The 
incorporation of these signals has been widely used to engineer synthetic 
extracellular matrix (ECM) analogues for use as therapeutic scaffolds for tissue 
engineering or drug delivery applications. Such an engineering approach allows 
for reproducibility and more accurate control over physiochemical properties, when 
compared to naturally derived materials that exhibit many of the same features.1,2 
The incorporation of degradation into hydrogels is necessary for many 
applications, such as to control therapeutic delivery or to enable autonomous, 
noninvasive clearance of implanted or injected materials. Although numerous 
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degradation mechanisms exist (e.g. hydrolysis,2-5 and stochastic surface erosion6-
8), recent studies have focused on incorporating enzymatically degradable peptide 
crosslinkers9 to engineer cell-material interactions,10-14 drug delivery systems,1,15-
17 tissue engineering scaffolds,18-21 and biosensors.22-24 Such enzymatic 
degradation may be accomplished through polymeric or oligopeptide based 
crosslinkers with sensitivity to various enzymes, as discussed in numerous 
reviews.2,4,25,26 Of these enzymatically responsive systems, degradation by matrix 
metalloproteinases (MMPs)14,27,28 is particularly powerful, owing to the array of 
known MMPs, their specific expression patterns by cells and in response to 
injury,29 and the tailorable enzyme-substrate activity.30,31 These features lend 
themselves to therapeutic use, such as the generation of specific degradation in 
response to cell invasion or tissue damage.  
For employment of such systems in vivo, an implantable solid hydrogel may be 
formed by crosslinking ex vivo. This approach has been quite useful, including in 
drug delivery applications where cell-mediated degradation results in controlled 
biomolecule release.28,32 Alternatively, these systems may be injectable, such as 
through Michael-addition crosslinking where MMP-mediated delivery of multiple 
growth factors covalently bound to hydrogels is possible.16 Hydrogel formation 
through Schiff-base addition reactions has also enabled in situ hydrogel formation, 
with degradation used to modulate release of an MMP inhibitor, constituting a 
feedback system for modulation of tissue remodeling processes.17 While such 
covalent chemistries may enable injection, they pose the potential clinical 
challenge of premature crosslinking and delivery failure. These concerns are 
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particularly evident in the case of percutaneous delivery, where materials may be 
necessarily held within the injection device (i.e., syringe or catheter tubing) for a 
prolonged period (>1 hr) prior to injection.  
To address such challenges, self-assembling hydrogels may be of great utility. 
These systems may be exemplified by supramolecular self-assembling hydrogels, 
formed through the specific interaction of pendant or end group functionalities. In 
the majority of cases, these noncovalent interactions are readily reversible, 
enabling shear-induced flow for injection and rapid recovery at the target site for 
high retention.33,34 Systems based on various guest-host chemistries8,35 or 
engineered peptide and protein complexation7,36,37 demonstrate these desirable 
injectable properties. Numerous other noncovalently crosslinked networks have 
been formed that exhibit proteolytic degradation, including those based on 
thermogellation14,27 and ionic crosslinking.19 Self-assembling peptide systems 
have also been reported,15,38-43 including where degradation behavior influences 
molecule release15 and encapsulated cell behavior.39,43 While such systems show 
promise, their utility may be hampered by the limited scale of production and 
mechanical robustness, as well as difficulties associated with the synthesis and 
characterization of peptide units modified to incorporate degradable domains.40  
Herein, we sought to harness the advantages of both shear-thinning injectable 
materials and protease degradation. To accomplish this, we employed the guest-
host hydrogel system (Figure 6.1A), in which hydrogels undergo noncovalent 
hydrogel formation through the supramolecular interaction of adamantane (guest, 
Ad) and β-cyclodextrin (host, CD), which were separately coupled to hyaluronic 
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acid (HA). Such modification enabled formation of shear-thinning hydrogels with 
stochastically governed surface erosion. To permit proteolytic degradation, 
adamantane was bound via a peptide tether, which included the MMP degradable 
sequence VPMS-MRGG (Figure 6.1B, left) or the modified sequence VDMS-
MAGG (Figure 6.1B, right).  
 
Figure 6.1. Overview of material design. (A) Schematic of supramolecular assembly, 
with dynamic crosslink formation generated via guest-host complexation of β-cyclodextrin 
(host, CD) and adamantane (guest, Ad). (B) Design of the positively charged peptide linker 
(PAd – to allow MMP degradation) and negatively charged peptide linker (NAd – to limit 
specific MMP degradation), including Ad end-modification (i), cysteine residue for Michael-
addition coupling (ii), MMP cleavage site (iii), and local variation of charge near the 
cleavage site as underlined in amino acid sequence (iv).  
 
6.2 Materials and Methods 
6.2.1 General Materials and Methods.  
Sodium hyaluronic acid (HA, 90 kDa) was purchased from Lifecore Biomedical, 
Type II Collagenase from Worthington Biomedical, and recombinant human MMP-
2 (carrier-free) from R&D Systems. Other reagents were purchased from Sigma-
Aldrich and used as received unless otherwise indicated. 1H NMR spectra were 
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acquired at 360 MHz (Bruker) and chemical shifts are reported relative to the 
residual solvent peak.  
 
6.2.2 Peptide Synthesis.  
In order to permit guest-host assembly and MMP degradation, adamantane 
terminated peptides Ad-GGNSVPMSMRGGSNCG (PAd) and Ad-
GGNSVDMSMAGGSNCG (NAd) were prepared by standard solid phase peptide 
synthesis (PS3 automated peptide synthesizer, Protein Technologies) with glycinol 
2-chlorotrityl resin and FMOC protected amino acids (Novabiochem). The amine 
terminus was reacted with the free acid of 1-adamantane acetic acid by 
substitution of the guest compound in place of the terminal amino acid. The peptide 
was cleaved from the resin by hydrolysis in trifluoroacetic acid, triisopropyl silane, 
and water (95/2.5/2.5) and recovered by repeated precipitation from cold ethyl 
ether and lyophilization from water. To enable in vivo imaging, the near-IR 
fluorescent peptide Cy7.5-GKKCG (CyP) was likewise prepared by substitution of 
the free carboxylic acid of cyanine 7.5 in place of the terminal amino acid. Expected 
mass was confirmed by MALDI-tof mass spectrometry (Applied Biosystems 
Voyager 6030; PAd: m/z=1729.64, expected 1730.01 Da, NAd: m/z=1684.81, 
expected 1662.88 Da (measured mass corresponds to expected peptide 
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6.2.3 Peptide Degradation.  
In order to compare relative rates of proteolytic peptide degradation, 
fluorometric analysis of peptide cleavage was performed, based on modification of 
a previously reported protocol.44 Stock solutions of PAd and NAd peptides were 
prepared at 250 µM in PBS and supplemented with 1.0 mM CaCl2. The solutions 
were diluted by MMP-2 or Type II Collagenase to yield 125 μM peptide in either 1 
U/mL collagenase or 1.0 nM MMP-2, and samples were incubated at 37°C. 
Substrate cleavage was periodically monitored by sampling 75 µL of the 
substrate/enzyme solution, reacting with 20 μL fluorescamine (50 mM in acetone), 
and immediately detecting fluorescence (Tecan infinite M200 spectrophotometer; 
λabs/em = 380/480 nm). For determination of reaction kinetics, the fluorescence was 
converted to amine concentration relative to cystamine standards and plotted as a 
function of time. At early times, the concentration of substrate is much greater than 
the enzyme concentration, allowing approximation of zero-order kinetics and initial 
reaction rates were thus determined by linear fit.  
 
6.2.4 Peptide Modification of Hyaluronic Acid.  
Maleimide modified HA (MaHA) was prepared similar to previous reports12,32 
by coupling aminated maleimide to HA-TBA via amidation. Briefly, HA-TBA (1.6 g, 
2.23 mmol repeat units, 1.0 eq) and N-(2-aminoethyl)maleimide trifluoroacetate 
salt (0.37 g, 1.49 mmol, 0.67 eq) were dissolved at 2.0 wt% in DMSO under 
anhydrous conditions and the coupling agent (benzotriazol-1-
yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP; 0.66 g, 1.49 
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mmol, 0.67 eq) was added by dissolution in DMSO and subsequent cannulation. 
Purification was performed by extensive dialysis against DI water at 4ºC, to prevent 
maleimide hydrolysis, and filtration to remove insoluble byproducts from the 
reaction. The solution was frozen and lyophilized to obtain the final product. 
Functionalization was determined from integration of the vinyl group (δ=6.96, 2 H) 
relative to the methyl singlet of HA (δ=2.1, 3 H). The percent of HA repeat units 
modified was determined to be approximately 25%.  
For peptide coupling to the polymer, MaHA was dissolved in DI water at 1.0 
wt%. The desired peptide (1.1 eq PAd or NAd to maleimide) was dissolved in DI 
water and added dropwise. The reaction was slowly titrated to pH 6.5-7.0 with 0.1N 
NaOH and allowed to stir >2 hours at room temperature prior to purification by 
extensive dialysis and lyophilization to obtain the final product. For fluorescent 
derivatives, the peptide CyP (0.01 eq to HA repeats) was combined with the MaHA 
solution and stirred for 10 minutes prior to addition of PAd or NAd peptides.  
 
6.2.5 CD-HA Synthesis.  
β-Cyclodextrin modified hyaluronic acid (CD-HA) was prepared as previously 
described.8 Briefly, amine functionalized cyclodextrin was synthesized in the form 
of 6-(6-aminohexyl)amino-6-deoxy-β-cyclodextrin (β-CD-HDA) by methods 
analogous to our previous reports. Amidation of HA-TBA (2.0 g, 1.76 mmol repeat 
units, 1.0 eq) with β-CD-HDA (1.76 g, 0.5 eq) was performed in the presence of 
BOP (0.63 g, 0.5 eq) as described above for MaHA. Functionalization was 
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determined to be approximately 25% by integration of the hexane linker (δ=1.22-
1.77, 12 H) relative to the methyl singlet of HA (δ=2.1, 3 H). 
 
6.2.6 Hydrogel Formation.  
Hydrogels were formulated such that adamantane and β-cyclodextrin were 
present in stoichiometric balance and the concentration refers to the overall weight 
percent of combined polymers, which was maintained at 7.5 wt% unless otherwise 
noted. Hydrogels were prepared from stock solutions of the desired polymers in 
PBS. The two component solutions were combined, mixed by manually stirring, 
and then briefly centrifuged to remove entrapped air.  
 
6.2.7 Rheological Characterization.  
Characterization was performed using an AR2000 stress-controlled rheometer 
(TA Instruments) fitted with a 20 mm diameter cone and plate geometry, 59 min 
42 s cone angle, and 27 μm gap. Rheological properties were examined at 37ºC 
by oscillatory frequency sweeps (0.01-100 Hz; 0.5% strain), oscillatory time 
sweeps at various frequencies (0.01, 1.0 or 10.0 Hz; 0.5% strain), and continuous 
flow experiments with the shear rate linearly ramped from 0-0.5 s-1 and returned. 
For shear recovery experiments, shear-thinning was performed at 250% strain with 
recovery at 0.5% strain, each at 10 Hz.  
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6.2.8 In Vitro Hydrogel Erosion.  
Acrylamide molds were used to contain the hydrogels within a depression 
having 5 mm diameter and 6 mm height. Hydrogels were prepared as described 
and 30 μL of the desired hydrogel was loaded into the depression. Hydrogels were 
submerged with the desired buffer and allowed to degrade at 37°C. For 
collagenase degradation, the buffer was constituted of PBS supplemented with 1.0 
mM CaCl2 and collagenase at 0, 10, or 100 U/mL. For MMP-2 degradation, the 
buffer was similarly constituted of PBS supplemented with 1.0 mM CaCl2 and 
containing 5.0 nM MMP-2 and 0.1 wt% BSA (R&D, DY995) to prevent MMP-2 
adsorption to the acrylamide surface. The buffer was sampled periodically, with 
replacement of buffer or protease solution (to maintain protease activity in the 
hydrogel). At the study terminus, 1.0 mg/mL hyaluronidase was used to degrade 
any remaining hydrogel to allow determination of remaining HA content and 
release was quantified by uronic acid assay.45  
 
6.2.9 In Vivo Hydrogel Erosion.  
To allow for degradation to be longitudinally assessed in vivo, polymer 
components were labeled by the near-IR dye Cy7.5 as described above. All 
experiments conformed to the NIH Guide for the Care and Use of Laboratory 
Animals, and the procedures were approved by the Institutional Animal Use and 
Care Committee of the University of Pennsylvania. After injection of 25 µL of 
hydrogel subcutaneously in the upper right flank of BALB/c mice, degradation was 
assessed biweekly over 6 weeks (Pearl Impulse, LI-COR). For all animals, the 
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fluorescence signal (λex/λem=785/820 nm) was integrated over identically sized 
regions of interest centered over the injection site. Values were baseline corrected 
to the intensity of images of mice prior to injection, and normalized to the peak 
intensity (reached at one week post injection) for the material group.  
 
6.2.10 Statistical Analysis.  
All data is reported as mean ± standard deviation (SD). For peptide degradation 
studies, fit parameters were determined by linear regression in R and compared 
directly by ANOVA; error in fit parameters was determined from the regression 
analysis with propagation of error where necessary for calculation of dependent 
parameters (kcat). For degradation studies, comparison between groups was 
performed by Students t-test with two-tailed criteria and significance determined at 
α < 0.05.  
 
6.3 Results and Discussion 
6.3.1 Modulation of Peptide Proteolysis.  
Numerous MMP sensitive sequences have been investigated in the context of 
biomaterials; many have utilized the α1(I) collagen derived sequence 
GPQG↓IAGQ or its derivative with enhanced degradation rate, 
GPQG↓IWGQ.23,28,43,46 The α1(IV) collagen sequence GDQG-IAGF has been 
utilized as a non-degradable control,28,43,46 where a lack of proteolysis may be 
attributed to amino acids adjacent to the cleavage site. Indeed, it has been shown 
  151 
that MMP activity and selectivity towards specific substrates may be controlled, at 
least in part, as a response to the position-sensitive selection of neighboring amino 
acids.30 Of particular interest are the P3 and P2’ sites which differ between the 
non-degradable α1(IV) and degradable α1(I) collagen sequences. Basic or 
hydrophobic amino acids are generally preferred for the P2’ site, and the P3 site 
selects strongly for proline across all MMPs examined.30 Building on this work, we 
hypothesized that similar amino acid substitution could be used to alter peptide 
susceptibility to degradation via specific proteases. We therefore examined the 
degradation potential of two peptides. The first is optimized for activity in MMP-1, 
but shows high activity toward MMP-2 and other mammalian MMPs 
(VPMS↓MRGG),12,31 designated PAd due to the positive charge and adamantane 
terminus. The second sequence (VDMS-MAGG) incorporates the substitutions 
described and is designated NAd due to its negative charge and adamantane 
terminus. 
To examine the general peptide susceptibility to proteolytic activity, kinetic 
analysis of both PAd and NAd was first performed in Type II Collagenase (1 U/mL). 
Proteolysis was monitored by formation of the free amine terminus by reaction with 
fluorescamine, following modification of reported protocols.44 In response to 
collagenase, both PAd and NAd peptides were observed to undergo proteolysis 
and exhibited temporal profiles indicative of Michaelis-Menten kinetics (Figure 
6.2A). Linear fits to early timepoints yielded initial velocities for proteolytic 
cleavage, which did not differ between PAd (162.57±9.33 µM/hr) and NAd 
(155.41±36.94 µM/hr) peptides (p=0.78). The similar response toward degradation 
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in collagenase may be expected, as bacterially derived collagenases are known to 
exhibit broad activity, including toward nearly all collagenase types. The observed 
products are therefore a consensus of fragments generated by multiple MMPs, 
caseinase, clostripain, and other enzymes prevalent in bacterial collagenases.47  
To further examine specific activity toward mammalian MMPs, a similar 
analysis was performed in the presence of MMP-2 (1.0 nM). As the peptides are 
readily accessible in solution and the enzyme-substrate pair exhibits high affinity 
(Km ≈ 2 mM),31 saturation of the enzyme and observation of zero-order degradation 
may be expected, where the velocity is determined as  
𝑣 =  𝑣𝑚𝑎𝑥 = 𝑘𝑐𝑎𝑡[𝐸]. 
Indeed, degradation of PAd (Figure 6.2B) was observed to be linear (R2>0.98) in 
agreement with these predictions and prior observations.28 A velocity of 18.98 
±1.77 uM/hr was determined and an estimation of kcat obtained, based on the 
observed zero-order behavior and known MMP-2 concentration. The determined 
value of 5.27±0.49 s-1 is in good agreement with the reported literature value.31 
Examination of NAd showed no proteolysis in the presence of MMP-2, as there 
was no significant difference between the amine concentration at baseline and 6 
hours post incubation with MMP-2 (p=0.53). Correspondingly, analysis of fit 
parameters by ANOVA revealed that the initial velocity for degradation of NAd did 
not significantly different from 0 (p=0.41). These results demonstrate that both 
peptides undergo proteolytic cleavage in the presence of Type II collagenase, 
indicating that it is suitable for analysis of degradation behavior in vitro. Moreover, 
specific substitution of select amino acid residues was successful in modulating 
eq. (6.1) 
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substrate activity for a specific mammalian MMP, indicating that the sequence is 
suitable to investigate modular degradation behavior and that the chosen 
substitutions may be a generalizable methodology to achieve this end.  
 
Figure 6.2. Proteolytic degradation characterization. (A) Cleavage of PAd (green, solid 
lines) and NAd (blue, dashed lines) peptides in either (A) collagenase (Type II, 1.0 U/mL) 
or (B) MMP-2 (1.0 nM). Values represent mean ± SD; n=4. 
 
6.3.2 Chemical Modification of Hyaluronic Acid.  
After establishing the specific proteolytic potential of the peptides, they were 
used to modify HA for hydrogel formation. Due to the high efficiency and selectivity 
of the maleimide-thiol Michael-addition reaction,12 the maleimide modification of 
HA is a potent means of intermediate pendant HA modification. Such modification 
has previously enabled processes such as selective addition-crosslinking in the 
presence of methacrylates to enable secondary photopolymerization.13 Here, this 
methodology was extended to allow for efficient modification of HA by complete 
reaction of the maleimide with excess peptide (Figure 6.3A). 1H NMR confirmed 
the desired maleimide modification of HA (25%) and quantitative addition of 
peptide (PAd) both by complete consumption of the maleimide peak and 
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quantification of the adamantane ethyl peak (Figure 6.3B). Results demonstrate 
that maleimide modification is a facile means of biopolymer modification by 
oligopeptides containing a cysteine residue or other similarly thiolated molecules.  
Moreover, maleimide modification allows for modular modifications of HA by 
multiple peptides in a one-pot process. Previously, networks containing vinyl 
functional groups were formed with addition of cysteine-containing cell-adhesion 
peptides and then crosslinking via a bifunctional thiol.12,20,28,31,32,46 Similar to such 
procedures, MaHA was reacted with the fluorescent peptide CyP as the limiting 
reagent with subsequent addition of excess PAd or NAd peptides. We previously 
showed that similarly prepared fluorescent peptides retain native fluorescence and 
are useful for longitudinal analysis of degradation in vivo.48 Further, such reaction 
allows for an estimated 1.05% modification of repeat groups by the fluorophore. 
The extent of modification is in agreement with previous reports for fluorophore 
modifications of HA as an optical imaging agent, not exhibiting interchain 
quenching.49 Subsequent consumption of maleimides by PAd or NAd enabled 
facile preparation of such fluorescent material derivatives, necessary for later in 
vivo imaging. Therefore, this synthetic modification scheme allows for modular 
one-pot modification by two, or potentially more pendant groups, which may be 
useful to impart additional crosslinking or cell-directive functionalities.  
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Figure 6.3. Synthesis of peptide-modified HA. (A) The tetrabutyl ammonium salt of HA 
(HA-TBA) underwent amidation with N-(2-aminoethyl)maleimide (i) to form maleimide 
modified HA (MaHA) and successive coupling to the desired peptide (PAd) via Michael-
addition (ii) to form PAd modified HA (PAd-HA). (B) 1H NMR confirmed the maleimide 
modification (MaHA, 25% disaccharide repeats), as well as the complete conversion to 
peptide modification (PAd-HA). The same approach was taken for synthesis of NAd 
modified HA. 
 
6.3.3 Hydrogel Formation and Mechanical Properties.  
Following modification by guest and host pendant groups, we characterized 
hydrogel formation and properties to ensure maintenance of the guest-host 
assembly mechanism, as well as the shear-thinning and self-healing properties 
necessary for injectable delivery. As in previous reports,8,48 the individual modified 
HA components were solutions, exhibiting moderate viscosity due to polymer 
entanglement. Upon mixing of the two solutions, a hydrogel was rapidly formed 
through desired guest-host complexation of β-cyclodextrin and adamantane. 
Correspondingly, an increase in moduli was observed by oscillatory rheology 
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(Figure 6.4A). As expected, the moduli were dependent upon crosslink density as 
may be controlled through polymer concentration (Figure 6.4A,B).  
Due to the dynamic character of the guest-host crosslinks, hydrogels exhibited 
frequency dependence (Figure 6.4B). In contrast to previous reports,8,50,51 bulk 
relaxation was not observed over the frequency range examined. This may be the 
result of bridging between multifold junctions by the elongated peptide linker, which 
would result in bonding of adjacent multifold junctions and a concurrent decrease 
in network dynamics.51 We therefore concluded that guest-host assembly is 
retained in the presence of the peptide crosslinker PAd, and that the dynamic 
nature of crosslinks is evident despite a reduction in fluid-like stress relaxation. 
 
Figure 6.4. Rheological characterization of guest-host assembled hydrogels. (A) 
Oscillatory time sweeps of individual guest (5.0 wt% PAd-HA, blue) and host (5.0 wt% CD-
HA, red) macromers and hydrogel (purple) formed at various polymer concentrations as 
indicated; storage modulus (G’, filled symbols) and loss modulus (G’’, empty symbols) at 
0.1 Hz, 0.5% strain. (B) Representative oscillatory frequency sweeps showing storage 
modulus (G’, filled symbols) and loss modulus (G’’, open symbols) of PAd-HA hydrogels 
formed at different polymer concentrations as indicated (0.5% strain). 
 
For comparison of degradation behavior between hydrogels containing PAd 
and NAd tethers, it is desirable to attain similar mechanical properties between the 
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two groups. In direct comparison of the two systems, mechanical features of the 
hydrogels were consistent. Hydrogels formed from PAd-HA and NAd-HA exhibited 
similar moduli across the frequency domain (Figure 6.5A). Moreover, the 
incorporation of peptide linkers did not hinder the guest-host hydrogels known 
capacity for shear-induced flow recovery. For both hydrogels, strain sweeps 
(Figure 6.5B) displayed characteristic shear-yielding behavior, with applied strains 
in the range of 50-80% inducing network yielding and a reduction in mechanical 
properties. As a direct consequence of dynamic crosslink yielding, materials 
exhibited shear-thinning behavior (Figure 6.5C,D) following accumulation of 
internal shear-stresses capable of inducing yield and subsequent flow. To 
demonstrate self-healing following the cessation of flow, hydrogels were subjected 
to repeated cycles of high (250%) and low (0.5%) strain. In accordance with 
previous observations, high strain induced a drastic change in shear moduli (>50% 
G’) with complete recovery (>95% G’) within 3 seconds following reduction in shear 
(Figure 6.5E,F). 
It may be expected that changes in crosslinker length, charge, or conformation 
may affect the mechanical properties. However, we show here that the hydrogel 
mechanical properties with PAd and NAd tethers remain similar. These 
observations may be due to the minimal and selective modification of the non-
degradable peptide sequence, allowing it to retain its functional conformation. 
Moreover, we demonstrate that the guest-host hydrogel system retains dynamic 
properties similar to that of other binary associating systems. These dynamic 
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properties are important toward percutaneous delivery, as they enable shear-
thinning for injectable delivery and rapid recovery at the injection site.   
 
Figure 6.5. Rheological characterization of hydrogel mechanics and flow. (A) 
Representative oscillatory frequency sweeps of 7.5 wt% PAd-HA (green) and NAd-HA 
(blue) hydrogels; storage modulus (G’, filled symbols) and loss modulus (G’’, open 
symbols) at 0.5% strain. (B) Oscillatory strain sweeps of 7.5 w% PAd-HA and NAd-HA 
hydrogels; storage modulus (G’, filled symbols) and loss modulus (G’’, empty symbols) at 
10 Hz. (C,D) Continuous flow examination of 7.5 wt% PAd-HA (C) and NAd-HA (D) 
hydrogels under linearly ramped shear rate; shear stress (closed symbols) and viscosity 
(open symbols). (E,F) Recovery characterization of 7.5 wt% PAd-HA (E) and NAd-HA (F) 
hydrogels; storage (G’, red dotted line), loss modulus (G’’, blue dashed line), and loss 
tangent (tan (δ), black solid line) throughout cyclic deformation of 0.5% (low, unshaded 
areas) and 250% (high, shaded areas) strain at 10 Hz.  
 
6.3.4 Control of Proteolytic Hydrogel Degradation.  
Proteolytic degradation of hydrogels has emerged as a key hydrogel feature 
for in vitro studies of cell behavior and in vivo applications toward drug and cell 
delivery. We sought to transfer such features to guest-host hydrogels as well as to 
verify the synthesis of peptides with selectively modified relative degradation. 
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Importantly, the hydrogel degradation is mediated by the interplay of two distinct 
mechanisms, as depicted in Figure 6.6A.  
First, it is recognized that dissociation of any polymer chain from the network 
requires the simultaneous dissociation of all guest-host crosslinks, which 
dynamically oscillate between a bound (i) and unbound (ii) state. The probability a 
polymer chain having n modified groups with k groups unbound is described by 
the probability mass function  




where n is the number of guest or host molecules per polymer chain and Xk is the 
probability of dissociation for a single complex. Because states are binary (bound 
or unbound) and assuming the probabilities for each guest-host dissociation are 
identical (Xk = p) and independent, the function simplifies to the binomial 
distribution, allowing approximation of the number of dissociated chains by the 
binomial distribution, which simplifies to (3) for complete dissociation. 
𝑃 =  𝑝𝑛 
In the absence of proteolytic degradation, PAd and NAd hydrogels were observed 
to undergo degradation due to spontaneous, stochastically governed erosion at 
identical rates, as all timepoints are statistically undifferentiated between groups 
(p > 0.31). Results indicate that hydrogels are similarly formed and undergo 
identical degradation behavior in the absence of proteolytic degradation, despite 
modification of the peptide tether.  
eq. (6.2) 
eq. (6.3) 
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In the presence of proteolysis (Figure 6.6A, (iii)), dynamic crosslinks are 
permanently removed from the system. By extension of eq. (6.3), the probability 
function for polymer dissociation is:  
𝑃 = 𝑝(𝑛−𝛿(𝑡)) 
where δ(t) is the number of degraded crosslinks at any time, t. The probability for 
dissociation thus increaes with degradation. Accordingly, both PAd and NAd 
peptides underwent proteolysis and exhibit increasing degradation rates in a dose 
dependant manner in the presence of collagenase (Figure 6.6B,D). Moreover, as 
the peptides undergo proteolysis at near identical rates in collagenase, it is 
expected that δ(t) is similar between groups. Degradation kinetics in 25 U/mL 
collagenase were observed to be similar between groups, with no statistical 
differences before the terminal point at day 5. Cumulative degradation was likewise 
similar between groups in the presence of 100 U/mL collagenase.  
Finally, we examined the degradation kinetics of the two hydrogels in response 
to MMP-2. For the MMP-2 degradable sequence, PAd, increased erosion was 
observed in response to MMP-2 (Figure 6.6C). Beyond day 6, statistical 
differences between groups were noted and degradation followed a linear trend 
(R2 > 0.98) in agreement with results for peptide degradation in solution and other 
literature observations.17,28 In contrast, the proteolysis of NAd by MMP-2 is 
negligible, and thus dynamic crosslinks are not proteolytically removed from the 
network (Figure 6.6A, (iv)). Correspondingly, the probability of polymer 
dissociation is unaltered from eq. (6.3) and erosion proceeded without observation 
of a degradation response (Figure 6.6E).  
eq. (6.4) 
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Figure 6.6. Hydrogel erosion and degradation characteristics in vitro. (A) Schematic 
of mass loss due to combined erosion and degradation processes. Guest-host crosslinks 
(i) undergo continuous dissociation (ii) and re-association processes, which contribute to 
erosion. Proteolysis of peptide crosslinks (iii) contributes to degradation, which may be 
hindered by selective peptide modification (iv). (B-E) Cumulative hydrogel erosion profiles 
of 7.5 wt% PAd-HA (B,C) and NAd-HA (D,E) hydrogels in in either collagenase (B,D) or 
MMP-2 (C,E) at concentrations noted. Values represent mean±SD; n=4. 
 
These results provide proof of principle for the design of injectable, degradable 
hydrogels based on direct binary associations, as well as a context for describing 
their combined erosion and degradation behaviors. Hydrogels formed containing 
either oligopeptide tether exhibited similar and complete degradation in 
collagenase, indicating a propensity for proteolytic degradation. Though, only the 
PAd sequence displayed enhanced degradation in response to MMP-2, indicative 
of the desired sequence modification. Moreover, statistical conceptualization of the 
erosion behaviors provides an initial context to understand the erosion behaviors, 
though such methodology may benefit from more rigorous mathematical 
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treatment51 to aid in modeling approaches capable of describing these behaviors 
more completely.1  
While numerous material systems with tunable degradation behavior have 
been developed, not all such systems translate to similarly distinguishable 
differences in vivo,52,53 including those with designed enzymatic degradation.23,54 
Therefore, the material system was investigated in a subcutaneous injection 
model, where degradation was monitored to demonstrate their capacity toward 
injectable delivery, target site retention, and modulation of the in vivo degradation 
response. Hydrogels were injected subcutaneously into the flank of mice, forming 
a visible and palpable mass directly at the injection site. Degradation behavior was 
continuously monitored by non-invasive imaging and quantification of the bound 
near-IR fluorophore (Figure 6.7). Both hydrogel systems approached near-
complete clearance by 6 weeks post-injection. However, the clearance of 
hydrogels containing the NAd tether proceeded at a reduced rate, with significantly 
reduced clearance observed prior to day 35. The observed degradation behavior 
is in qualitative agreement with in vitro proteolysis and degradation studies, which 
demonstrated enhanced proteolysis and degradation of PAd hydrogels. However, 
there is a notable quantitative discrepancy between the in vivo and in vitro 
degradation rates. In vitro, degradation is likely accelerated by supraphysiological 
MMP concentrations as well as the unconfined conditions (i.e., exposed directly to 
buffer without confinement). In vivo, degradation and erosion is also affected by 
mechanical confinement to prevent erosion as well as the presence of tissue 
inhibitors of MMPs (TIMPs), native to the tissue. 
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Figure 6.7. Hydrogel erosion and degradation characteristics in vivo. Time course 
images of near-IR fluorescence imaging of 7.5 wt% PAd-HA (A, green) and NAd-HA (B, 
blue) hydrogels after injection subcutaneously in the right flank of mice. Both hydrogels 
included covalent conjugation of the near-IR dye Cy7.5. (C) Quantification of normalized 
signal intensities. Values represent mean±SD; n=3.  
 
Herein, we have directly examined the clearance of polymer from the injection 
site and the capacity for this degradation to be influenced by proteolytic 
degradation. Such release kinetics may also reflect those experienced by 
therapeutics which are covalently bound to the polymer network.46,55 However, the 
degradation response may also be of interest to direct the release of therapeutitc 
proteins which are diffusively released from a physically crosslinked network at the 
site of action.56 Toward the controlled release of such factors, their sequestration 
by interaction with the polymer network may be of interest. Such methods may 
include the exploitation of native protein-matrix afffinity.17,32,57 Due to the inclusion 
of cyclodextrin in the material formulation, utilization of guest-host interractions in 
sequestration of therapeutic agents is also of key interest. Indeed, numerous small 
molecule pharmacologics are known to interect strongly with β-cyclodextrin.58,59 
Moreover, their interaction with specific amino acid resudues both in peptides and 
proteins has been investigated and is a promosing approach toward engineered 
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affinity for peptide-based pharmaceutical agents.60,61 Further exploration into the 
role of proteolytic degradation’s influence on such modes of molecule release is of 
great interest toward the development of therapeutic biomaterials.  
 
6.4 Conclusion 
In sum, we have developed a materials system for the formation of self-
assembling, injectable, and enzymatically degradable hydrogels. Rational peptide 
design was used to alter MMP-mediated hydrogel degradation kinetics. As a result 
of minimal changes in two amino acids, both mechanical and stochastic erosion 
properties of hydrogels were conserved. Importantly, the utilization of direct binary 
association between the guest and host functional groups enabled injection with 
high target site retention and prolonged degradation in vivo, which was influenced 
by proteolytically degradation. There has been a recent and concurrent drive 
toward the development of injectable and biodegradable materials, owing to their 
potential for clinical translation and versatility. The materials system developed 
herein may serve as a vital bridge between these two important fields, facilitating 
such applications as drug and cell delivery in regenerative medicine. 
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CHAPTER 7 
 
Shear-Thinning Supramolecular Hydrogels with Secondary 
Autonomous Covalent Crosslinking to Modulate Viscoelastic 
Properties In Vivo 
 
Adapted from: Rodell CB, MacArthur JW, Dorsey SM, Wade RJ, Woo YJ, Burdick 
JA. Shear-Thinning Supramolecular Hydrogels with Secondary Autonomous 
Covalent Crosslinking to Modulate Viscoelastic Properties In Vivo. Advanced 
Functional Materials 25, 636-644 (2015). 
 
7.1 Introduction 
Hydrogels are water-swollen polymeric networks that are used widely in 
biomedical applications as scaffolds for tissue reconstruction and regeneration or 
as delivery vehicles for cells, pharmaceuticals, or other cargo. Injectable hydrogels 
hold particular value in translational medicine as they may be implanted with 
minimally invasive methods.1-5 To accomplish this, in vivo self-assembly either 
through physical or covalent mechanisms is often employed. Unfortunately, neither 
of these mechanisms is without issue for widespread use in biomedical 
applications.  
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Hydrogels assembled by physical mechanisms may be formed from numerous 
materials and interactions. These include biologically derived materials such as 
alginate, fibrin, gelatin, Matrigel or decellularized extracellular matrix;2-4,6,7 
however, these systems are limited in application, due to a high degree of batch-
to-batch variability and minimal control over important material properties (e.g., 
mechanics and degradation). Thermoresponsive hydrogels, such poly(N-isopropyl 
acrylamide), block copolymers, and polymer blends8,9 often display rapid sol-gel 
transition on injection to aid in localized retention.10 However, these systems may 
not be suitable for percutaneous delivery (e.g., catheters) where materials are 
subject to necessary prolonged exposure at 37°C within the catheter, prior to 
injection. Under these conditions, the sol-gel transition may occur within the device 
and prevent desired delivery. Synthetic hydrogels including self-assembling 
peptides and α-cyclodextrin/PEG pseudopolyrotaxanes have also been 
extensively investigated, as discussed in a recent review.1-3,7 These systems are 
synthetically well defined and are stable toward external stimuli, such as 
temperature. However, they require potentially slow formation of higher order 
assemblies such as entanglements or microcrystalline domains in order to recover 
mechanical strength, compromising material retention at the target site. Moreover, 
extension of these systems to include end capped polyrotaxanes has shown the 
capacity to afford highly elastic and even thermoresponsive systems.11 Yet, 
extension of these systems to include in vivo formation has yet to be demonstrated.  
As an alternative to these systems, supramolecular self-assembly based on the 
direct association of molecular components has recently emerged as a means of 
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preparing hydrogels through specific, non-covalent crosslinks. Such assembly 
produce inherently dynamic networks that enable shear-thinning and self-healing 
properties, and thus injectability.12 Both binary and ternary associating systems, 
such as those based on heterodimeric peptide/protein13,14 or host macrocycle 
interactions,15,16 have demonstrated shear-thinning abilities in conjunction with 
rapid network recovery. Similarly, the utilization of cationically terminated linear or 
dendritic binders in conjunction with clay nanosheets has demonstrated utility in 
formation of shear-thinning and self-healing nanocomposites through ionic 
interactions.17,18 Such recovery characteristics may aid in retention at the injection 
site,9,19-21 particularly for tissues that are under mechanical stress (e.g., nucleus 
pulpous) or those that undergo continual dynamic motion (e.g., cardiac tissue). 
Unfortunately, these materials are inherently limited in that they typically exhibit 
low mechanical strength1,12 and may exhibit rapid erosion dependent on the 
valence of crosslinking groups and their affinity.1,14,22  
For more physically demanding applications, covalently crosslinked systems 
may be more appropriate. In addition to increased relative mechanical strength, 
hydrogels formed through covalent means display great versatility with the allowed 
inclusion of controlled network degradation and the introduction of biological cues 
such as cell adhesion and bioactive factor delivery. Indeed, numerous chemical 
mechanisms have been employed for in vivo crosslinking including redox-
initiated23 and externally triggered24,25 radical polymerizations, as well as various 
addition reactions including Schiff-base, Michael-addition, and Huisgen 
cycloaddition chemistries.3 Michael-addition reactions remain prominent in the 
  174 
field, due in part to mild reaction conditions, bioorthogonal mechanisms, and 
readily tailorable reaction kinetics.26 These properties are highly beneficial toward 
injectable applications where the hydrogel must form in vivo without cross-
reactivity (e.g., with protein amine residues) or other biological consequence (e.g., 
exothermic necrosis). The ability to control crosslinking kinetics is also of utmost 
importance, as clinical procedures may require the hydrogel to remain in an 
injectable state for an hour or more, making rapid crosslinking reactions unsuitable. 
For ease of clinical application, the hydrogel must therefore undergo crosslinking 
with slow reaction kinetics to prevent premature crosslinking and delivery failure. 
While such slow reaction kinetics may allow delivery, it is realized that slow 
crosslinking results in undesirable loss of material from the injection site.19,27 Thus, 
there is basic design flaw with currently developed hydrogels for applications as 
an injectable material.  
To address these inherent limitations of current injectable hydrogel systems, a 
generally applicable dual-crosslinking mechanism is developed herein. The 
hydrogels first undergo physical assembly ex vivo through supramolecular self-
assembly mediated by guest (adamantine, Ad) and host (β-cyclodextrin, CD) 
pendant groups. This mechanism enables shear-thinning delivery with high 
retention at the target site. Following injection, a secondary covalent crosslinking 
occurs in situ via Michael-addition to stabilize the network. Crosslinking kinetics of 
this secondary network are clinically appropriate and controlled through both the 
Michael-acceptor reactivity and catalytic conditions. The novel combination of 
autonomous physical and covalent crosslinking demonstrated is a generally 
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applicable method for retention and subsequent reinforcement of injectable 
materials amenable to clinical application and may serve as a platform for 
numerous ventures in bioengineering and regenerative medicine. To demonstrate 
this, the materials developed are utilized in a mechanical stabilization approach for 
treatment of myocardial infarctions. 
 
7.2. Materials and Methods  
7.2.1 General Materials and Methods.  
Sodium hyaluronic acid (HA, 90kDa) was purchased from Lifecore (Chaska, 
MN). All other chemicals were purchased from Sigma-Aldrich unless otherwise 
indicated. 1H NMR spectra were acquired at 360MHz (Bruker) and chemical shifts 
reported relative to the residual solvent peak.  
 
7.2.2 HA-TBA Preparation.  
To prepare the organic soluble tetrabutylammonium salt of HA (HA-TBA), the 
sodium salt of HA was dissolved in DI water at 2.0 wt%, exchanged against Dowex-
100 resin, neutralized by tetrabutylammonium hydroxide, and then frozen and 
lyophilized.28 
 
7.2.3 Ad-HA Synthesis.  
Ad-HA was prepared by coupling 1-adamantane acetic acid to HA-TBA via 
esterification (Figure 7.1).15 A round bottom flask was charged with HA-TBA (3.0 
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g, 4.18 mmol repeat units, 1 eq), 1-adamantane acetic acid (2.44 g, 12.52 mmol, 
3 eq), and 4-dimethylaminopyridine (DMAP; 0.76 g, 6.26 mmol, 0.5 eq). The vessel 
was purged by nitrogen, and anhydrous DMSO added via cannulation to afford an 
approximately 2wt% solution. Once fully dissolved, di-tert-butyl dicarbonate 
(BOC2O) was added via syringe (0.32 mL, 1.40 mmol,0.33 eq) and the reaction 
carried out at 45°C for 24 hours. Purification was performed by dialysis for 3 days 
against DI water, precipitation in acetone, and further dialysis. The solutions were 
frozen and lyophilized to obtain the final products. Adamantane functionalization 
was quantified by 1H-NMR and determined to be 21.4% from integration of the 
ethyl multiplet of adamantane (δ=1.42-1.70, 12 H) relative to the HA backbone 
(δ=3.10-4.10, 10 H). 
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7.2.4 β-CD-HDA Synthesis.  
Synthesis of 6-(6-aminohexyl)amino-6-deoxy-β-cyclodextrin (β-CD-HDA) was 
performed by adaptation of similar reported syntheses.15,29-31 β-cyclodextrin (45 g, 
39.65 mmol, 1 eq) was suspended in water (300 mL) and cooled to 0°C. p-
toluenesulfonyl chloride (TosCl; 8.35 g, 43.61 mmol, 1.1 eq) was dissolved in 
minimal acetonitrile (25 mL) and added dropwise. The reaction was stirred at room 
temperature for 2 hours. The reaction was cooled on ice prior to the dropwise 
addition of NaOH (4.75 g, 118.94 mmol, 3.0 eq) dissolved in water (20 mL). The 
reaction was stirred further at room temperature for 30 minutes before the pH was 
adjusted to 8.5 by addition of solid ammonium chloride (~40 g). The solution was 
then cooled on ice and the precipitate collected. The crude product was re-
precipitated from cold water (3x400mL), washed by acetone (3 x 200 mL) and dried 
under vacuum to afford the intermediate 6-o-monotosyl-6-deoxy-β-cyclodextrin 
(8.80 g, 22%) as a white powder. 1H-NMR (DMSO-d6) δ = 2.42 (s, 3 H), 3.12-3.80 
(m, overlaps with HOD), 4.12-4.40 (m, 6 H), 4.77 (s, 2 H), 4.83 (s, 5 H), 5.60-6.05 
(br s, 14 H), 7.43 (d, 2 H), 7.75 (d, 2 H). A round bottom flask was charged with 6-
o-monotosyl-6-deoxy-β-cyclodextrin (8.8 g, 6.83 mmol, 1 eq), 1,6-hexanediamine 
(HDA; 35 g, 300.17 mmol, 44.2 eq), and DMF (50 mL). The reaction was carried 
out under nitrogen at 80°C for 18 hours. The product was repeatedly precipitated 
from cold acetone, washed by cold diethyl ether and dried under vacuum to afford 
the final product (6.75 g, 80%) as a white powder. 1H-NMR (DMSO-d6) δ = 1.14-
1.61 (m, 12 H), 3.12-3.45 (m, overlaps with HOD), 3.48-3.78 (m, 28 H), 4.28-4.56 
(br s, 6 H), 4.83 (s, 7 H), 5.59-5.88 (br s, 14 H). 
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7.2.5 CD-HA Synthesis.  
CD-HA was prepared by coupling β-CD-HDA to HA-TBA via amidation (Figure 
7.2).15,32 A round bottom flask was charged with HA-TBA (1 g, 1.41 mmol repeat 
units, 1 eq) and β-CD-HDA (0.70 g, 5.65mmol, 0.4 eq). The vessel was purged by 
nitrogen and anhydrous DMSO added via cannulation to afford an approximately 
2wt% solution. Once fully dissolved, (benzotriazol-1-
yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP; 0.25 g, 0.565 
mmol, 0.4 eq) was dissolved in minimal DMSO and transferred to the reaction 
vessel via cannulation. The reaction was carried out at room temperature for 2 
hours. Purification was performed by extensive dialysis against DI water and 
filtration to remove insoluble byproducts from the reaction. The solution was frozen 
and lyophilized to obtain the final product. Functionalization was determined to be 
20% by integration of the hexane linker (δ=1.22-1.77, 12 H) relative to the methyl 
singlet of HA (δ=2.1, 3 H). 
 
Figure 7.2. Synthesis of CD-HA. (A) Synthesis scheme. (B) Corresponding 1H NMR 
spectra.  
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7.2.6 HA-SH Synthesis.  
HA-SH was prepared by coupling 3,3’-dithiopropionic acid (DTPA) to HA-TBA 
via esterification, followed by reduction with DTT to obtain the free thiol (Figure 
7.3). Esterification was performed as above, with reactants: HA-TBA (0.75 g, 1.14 
mmol repeat units, 1 eq), DPTA (1.20 g, 5.71 mmol, 5.0 eq), DMAP (0.35 g, 2.85 
mmol, 2.50 eq), and Boc2O (0.20 mL, 0.88 mmol, 0.4 eq) to afford the intermediate 
DTP-HA. Functionalization of the macromer was quantified by 1H-NMR and 
determined from integration of the ethyl multiplet (δ=2.61-2.72, 2 H) relative to the 
methyl singlet of HA (δ=2.1, 3 H). Subsequently, the disulfide was reduced with 
DTT to obtain the free thiol. DTP-HA (0.5g, 1.27 mmol, 1.0 eq) was dissolved in DI 
water (50mL), and DTT (0.5g, 32.41 mmol, 25.5 eq) and NaCl (0.5g) added in solid 
form. The pH was increased to 8.5 with 0.1N NaOH and the reaction stirred at 
room temperature for 3 hours, at which time the NaCl concentration was increased 
to 5.0%w/v and the pH adjusted to 3.5 by 0.1N HCl. The product was recovered 
by precipitation in cold EtOH (450mL) followed by repeated washing by 100% 
EtOH. EtOH was removed under vacuum prior to re-dissolving in DI water and 
lyophilization to obtain the final thiolated HA (HA-SH). Functionalization of the 
macromer was quantified by 1H-NMR and determined from integration of the ethyl 
singlet (δ=2.80-3.0, 4 H) relative to the methyl singlet of HA (δ=2.1, 3 H). Both the 
intermediate, DTP-HA, and HA-SH modification of the HA by the desired functional 
group was determined to be approximately 20%.  
As attempts to thiolate HA via amidation showed a high degree of disulfide 
crosslinking and because acidic conditions utilized in product isolation may be 
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hydrolytic toward the polymer backbone, products were examined by gel 
permeation chromatography (GPC) with 90kDa sodium hyaluronate (HA) as a 
control reference. Elution traces showed partial crosslinking as a result of HA 
modification with the bifunctional carboxylic acid DTPA. However, following 
reduction by DTT and isolation as described above, HA-SH elution traces showed 
recovery of product without disulfide formation or degradation of the macromer. 
 
Figure 7.3. Synthesis of HA-SH. (A) Synthesis scheme. (B,C) Corresponding 1H NMR 
spectra of the intermediate prior to DTT reduction (B) and following reduction (C).  
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7.2.7 MeHA Synthesis.  
Methacrylated HA (MeHA) was prepared through the conventional methacrylic 
anhydride route (Figure 7.4).33 Briefly, HA (3g, 7.61mmol, 1.0 eq) was dissolved in 
DI water (300mL) and cooled on ice. The pH was adjusted to 8.5, and methacrylic 
anhydride (2.25 mL, 15.1 mmol, 2 eq) added. With vigorous stirring, the pH was 
maintained at pH 7.5-8.5 by addition of 5N NaOH for 8 hours. Additional 
modification was similarly performed the following day by addition of 1.125mL 
methacrylic anhydride and maintenance of the pH at 7.5-8.5 for an additional 4 
hours. Functionalization of the macromer was quantified by 1H-NMR and 
determined to be 30% from integration of the vinyl group (δ=5.82, 1 H and δ=6.25, 
1 H) relative to the HA backbone (δ=3.20-4.20, 10 H). 
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7.2.8 AHA Synthesis.  
Acrylated HA (AHA) was prepared by esterification of acrylic acid to HA-TBA 
as previously described (Figure 7.5).34 Synthesis was performed analogous to that 
of Ad-HA, with reactants: HA-TBA (0.5 g, 0.715 mmol repeat units, 1 eq), acrylic 
acid (0.122 mL, 1.79 mmol, 2.5 eq), DMAP (6.5 mg, 53.5 μmol, 0.075 eq), and 
BOC2O (0.144 mL, 0.625 mmol, 0.875 eq). Acrylate functionalization was 
quantified by 1H-NMR and determined from integration of the vinyl peaks 
(δ=5.6.55, 6.30, 6.09 1 H ea.) relative to the methyl peak of HA (δ=2.10, 3 H). The 
percent of HA repeat units modified was determined to be 17.5%.  
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7.2.9 VS-HA Synthesis.  
Vinyl sulfone HA (VS-HA) was prepared by reaction of HA-SH with 
divinylsulfone (Figure 7.6). HA-SH was prepared as described above. Following 
precipitation in EtOH, HA-SH (0.1g, 0.359mmol, 1.0eq) was dissolved in DI water 
at approximately 2wt% and added dropwise to excess divinylsulfone (0.7mL, 
7.19mmol, 20eq) dissolved in 5mL DI water. The solution was titrated to pH 7.0 by 
0.1N NaOH and stirred on ice for 2 hours. Purification was performed by extensive 
dialysis against DI water. The solution was frozen and lyophilized to obtain the final 
products. Vinyl functionalization of the macromers was quantified by 1H-NMR and 
determined from integration of the vinyl peak multiplets (δ=6.50, 2 H and δ=6.95, 
1 H) relative to the HA backbone (δ=3.20-4.20, 10 H). The percent of HA repeat 
units modified was determined to be approximately 20%. 
 
Figure 7.6. Synthesis of VS-HA. (A) Synthesis scheme. (B) Corresponding 1H NMR 
spectra. 
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7.2.10 MaHA Synthesis.  
MaHA was prepared by coupling N-(2-Aminoethyl)maleimide trifluoroacetate 
salt to HA-TBA via amidation (Figure 7.7). Reaction was carried out as described 
above, with reactants: HA-TBA (1.6 g, 2.26 mmol repeat units, 1.0 eq), N-(2-
Aminoethyl)maleimide (0.215 g, 0.848 mmol, 0.375 eq), and BOP (0.375 g,0.848 
mmol, 0.375 eq). Purification was performed by extensive dialysis against DI water 
at 4ºC, to prevent maleimide hydrolysis, and filtration to remove insoluble 
byproducts from the reaction. The solution was frozen and lyophilized to obtain the 
final product. Functionalization was determined from integration of the vinyl group 
(δ=6.96, 2 H) relative to the methyl singlet of HA (δ=2.1, 3 H). The percent of HA 
repeat units modified was determined to be approximately 19%. 
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7.2.11 Ad-HA-SH Synthesis.  
 
Figure 7.8. Synthesis of Ad-HA-SH. (A) Synthesis scheme. (B) Corresponding 1H NMR 
spectra.  
 
Ad-HA-SH was prepared by sequential modification of HA by adamantane then 
the mercapto group as described above (Figure 7.8). A portion of Ad-HA prepared 
(1.1g) was dissolved in 50mL DI water and exchanged against 3.3g Dowex-100 
resin, neutralized by tetrabutylammonium hydroxide, and then frozen and 
lyophilized to obtain the intermediate Ad-HA-TBA. A round bottom flask was 
charged with Ad-HA-TBA (1.44 g, 2.19 mmol repeat units, 1 eq), 3,3’-
dithiopropionic acid (2.30 g, 10.95 mmol, 5.0 eq), and 4-dimethylaminopyridine 
(0.70 g, 5.48 mmol, 2.50 eq). The vessel was purged by nitrogen, and anhydrous 
DMSO added via cannulation to afford an approximately 2wt% solution. Once fully 
dissolved, di-tert-butyl dicarbonate (BOC2O) was added via syringe (0.20 mL, 0.88 
mmol, 0.4 eq) and the reaction carried out at 45°C for 24 hours. Purification was 
performed by dialysis for 3 days against DI water, precipitation in acetone, and 
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further dialysis. The solutions were frozen and lyophilized to obtain the 
intermediate Ad-HA-DTP. Functionalization of the macromer was quantified by 1H-
NMR and determined from integration of the ethyl multiplet (δ=2.61-2.72, 2 H) 
relative to the backbone of HA. Subsequently, the disulfide was reduced by DTT 
to afford the free thiol, as described above for HA-SH. Thiol modification of the 
macromer was quantified by 1H-NMR and determined from integration of the ethyl 
singlet (δ=2.60-2.82, 4 H) relative to the HA backbone.  
 
7.2.12 CD-MeHA Synthesis.  
CD-MeHA was prepared by sequential modification of HA by methacrylates 
then CD-HDA by reactions as described above (Figure 7.9). A portion of MeHA 
(1.5g) was converted to the TBA salt as previously described to afford the 
intermediate MeHA-TBA. A round bottom flask was charged with MeHA-TBA (1 g, 
1.41 mmol repeat units, 1 eq) and cyclodextrin modification carried out identically 
to that for preparation of CD-HA. Because both the HA backbone and methyl peak 
are obscured by cyclodextrin and the methacrylate, respectively, methacrylate 
modification was assumed to remain unchanged and functionalization by CD-HDA 
was determined to be 20% by integration of the hexane linker (δ=1.35-1.85, 12 H). 
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Figure 7.9. Synthesis of CD-MeHA. (A) Synthesis scheme. (B) Corresponding 1H NMR 
spectra.  
 
7.2.13 CD-MeHA-CyP Synthesis. 
In order to label guest-host (GH) and dual-crosslinking (DC) hydrogels for 
monitoring in vivo degradation, the fluorescent peptide GCKKG-Cy7.5 (Figure 
7.10A) was prepared by standard solid phase peptide synthesis (PS3 automated 
peptide synthesizer, Protein Technologies) with glycinol 2-chlorotrityl resin and 
FMOC protected amino acids. The amine terminus was reacted with the free acid 
of Cy7.5 (Lumiprobe; 3x molar excess to resin loading) by substitution of the 
fluorophore in place of the terminal amino acid. The peptide was cleaved from the 
resin by reaction with trifluoroacetic acid, triisopropyl silane, and water (95/2.5/2.5) 
and recovered by repeated precipitation from cold diethyl ether. Expected mass 
(1165 Da) was confirmed by MALDI-tof mass spectrometry (Applied Biosystemd 
Voyager 6030; Figure 7.10C). Absorbance and emission spectra were obtained 
(Tecan infinite M200 spectrophotometer (Figure 7.10D) in dilute aqueous solution. 
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The peptide displayed a characteristic absorbance in the 560-850 nm range (λmax 
abs=800 nm) and strong fluorescence in the near-IR range (λmax em=808 nm).  
For peptide coupling (Figure 7.10B) to the polymer for imaging, CD-MeHA (100 
mg, 0.15 mmol, 1.0 eq) was dissolved in 20mL of triethanolamine buffer, pH 10. 
The fluorescent peptide (6.5 mg, 5.56µmol, 0.036eq) was dissolved in minimal DI 
water and added dropwise. The reactions were allowed to proceed at 4oC for 4 
hours prior to extensive dialysis and lyophilization which afforded the final product. 
 
Figure 7.10. Synthesis of CD-MeHA-CyP. (A) Design of Cy7.5-terminated fluorescent 
peptide (CyP). (B) Scheme for coupling of CyP with CD-MeHA. (C) MALDI-MS conforming 
molecular weight of CyP. (D) Absorbance and emission spectra of CyP. . 
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7.2.14 Hydrogel Formation.  
For all studies, hydrogels were prepared from stock solutions of the individual 
macromers in PBS at the desired concentration. For hydrogel formation by guest-
host assembly, the two component solutions were combined and mixed by 
manually stirring to ensure a homogenous hydrogel then centrifuged to remove 
entrapped air. Hydrogels were formulated such that adamantane and β-
cyclodextrin were present in stoichiometric balance, and the concentration refers 
to the overall weight percent of combined macromers. Formation of hydrogels via 
the Michael-addition and dual-crosslinking mechanisms was similarly performed, 
with the pH of dissolution buffers adjusted to obtain the desired pH. 
 
7.2.15 Mechanical Characterization.  
Rheological characterization was performed using an AR2000 stress-
controlled rheometer (TA Instruments) fitted with a 20 mm diameter cone and plate 
geometry, 59 min 42 s cone angle, and 27 μm gap. Rheological properties were 
examined at 37 ºC by oscillatory frequency sweeps (0.01-100 Hz; 1% strain), time 
sweeps (1.0; 1% strain), strain sweeps (10 Hz; 0.05-250% strain), and continuous 
flow experiments (linearly ramped: 0-0.5 s-1 and returned). For shear recovery 
experiments, shear-thinning was performed at 100% strain with recovery at 1.0% 
strain, each at 10 Hz. Compressive mechanics were performed on samples (n=3) 
following crosslinking at pH 8.0 overnight at 37 ºC with a dynamic mechanical 
analyzer (DMA, Q800 TA Instruments) at a strain rate of 10%/min. Moduli were 
calculated at a strain of 10-20%.   
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7.2.16 MRI Imaging and Analysis.  
Cardiac explants were imaged using either a 3T or 9.4T MRI Scanner 
(Siemens) to directly visualize material distribution and quantify retention. 
Hydrogels injections were performed via syringe (28G ½” needle) at a depth of 
approximately 4 mm from the epicardial surface of porcine myocardial explants. 
Tissue samples were stored in PBS supplemented with Penicillin-Streptomycin 
before initial imaging (<2 hours post-injection) and between subsequent 
timepoints. Imaging at 3T was performed with submersion in PBS to minimize 
dielectric artifacts near the tissue surface. A T2 weighted turbo spin echo pulse 
sequence was used with the following parameters: echo time (TE) = 71 ms, 
repetition time (TR) = 6000 ms, averages = 2, matrix size = 320 x 320 x 50, voxel 
size = 0.3125 x 0. 3125 x 0.1 mm3. Imaging at 9.4T was performed in ambient 
conditions. A T2 weighted spin echo pulse sequence was employed with the 
following imaging parameters: TE = 40 ms, TR = 4000 ms, averages = 4, matrix 
size = 256 x 256 x 128, voxel size = 0.14 x 0. 14 x 0.25 mm3. 
For all image analysis, segmentation and 3D reconstruction was performed in 
ITK-Snap.35 Images were converted into NIFTI format using ImageJ software. 
Reconstruction was carried out in ITK-SNAP by automated segmentation with 
manual edge correction, allowing three-dimensional reconstruction and 
quantification of retained hydrogel volumes.  
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7.2.17 In Vitro Degradation. 
Acrylamide molds were used to contain the hydrogels within a 5 mm diameter 
6 mm high depression. Hydrogels were prepared as described and 30 μL of the 
desired hydrogel loaded into the depression. Hydrogels were covered with 1 mL 
PBS and allowed to erode at 37°C. The buffer was replaced twice weekly. 
Following 28 days, hydrogels were degraded in 1mg/mL hyaluronidase to allow 
determination of remaining hydrogel content necessary for data normalization. 
Macromer release was quantified by uronic acid assay.  
 
7.2.18 In Vivo Degradation. 
To allow for degradation to be directly observed in vivo, CD-MeHA was labeled 
by the near-IR dye Cy7.5 through preparation of the peptide GCKKG-Cy7.5 and 
subsequent Michael-addition of the peptide to form the derivatized HA macromer. 
After injection (25µL), degradation was assessed biweekly over 4 weeks (Pearl 
Impulse, LI-COR). The fluorescence signal (λex/λem=785/820 nm) was integrated 
over identically sized regions of interest centered over the injection site for all 
animals. Values were baseline corrected to images of mice prior to injection 
(n=11), and normalized to the peak intensity for the material group.  
 
7.2.19 Myocardial Infarct Model. 
MI was induced in adult male Wistar rats using an established and highly 
reproducible model. Infarct induction and analyses were performed similar to that 
previously described.36 Male Wistar rats weighing 250 to 300 g were obtained from 
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Charles River Laboratories (Wilmington, MA) and housed with food and water 
provided ad libitum. All experiments conformed to the Guide for the Care and Use 
of Laboratory Animals, published by the US National Institutes of Health (Eighth 
Edition, 2011). The protocol was approved by the Institutional Animal Use and 
Care Committee of the University of Pennsylvania (protocol number 804952). 
Rats were first anesthetized in an induction chamber (VetEquip, Pleasantville, 
CA) by 3% isoflurane. A 16-gauge angiocatheter was used for endotrachial 
intubation and connected to mechanical ventilation (Hallowell EMC, Pittsfield 
Mass), allowing 1-3% isoflurane to be maintained throughout the operation. A 
thoracotomy was performed through the left fourth intercostal space, the heart was 
exposed, and a 7-0 polypropylene suture was placed around the left anterior 
descending artery (LAD) 2 mm below the left atrium. The suture was briefly snared 
to verify the size and location of myocardial ischemia based on color change and 
was permanently tied down to produce a large anterolateral MI comprising ~20% 
of the left ventricular wall, which was visually confirmed by color change resulting 
from myocardial ischemia.36 The animals were randomized into 3 groups and 
received 6-8 separate intramyocardial injections (75 µL per animal) of saline 
(n=22), GH hydrogel (n=8), or DC hydrogel (n=8) into the border zone of the infarct. 
Sham control procedures (n=14) followed an identical protocol to the saline group, 
without ligation of the LAD. The thoracotomy was closed in multiple layers, and 
tissue adhesive (VetBond; 3M, Minneapolis, MN) was applied over the incision. 
Animals were allowed to recover with buprenorphine (0.5 mg/kg) administered for 
postoperative pain control and subject to endpoint analysis at 28 days post-infarct.  
  193 
7.2.20 Echocardiographic and Hemodynamic Assessment.  
LV geometry and function were evaluated preoperatively and at 4 weeks in all 
animals.37 A Phillips Sonos 5500 revD ultrasound system (Philips Medical 
Systems, Amsterdam ND) was used, with a 12-MHz transducer at an image depth 
of 2 cm. LV parasternal short-axis 2-dimensional and M-mode images at the level 
of the papillary muscle were used to obtain echocardiographic data. All analyses 
were performed by a single investigator who was blinded to the treatment groups. 
Four weeks after LAD ligation, animals underwent invasive hemodynamic 
measurements with a pressure–volume conductance catheter (SPR-869; Millar 
Instruments, Inc). Rats were anesthetized as above, and the catheter was 
introduced into the LV using a closed-chest approach via the right carotid artery. 
Measurements were obtained before and during inferior vena cava occlusion to 
produce static and dynamic pressure–volume loops under varying load conditions. 
Data were recorded and analyzed with LabChart version 8.0 software (AD 
instruments). Finally, cardiac output was assessed by placing a 2.5-mm periaortic 
Doppler flow probe (Transonic Systems, Ithaca, NY) around the ascending aorta. 
 
7.2.21 Histological Analysis and Immunohistochemistry.  
To assess infarct size and vascular density, hearts were explanted following 
invasive hemodynamic assessment and flushed with PBS and then injected 
retrograde with Tissue Tek optimum cutting temperature (OCT) compound 
(Sekura, The Netherlands) through the aorta and pulmonary artery. Hearts were 
submerged in OCT, frozen, and stored at −80°C. 10-μm-thick sections were 
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prepared from each heart at the level of the papillary muscles and subject to 
staining by hematoxylin and eosin (H&E) and Masson’s trichrome. Standardized 
digital photographs were taken with a Nikon D5100 SLR camera (Nikon, Tokyo, 
Japan). Photographs were uploaded to ImageJ (v1.46b) and the size of the infarct 
assessed with digital planimetry. Two 10-μm-thick sections from each animal were 
stained with antibodies directed against von Willebrand Factor (vWF) and 
separately for alpha smooth muscle actin (αSMA) to quantify capillary and arteriole 
densities, respectively. Sections were fixed with ice cold acetone, blocked in 10% 
fetal bovine serum, and incubated with either rabbit anti-vWF (1:200 dilution; 
Abcam) or mouse anti-αSMA (1:50 dilution; Thermo) for 2 hours. Donkey anti-
rabbit antibody (Alexa Fluor 488, 1:200; Abcam) or donkey anti-mouse antibody 
(Alexa Fluor 555, 1:50 dilution; Invitrogen) were used as secondary reagents and 
incubated for 1 hour, after which sections were washed and counterstained with 
4’,6-diamidino-2-phenylindole (DAPI) to visualize nuclei. Quantitative analysis of 
capillary and arteriolar density within the borderzone was conducted under the 20x 
objective of a Leica DM5000B microscope. Group blinded counts were averaged 
over 4 fields per specimen with a minimum of 4 animals per group. 
 
7.2.22 Statistical Analysis. 
All data is reported as means ± standard error (SEM) or standard deviation 
(SD), for in vitro data. For degradation studies, comparison between groups was 
performed by Students t-test with two-tailed criteria and significance determined at 
p<0.05. For the infarct model, statistical significance was determined by one-way 
ANOVA with post hoc testing to compare between groups. Bonferroni correction 
was used to account for multiple comparisons, with α=0.05.  
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7.3 Results and Discussion 
7.3.1 Guest-Host Hydrogels for Shear-Thinning Delivery.  
β-Cyclodextrin is a macrocycle composed of 7 D-glucose units arranges in a 
toroidal fashion through 1,4-glucosidic bonds, enabling it to include a range of 
hydrophobic molecules in its interior cavity.38 Of these potential guest molecules, 
adamantane is widely regarded as having one of the greatest affinities (Ka≈105 M-
1)12 due both to its hydrophobicity and complementary size. Together, the 
molecules form a guest-host pair known to interact in a one-to-one fashion upon 
mixing in aqueous conditions (Figure 7.11A). Hyaluronic acid (HA) is a linear 
polysaccharide found in native ECM and is well suited to applications in 
translational medicine, as it plays a role in embryogenesis, angiogenesis, cell 
migration and scar reduction.39 Importantly, HA also provides carboxyl and 
hydroxyl functionalities, useful as reactive handles for ease of modular chemical 
modification. For assembly of guest-host (GH) hydrogels, HA was modified (Figure 
11B) either by coupling of 1-adamantane acetic acid via esterification (guest, Ad-
HA) or aminated β-cyclodextrin via amidation (host, CD-HA) as previously 
described.15  
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Figure 7.11. Guest-host hydrogel formation enables shear-thinning injection and 
hydrogel retention. (A) Interaction of adamantane (Ad, guest) and β-cyclodextrin (CD, 
host) in formation of a reversible guest-host (GH) complex crosslink, and corresponding 
synthesis (B) for specific guest (Ad-HA) and host (CD-HA) macromers. (C) Schematic of 
supramolecular hydrogel formation utilizing guest-host complexation. (D) Oscillatory time 
sweeps of individual macromers and hydrogel formed at 3.5wt%; storage modulus (G’, 
filled symbols) and loss modulus (G’’, empty symbols) at 1.0 Hz, 1.0% strain. (E-F) Shear-
thinning and recovery characterization, demonstrating shear yielding behavior at high 
strain (E) for GH hydrogel (3.5wt%) and corresponding recovery under repeated 
deformation (F) of 1.0 (low) and 100% strain (high, shaded) at 10Hz. (G) Short axis MRI 
cross-section of an explanted porcine heart showing retention of injected hydrogels (left, 
injection sites indicated), with corresponding 3D reconstruction (right) of nine 300μL GH 
hydrogel injections (purple) in a porcine whole heart explant (red); imaged at 3T.  
 
Guest-host complexation drives supramolecular assembly of a physically 
crosslinked hydrogel. Owing to the linear polymer architecture and pendant 
functionality of the guest and host groups, macromer components self-assemble 
through the binary complexes, which act cooperatively to result in a net avidity 
between polymer chains.15,40 These interactions were demonstrated by rheological 
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measurements, showing that individual macromers were viscous solutions and 
mixing resulted in a hydrogel composed of non-covalent bonds (Figure 7.11C,D). 
Owing to the reversible nature of the guest-host complex, the networks formed are 
dynamic. Hydrogels thus displayed stress relaxation at low frequency, indicative 
of bond restructuring (Figure 7.12A); the relaxation behavior of these networks was 
previously characterized.15  
 
Figure 7.12. Rheological examination of guest-host hydrogel dynamics. (A) 
Representative oscillatory frequency sweep showing storage modulus (G’, filled symbols) 
and loss modulus (G’’, open symbols) of guest-host hydrogel (Ad20HA+CD20HA; 3.5wt%) 
with bulk relaxation time (1/Frequency) indicated by the black arrow. (B) Continuous flow 
experiment showing the shear stress (closed symbols) and viscosity (open symbols) of 
guest-host hydrogel (Ad20HA+CD20HA; 3.5wt%) at increased shear rate.  
 
As a result of the dynamic bonding structure, hydrogels are capable of shear-
induced flow and rapid recovery. In particular, GH hydrogels exhibited yielding 
behavior and transition to liquid-like flow under high strain (>35%, Figure 7.11E) 
and displayed characteristic shear-thinning behavior under continuous flow 
conditions (Figure 12B). Owing to the high valence of polymer modifications (>40 
groups per HA chain) and moderate association constant of the guest-host 
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complex, near-instantaneous reassembly of the networks was exhibited with >85% 
recovery of G’ within 3s following shear-thinning (Figure 7.11F). As a direct result 
of these flow and recovery characteristics, GH hydrogels are easily injectable, self-
healing, and readily re-form even upon injection into aqueous media.  
Finally, we sought to demonstrate the capacity of GH hydrogels for injection 
site retention. Towards this, magnetic resonance imaging (MRI) has been useful 
to image HA hydrogels, as T2 relaxation behavior of the multiple hydroxyl moieties 
enables ease of imaging both in vitro and in vivo.24,41 For this investigation, 
hydrogels were injected into explanted porcine myocardium and subjected to T2 
weighted MRI, allowing visualization of material in situ. The pattern of nine 
injections was observed both in the tissue cross-section and corresponding 3D 
reconstruction (Figure 7.11G). Hydrogel injections were quantitatively evaluated at 
higher field strength and resolution to evaluate retained volumes and morphology 
over time, demonstrating GH hydrogels were initially well retained (>98% in all 
cases), and the hydrogel retention was independent of injection volume (50-300μL 
examined; Figure 7.13A, Table 7.1). Hydrogels were sustained within the tissue 
for greater than one week in vitro and exhibited minimal morphological changes 
over time with the exception of modest swelling (Figure 7.13B, Table 7.1). In 
summary, the guest-host hydrogel mechanism developed affords a 
supramolecular hydrogel through dynamic binary guest-host associations. The GH 
hydrogel is capable of shear-yielding and rapid mechanical recovery, thus enabling 
injectable delivery with high target site retention.  
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Figure 7.13. MRI analysis of hydrogel retention. (A) Representative cross sections of 
T2 weighted MRI for guest-host hydrogel injections of various volume, as indicated. (9.4T; 
day 3 post-injection) (B) Representative 3D reconstructions of T2 weighted MRI for a 
single guest-host hydrogel injection acquired at various times post-injection, as indicated. 
(9.4T; 50μL) 
 






Day 0 Day 3 Day 7
50.0 55.9 64.8 67.8
150.0 149.2 161.7 169.6
300.0 297.8 327.7 337.6
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7.3.2 Dual-Crosslinking Hydrogels with Controlled Michael Addition Kinetics.  
Michael-addition (MA) crosslinking (Figure 7.14) occurs through the 
condensation of a nucleophile, such as a thiol, and an activated olefin. Common 
thiolated small molecule crosslinkers42 were avoided in material design, opting 
rather for the modification of HA macromers to limit diffusion from the reaction site. 
Initial attempts were made to functionalize HA with thiols (HA-SH) via cystamine 
amidation; however, the product could not be isolated in soluble form following 
disulfide bond reduction and lyophilization. This is presumably a result of 
decreased pKa of the thiol due to regional chemical structure,43 leading to 
accelarated generation of the thiolate anion and resultant interchain disulfide bond 
formation. HA was thus modified by esterification of HA with 3,3’-dithiodipropionic 
acid followed by reduction with DTT. The product was isolated by precipitation from 
EtOH and subsequent lyophilization from acidified water (HCl, pH 3.5). The degree 
of HA modification, determined by 1H-NMR, demonstrated complete reduction of 
the disulfide bond with no change in modification before and after reduction. 
Moreover, GPC analysis demonstrated that HA-SH was recovered without 
degradation of the polymer or formation of interchain disulfide bonds.  
  201 
 
Figure 7.14. Michael-Addition hydrogel formation, tuning of crosslinking kinetics. (A) 
Schematic of covalent crosslink formation via generalized Michael-addition reaction 
between a thiol-modified HA macromer and Michael-acceptor (VSHA: vinyl sulfone HA, 
AHA: acrylated HA, MeHA: methacrylated HA). (B-D) Real-time rheological observation 
(storage modulus (G’), 1.0 Hz, 1.0% strain) of Michael-addition crosslinking with variations 
in the Michael-acceptor reactivity (B), pH (C), and macromer concentration (D).  
 
Reactants and reaction conditions were directly investigated through real-time 
rheological observation to identify conditions with a range of gelation times from 
minutes to hours. As addition reaction kinetics are highly dependent on the 
structure and electrophilic activation of the Michael-acceptor, various Michael-
acceptor modifications of HA were performed including the methacrylate (MeHA), 
acrylate (AHA), vinyl sulfone (VSHA), and maleimide (MaHA) derivatives. Reaction 
pH was also considered, as the thiolated anion (generated via deprotonation in 
basic conditions) is the reactive species.26,43 Gel times were observed to decrease 
with increasing reactivity of the Michael-acceptor (Figure 7.14B), pH (Figure 
7.14C), and polymer concentration (Figure 7.14D). These trends were consistent 
across the entirety of the parameter space investigated (Figure 7.15). From these 
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results, MeHA was determined to be a viable Michael-acceptor for clinical use, as 
it exhibited gel times greater than 45 minutes if the polymer concentration and pH 
were properly controlled. Based on these trials in conjunction with guest-host 
hydrogel behavior, we selected hydrogels of approximately 3.5wt% as optimal for 
pursuit of subsequent in vivo applications. 
 
Figure 7.15. Real-time rheological observation of Michael-addition crosslinking with 
variation in the Michael-acceptor reactivity (left: vinyl sulfone HA (VSHA), acrylated HA 
(AHA), methacrylated HA (MeHA)) or pH (right) for all conditions examined showing the 
storage modulus (G’) at 1.0 Hz, 1.0% strain. Maleimide modified HA (MaHA) was also 
investigated, but crosslinking occurred too rapidly to allow rheological investigation, 
independent of pH.  
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To allow combination of physical and covalent crosslinking mechanisms for 
dual-crosslinking (DC) hydrogels (Figure 7.16), thiolated Ad-HA and methacrylated 
CD-HA were prepared by modular, sequential synthesis (Figure 7.16B). The 
degree of HA modification was maintained at approximately 20% for all groups, 
and sequential reactions were observed to be independent of prior modifications. 
Despite the secondary polymer modification for Michael-addition, GH hydrogels 
retained their native mechanical properties prior to liberation of the reactive 
mercapto group by reduction with DTT (Figure 7.17) and were qualitatively 
observed to have similar injectable properties. To demonstrate the necessity and 
efficacy of the dual-crosslinking approach toward retention, hydrogel injections 
were performed into explanted porcine myocardium followed by washing in PBS 
for 24 hours. MRI imaging (Figure 7.16D) showed that MA gels alone did not have 
sufficient initial mechanics for retention, even in a stationary tissue explant. Such 
a crosslinking approach is therefore insufficient for therapeutic use, despite its 
suitability for percutaneous injection. Conversely, the GH and DC gels were both 
well retained at the injection site. Rheological time sweeps show that upon initial 
formation, DC hydrogels have moduli similar to that of GH hydrogels, yet 
subsequent crosslinking via the desired Michael-addition resulted in a more rigid 
viscoelastic solid with increased shear modulus (Figure 7.16E). Following this 
covalent crosslinking step, cessation of flow and bulk relaxation behaviors was 
observed as evidenced by oscillatory frequency sweeps demonstrating the loss of 
bulk relaxation behavior at low frequency (Figure 7.17). Allowing crosslinking to 
proceed to completion, hydrogels with compressive moduli of 25.0±4.5kPa were 
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obtained, whereas GH hydrogels did not have sufficient mechanics for unconfined 
compression testing. In sum, secondary modification of HA to allow Michael-
addition was accomplished in a modular fashion, allowing in situ stabilization 
without compromising the injectable behavior of the GH gel.  
 
Figure 7.16. Dual-Crosslinking hydrogel formation, retention, and altered 
biophysical properties. (A) Addition of thiol and methacrylate in formation of a covalent 
crosslink (a), and corresponding synthesis (B) of guest Michael-donor (Ad-HA-SH) and 
host Michael-acceptor (CD-MeHA) macromers. (C) Schematic of dual-crosslinking (DC) 
hydrogel formation. (D) MRI cross-section of explanted porcine myocardium injected with 
the Michael-addition (MA), guest-host (GH), and dual-crosslinking (DC) hydrogels; imaged 
at 9.4T (for interpretation in color as well as histological confirmation, the reader is referred 
to Figure 7.18 and 7.19). (E) Oscillatory time sweeps (1.0 Hz, 1.0% strain) of GH and DC 
hydrogels immediately after mixing. (F) Cumulative in vitro erosion profiles (mean±SD; 
n=3) for GH and DC hydrogels.  
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Figure 7.17. Rheological examination of hydrogel properties prior and subsequent 
to disulfide reduction. (A) Representative oscillatory frequency sweeps showing storage 
modulus (G’, filled symbols) and loss modulus (G’’, open symbols) of the unmodified 
guest-gost (GH) hydrogel (top left; Ad20-HA+CD20-HA; 5.0wt%), GH hydrogel including 
secondary modifications (top right; Ad20-HA-DTPA20+CD20-Me25HA; 5.0wt%), and the 
overlay of both plots (bottom). (B) Representative oscillatory frequency sweeps showing 
storage modulus (G’, filled symbols) and loss modulus (G’’, open symbols) of the 
unmodified guest-host (GH) hydrogel (top left; Ad20-HA+CD20-HA; 3.5wt%), dual-
crosslinking (DC) hydrogel (top right; Ad20-HA-SH20+CD20-Me25HA; 3.5wt%), and the 




Figure 7.18. MRI reconstruction of hydrogel injection. (A) 3D reconstruction of 
hydrogel injections: Michael-addition (blue, left), guest-host (purple, middle), and dual-
crosslinking (green, right) into porcine myocardium (red). (B) Cross-section of injection 
site with interpretation in color.  
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Figure 7.19. Histological confirmation of hydrogel injections: Michael-addition (blue, 
left), guest-host (purple, middle), and dual-crosslinking (green, right) into porcine 
myocardium. Paraffin embedded sections were sectioned in the x-z plane of (Figure 7.18) 
near the center of the injection site and subject to H&E staining. Hydrogel is stained 
purple, indicated by “G.” 
 
In addition to modification of the hydrogel stiffness, secondary covalent 
crosslinking is expected to alter hydrogel degradation. Physically crosslinked 
hydrogels, including the GH system, undergo mass loss dominated by surface 
erosion through stochastically governed network disassembly.1,14,15 Rapid erosion 
and release of encapsulated cargo, often on the order of hours to days, is exhibited 
and known to be dependent on the affinity of the heterodimeric interactions and 
their valence.1,14,22,44 The GH hydrogel system demonstrated surprising stability 
toward erosion in vitro (65.6±1.9% remaining at day 28), likely owing to the high 
valence of functional groups. Mass loss, however, was relatively rapid as 
compared to the DC hydrogels, which exhibited a significant reductions in mass 
loss at all observed time points beyond day 3 (Figure 7.16F). For DC hydrogels, 
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mass loss was still observed, likely resulting from macromer surface erosion 
preceded by the expected slow hydrolysis of thioether-ester bonds formed through 
Michael-addition.45  
 
Figure 7.20. In vivo degradation behavior modulated by dual-crosslinking. (A-C) 
Near-IR fluorescence imaging of guest-host (GH) and dual-crosslinking (DC) hydrogels 
after injection subcutaneously in the right flank of mice (A) and monitored over 28 days (B: 
fluorescent images, C: normalized signal intensity (mean±SEM; n=3)). (D-F) Epicardial 
injection and retention in a rat infarct model. Injections were performed in the infarct border 
(D: schematic, E: visualization immediately after injection). (F) Fluorescence imaging of 
hearts explanted at the terminal time point (top) and quantification of fluorescence signal 
intensity (bottom, (mean±SEM; n>5)).  
 
As established in vitro, the material systems described are intended to afford 
physically crosslinked hydrogels with injectable capacity and optional in vivo 
stabilization through covalent dual-crosslinking. However, in vitro degradation is 
not always a reliable predictor of in vivo behavior.46,47 Our lab and others have 
shown that near-IR fluorescent labeling has great utility in tracking material 
degradation and release of biological factors in vivo.36,48,49 To examine the 
potential for crosslinking and degradation in vivo, hydrogels were injected 
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subcutaneously in mice (Figure 7.20A). An innovative approach was used to 
provide fluorescence using a custom peptide sequence (GCKKG-Cy7.5). Standard 
solid phase peptide synthesis allowed preparation of the fluorescent peptide in 
high purity, where the amine terminus was capped by the free acid of Cyanine 7.5 
during the synthesis. Despite harsh reaction conditions, absorbance and emission 
spectra demonstrated the expected fluorescence properties (λmax abs/em = 800/808 
nm). Subsequent reaction with CD-MeHA under basic conditions enabled fascicle 
near-IR labeling of the macromer used to form the hydrogel. Upon injection, a 
visible gel formed under the tissue, and degradation was monitored over 4 weeks 
(Figure 7.20A,B). Over the time course, GH gels approached complete 
degradation, while DC gels remained as visible and palpable solids until the 
experiment endpoint (Figure 7.21). Quantification of fluorescence intensity (Figure 
7.20C) again showed significant differences between groups for all time points 
beyond day 3. Results are in qualitative agreement with in vitro degradation studies 
and demonstrate the capacity of the material systems toward injectable delivery 
as well as the ability to implement secondary crosslinking in vivo. In sum, both in 
vitro and in vivo results clearly demonstrate the ability of the materials to form GH 
hydrogels that flow for injectable delivery, rapidly recover for retention at the target 
site, and which undergo optional secondary covalent crosslinking to modulate their 
biophysical properties.  
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Figure 7.21. Macroscopic images of subcutaneous hydrogel injections (guest-host 
(GH) or dual-crosslinking (DC) hydrogels, as indicated) immediately after injection (A), at 
14 days (B), and at 28 days (C) exposed by retraction of the dermal tissue following 
sacrifice. 
 
7.3.3 Therapeutic Potential: Mechanical Stabilization of Myocardial Infarct.  
To demonstrate the therapeutic potential of the material systems developed, 
they were investigated in the context of a preventative treatment for heart failure 
(HF) resultant from myocardial infarction (MI). Heart failure is a clinical condition in 
which the contractile functions of the heart have been impaired to a level where 
normal bodily functions are compromised.50 In nearly 70% of cases, the condition 
has been attributed to maladaptive left ventricular (LV) remodeling following 
myocardial infarction (MI),51 making this the greatest cause of cardiovascular 
related death.52 Extensive work has shown these remodeling events are a result 
of initial expansion of the non-contractile and compliant infarct, altering normal 
stress distributions and precipitating progressive remodeling.50,53,54 DC hydrogels 
exhibit compressive moduli (25.0±4.5kPa) greater than that of native myocardium 
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(5.8±1.5kPa),55 and comparable to that of materials shown to have efficacy in 
attenuating remodeling through mechanical stabilization of the infarct.23,41,55,56 A 
combination of experimental and computational approaches has recently 
demonstrated that this may be due to reduction in the local and global myofiber 
stresses, related to anisotropic stiffening of the tissue.41 GH hydrogels are likewise 
investigated, as soft materials injections have shown some efficacy in the 
treatment of MI,57-60 though they may be limited in their ability to mechanically 
restrain the infarct to resist initial expansion. Due to the inability of MA hydrogels 
to be retained at the injection site in vitro, they were excluded from in vitro studies. 
We used a rodent model of MI to establish the efficacy of these material platforms 
in attenuating LV remodeling, as small animal models allow for relatively large 
sample size and thus reliable data analysis.61 
 
Figure 7.22. Epicardial GH injection in the infarct border zone. Macroscopic images 
of epicardial guest-host (GH) hydrogel injections into the infarct border zone, as indicated 
(A). Hydrogel injection (B) results in pockets of hydrogel that are well retained in the tissue 
(C), indicated by green circles in expanded view for clarity. (D) Histological confirmation 
of guest-host hydrogel injection, approximately 24 hours post-injection. 
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Adult male Wistar rats underwent permanent ligation of the left anterior 
descending artery (LAD) to induce MI, and a series of injections (6-8; 75uL total 
per animal) was performed into the myocardium in the infract border zone region 
(Figure 7.20D,E). Importantly, both GH and DC hydrogels were observed to be 
well retained at the injection site despite the forces of myocardial contraction, with 
continued retention at 1 day observed histologically (Figure 7.22). With respect to 
long-term retention, near-IR imaging of the explanted tissue (Figure 7.20F) shows 
diffuse fluorescence throughout the tissue for the GH hydrogel group, whereas DC 
hydrogels remain localized, even at 4 weeks post-MI, with a nearly 4-fold greater 
net retention. MI and sham groups showed similar, negligible background 
fluorescence indicating that the signal is not dependent on inflammation or 
remodeling of the myocardial tissue.  
Histological, geometric, and functional outcomes were evaluated at 4 weeks 
post-MI to assess the efficacy of treatments, with complete analysis provided in at 
the end of the chapter in Table 7.2. Treatment of MI by hydrogel injections resulted 
in desirable modulation of the tissue response. In particular, mechanical 
stabilization of the infarct is expected to protect the border zone from altered stress 
distributions and thereby reduce the infarct size. Histological evaluation revealed 
a trend toward reduction in the infarct size for DC treatment relative to GH, as 
quantified by fibrotic area (Figure 7.23A, Table 7.2). Importantly, a significant 
increase in border zone vascular density, including both capillary and arteriole 
densities, was observed for the DC relative to GH treatments (Figure 7.24). 
Histological analysis is in agreement with prior observations of border zone 
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protection by infarct stabilization and the angiogenic potential of HA.23,36,62 
Progressive remodeling post-MI is also known to result in dilation of the left 
ventricle, negatively affecting its contractile function. Echocardiographic 
measurement of the LV inner diameter at end systole (LVIDs, Figure 23B) and end 
diastole (LVIDd) showed significantly attenuated LV dilation relative to MI control 
for both the GH and DC treatment groups. In sum, histological and geometric 
outcomes demonstrate attenuation of infarct expansion through protection of the 
border zone and resultant prevention of LV dilation.  
 
Figure 7.23. Histological, geometric, and functional outcomes after hydrogel 
injection. (A) Histological cross-sections of myocardial infarction controls (MI) or after 
injection of either guest-host (GH) or dual-crosslinking (DC) hydrogels, demonstrating 
reduced scar formation (purple color in images) with hydrogel treatment at 28 days post-
infarction. (B-F) Geometric and functional outcomes of LV inner diameter at end systole 
(B), end-systolic pressure volume relationship (C) fractional shortening (D, ejection 
fraction (E), and cardiac output (F) for MI and sham controls, as well as after treatment 
with GH and DC hydrogels. Values represent mean±SEM, with sham values indicated by 
the shaded regions. 
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Figure 7.24. Immunohistochemical (IHC) staining. Utilized for determination of capillary 
density (A, von Willebrand factor: vWF, green) and arteriole density (B, α-smooth muscle 
actin: αSMA, red), with co-staining of cell nuclei (DAPI, blue) treatment groups of guest-
host (GH) or dual-crosslinking (DC) hydrogel injections. (B,C) Quantification shows 
increased vascular density for DC injection, relative to both MI controls and GH injections 
for determination of both capillary density (C) and arteriole density (D).  
 
Continued contractile function of the LV is, however, the ultimate measure of 
treatment efficacy. The end-systolic pressure volume relationship (ESPVR) is a 
measure of contractility, valuable in hemodynamic analysis due to its 
independence from load and heart rate.63 Determination of ESPVR (Figure 7.23C, 
Figure 7.25) showed a trend toward increased contractility for both material 
treatments, but was significant only for DC hydrogels. Examination of functional 
outcomes, including fractional shortening (Figure 7.23D), ejection fraction (Figure 
7.23E), and cardiac output (Figure 7.23F) likewise showed improved function over 
  214 
MI in both treatment groups, all with a consistent trend for stabilization by DC 
hydrogels to improve outcomes relative to GH. Moreover, the functional 
assessments of DC hydrogel treatments approached those of sham controls and 
were not statistically different for any measure performed (p>0.28), with the 
exception of ejection fraction, which was improved over MI but was statistically 
different than sham controls. Analysis of outcomes demonstrates the attenuation 
of adverse LV remodeling for both GH and DC hydrogels, with distinct histological 
and functional improvement afforded DC hydrogel treatment capable of 
mechanically stabilizing the infarct border zone.  
 
Figure 7.25. Response of pressure-volume (PV) relationships to varying load. End-
systolic pressure volume relationship (ESPVR) was determined by linear fit to the 
maximum volume of each cardiac cycle during inferior vena occlusion by linear fit to the 
maximum pressure of each PV loop (example provided for Sham). ESPVR values 
reported represent the slope of the linear fit, often regarded as the end-systolic 
elastance. Comparison between groups shows an increase in elastance for Sham 
relative to MI as well as DC relative to GH, though only improvements in elastance for 

























































































ESPVR: Pes = 2.666 * Ves - 247.07, r² = 0.9915
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Table 7.2. Complete geometric, functional, and histological outcomes of infarct 
model. Treatments include infarct controls (MI), guest-host (GH) or dual-crosslinking (DC) 





MI GH DC Sham 
Geometric     
 



















 Fibrotic Area (%) - 9.97±1.79 8.34±0.92 - 
Functional     
 Stroke Work (mmHg/uL) 977.5±156.2 1359.7±178.7 1356.0±88.6 1692.6±337.7 
 dP/dt max (mmHg/sec) 2702.7±174.2 3014.6±225.7 3284.4±272.7 3306.2±115.3 
 dP/dt min (mmHg/sec) 2217.8±170.4 2278.6±173.6 2457.9±194.7 2390.3±136.1 
 
End-Systolic Pressure 







0.22±0.04 0.21±0.06 0.19±0.02 0.21±0.07 






















Immunohistochemical     














Data provided as mean±SEM.  
* p<0.05 relative to MI 
†
 p<0.05 relative to Sham 
‡
 p<0.05 DC relative to GH 
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7.4. Conclusion 
In conclusion, the material system developed harnesses the beneficial features 
of both supramolecular assembly and addition reaction crosslinking in an 
orthogonal and complementary fashion to create a materials system with unique 
properties. Namely, the utilization of a physically crosslinked hydrogel enables 
initial retention at the injection site through shear-thinning delivery. This retention 
ability facilitates the employment of slow covalent crosslinking for stabilization in 
vivo, occurring on timescales that enable ease of clinical application. In recent 
years, there has been a significant drive toward percutaneous delivery of materials 
for both cosmetic and therapeutic purposes, with significant attention given to 
material retention as well as appropriate control of biophysical properties. Indeed, 
the material concept developed herein is a generalizable approach which 
addresses a fundamental challenge in percutaneous delivery: the ability to 
maintain hydrogel presence despite clinically required slow covalent crosslinking. 
The approach may be of great utility in many applications, including soft tissue 
reconstruction as well as toward therapeutic needs including nucleus pulpous 
replacement or treatment of MI.  
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CHAPTER 8 
 
Injectable Shear-Thinning Hydrogels for Minimally Invasive 
Delivery to Infarcted Myocardium to Limit Left-Ventricular 
Remodeling 
 
Adapted from: Rodell CB, M.E. Lee, H. Wang, S. Takebayashi, T. Takayama, T. 
Kawamura, J.S. Arkles, N.N. Dusaj, S.M. Dorsey, W.R.T. Witschey, J.J. Pilla, J.H. 
Gorman, J.F. Wenk, J.A. Burdick, R.C. Gorman. Injectable Shear-thinning 
Hydrogels for Minimally Invasive Delivery to Infarcted Myocardium to Limit Left-
Ventricular Remodeling. (In Review). 
 
8.1 Introduction 
In the United States, an estimated 785,000 acute myocardial infarctions (MIs) 
occur annually, and the speed of treatment and use of percutaneous coronary 
interventions have improved the in hospital survival rate by nearly 40% in recent 
decades.1-3 However, there remain downstream consequences for these patients, 
as MI is known to be a major contributor to the development of chronic heart failure 
(HF), which affects an estimated 5.7 million Americans, has been cited as a 
contributor to 1 in 9 deaths, and imposes an estimated financial burden of $30.7 
billion annually.1 Transplantation remains the only definitive treatment for HF, 
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motivating the development of preventative therapies to mitigate this morbidity, 
mortality, and financial burden through understanding and treatment of the 
underlying etiology. 
In the case of ischemic HF, loss of LV function is the result of LV remodeling 
(Figure 8.1A,B) through a deleterious cascade of biological and mechanical 
events, which ultimately result in geometric reshaping of the LV and loss of 
contractile function.4-6 It has been recognized in recent years that infarct 
compliance plays a major role in this process, as loss of infarct contractility results 
in increased systolic compliance, creating an energy sink which increases 
workload on the remaining healthy tissue.5 Moreover, passive mechanical 
properties of the infarct are reduced for as long as 6 weeks,7 largely as a result of 
a spatiotemporal imbalance of matrix metalloproteinase activity favoring 
proteolysis.8,9 Owing to these changes, the infarct is susceptible to energetic 
losses, thinning, and planar expansion in early stages post-MI, contributing to 
abnormal stress distributions and continued detriment to the borderzone 
contractility,10-12 which perpetuate ventricular dilation. 
In addition to these primary remodeling events, HF is complicated by additional 
maladaptive changes to myocardial function. Primary among these is ischemic 
mitral regurgitation (MR), wherein dysfunction of the mitral valve allows retrograde 
systolic flow from the LV to the left atrium (LA) (Figure 8.1B, expanded). Notably, 
MR is observed in nearly 20% of patients post-MI and in greater than 50% of 
patients in congestive HF.13,14 Patients with moderate-to-severe MR have 50% 
mortality at 3 years, even following revascularization,15 and mortality is graded with 
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MR severity.16 The combined prevalence and mortality of MR have motivated 
continued therapeutic investigation, where direct augmentation of the valve 
leaflet17  as well as surgical correction18,19 of the subvalvular apparatus position 
(i.e., papillary and associated chordae) have exhibited positive results. Similar to 
such approaches, annuloplasty seeks to restore the valve geometry to correct MR 
and remains the preferred clinical treatment in conjunction with revascularization.20 
Despite these efforts, relapse of MR occurs in a portion of the treatment population, 
indicating continued ventricular remodeling may compromise treatment 
durability.21 Indeed, the pathological basis of MR reveals that MR develops due to 
ventricular dilation, displacing the papillary and thereby distorting the valve via 
tethering.22-24 Ischemic MR is therefore a ventricular and not solely a valvular 
condition, motivating the prevention of MR by of intercepting the LV remodeling 
process.  
To counter the effects of infarct expansion, mechanical interventions early post-
MI have proven to be of great utility, including such devices as affixed patches or 
wraps that act as restraints and biomaterial injection to stabilize the infarct 25 Such 
restraints, including myocardial patches,26 have also proven effective in reducing 
MR. These therapies are most effective when applied at early stages post-MI prior 
to extensive LV remodeling. While effective in preclinical studies, therapeutic 
approaches that require thoracotomy for the application of restraints will likely not 
achieve widespread application due to the high risk associated with thoracic 
surgery early after MI. Thus, the use of biomaterials to mechanically stabilize the 
infarct is attractive, in part, because of the potential for minimally invasive 
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percutaneous delivery. Numerous injectable hydrogels have been investigated, 
spanning a wide range of material properties and methods of delivery27 and prior 
studies have demonstrated the importance of the material mechanical properties28 
and prolonged degradation29 on remodeling outcomes. In the use of biomaterials 
to stabilize the infarct (Figure 8.1C,D), reduced wall thinning and dilation have 
been demonstrated. Moreover, prevention of papillary displacement by these 
dilation processes, coupled with myocardial bulking, are anticipated to reduce 
maladaptive remodeling of the subvalvular apparatus thereby correcting MR 
(Figure 8.1D, expanded).  
 
Figure 8.1. Schematic long-axis representation of LV remodeling. Posterolateral 
infarct (i) at baseline (A) and following left-ventricular (LV) remodeling (B) where wall 
thinning, ventricular dilation, and associated posterior papillary displacement (ii) result in 
asymmetric tethering (iii, expanded). Corresponding treatment (C) by hydrogel injection 
(iv) to minimize LV remodeling (D) and prevent tethering (expanded).    
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Despite the need for minimally invasive techniques for hydrogel delivery, few 
currently availability hydrogels (e.g., decellularized ECM, alginate) have the 
properties that permit their delivery via intracoronary or intramyocardial injection.30-
32 While they have proceeded to clinical trials, the modest stiffness of these 
materials (10 Pa for decellularized ECM)33 make them  unsuitable for mechanical 
stabilization of the infarct and they have not yet observed attenuation of MR. It has 
been demonstrated that supraphysiological moduli of approximately 40kPa are 
required to effectively attenuate LV remodeling.28  To address this need, we have 
developed an injectable hydrogel system – based on guest-host (GH) interactions 
that present dynamic physical bonds that exhibit shear-thinning (i.e., flow easily 
through a syringe or catheter) and rapid re-assembly (i.e., localize at the injection 
site). The hydrogel includes an optional secondary crosslinking (DC) that occurs 
in situ to enhance mechanical properties (approximately 40kPa moduli, motivated 
by prior results) and prolong degradation of the hydrogel within the infarct region. 
Herein, we demonstrate the utility of these material systems toward attenuating 
the LV remodeling response post-MI and demonstrate the feasibility of 
percutaneous hydrogel delivery in an ovine model. 
 
8.2 Methods 
8.2.1 Hydrogel Synthesis and Preparation.  
Hyaluronic acid (HA, 90kDa) was purchased from Lifecore (Chaska, MN). β-
cyclodextrin (CD) and 1-adamantane acetic acid (Ad) were purchased from TCI 
America. All other reagents were purchased from Sigma, unless otherwise 
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indicated. Modified hyaluronic acid (HA) polymers were prepared by methods 
previously described.34,35 These included HA modified with adamantane (Ad-HA) 
or β-cyclodextrin (CD-HA) to form guest-host (GH) hydrogels, as well as HA 
modified with both adamantane and thiols (Ad-HA-SH) or both β-cyclodextrin and 
methacrylates (CD-MeHA) to form dual-crosslinking (DC) hydrogels. Following 
modification, modified hyaluronate was purified by dialysis (and vacuum filtration, 
where necessary to remove insoluble impurities) and recovered by lyophilization. 
Polymer modifications were determined by 1H NMR acquired at 360MHz (Bruker). 
Disaccharide modifications were approximately 25% of repeat groups; Ad-HA 
utilized in percutaneous delivery had a 50% modification.  
GH hydrogels were formed under sterile conditions by dissolution of the two 
modified HA polymers in PBS at the desired concentration (4.5wt%), mixing of the 
two solutions, centrifugation to remove entrapped air, and loading into syringes for 
injection. Formulations were designed such that adamantane (guest, Ad) and β-
cyclodextrin (host, CD) were present in equimolar ratios, and the concentration 
denotes the combined weight percent of both polymers in solution. DC hydrogels 
were prepared similarly to GH hydrogels, with the pH of dissolution buffers 
adjusted to obtain a desired final pH of 5. 
 
8.2.2 In vitro hydrogel evaluation.  
To assess hydrogel mechanical properties, oscillatory shear rheology (AR2000, 
TA Instruments) was performed using a 20 mm diameter cone and plate geometry 
(59 min 42 s cone angle, 27 μm gap) maintained at 37 ºC. GH hydrogel mechanics 
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were determined by frequency sweeps (0.01-100 Hz; 1.0% strain) and strain 
sweeps (1.0 Hz; 0.1-500% strain). Compressive mechanical analysis (Q800, TA 
Instruments) of DC hydrogels was performed serially on samples (n = 6) following 
overnight crosslinking at 37ºC with a compression rate of 10% strain/min (moduli 
were calculated from 10-20% strain).  
To examine hydrogel degradation, 30 μL hydrogels (n = 5) were contained 
within a 5 mm diameter 6 mm high depression in acrylamide molds. Hydrogels 
were submerged in 1 mL PBS and stored at 37°C. At set time points, the buffer 
was collected and replaced. At study completion, hydrogels were degraded in 
hyaluronidase (1 mg/mL) to allow determination of remaining hydrogel content. 
Degradation was quantified via a uronic acid assay and data was normalized to 
the cumulative release for each sample.   
 
8.2.3 Finite-Element (FE) modeling.  
To evaluate the effects of hydrogel injections on myocardial wall stress, FE 
modeling of end-diastolic myocardial thickness and corresponding myofiber stress 
distributions was conducted by adaptation of a method similar to those previously 
described.36 The LV geometry was approximated by an ellipsoidal model, where 
dimensions at end-systole were based on measurements performed in ovine 
hearts; images were acquired via TrueFISP CINE sequences. The wall thickness 
was 1.3 cm, the inner diameter of the endocardial wall near the equator was 4.0 
cm, and the distance from base to apex was 6.4 cm. To simulate hydrogel injection, 
the base model was modified to include 16 injections in a 4-by-4 array within the 
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free wall (Figure 8.2). The size and shape of the hydrogel injections were based 
on MR images of injected explant tissue (Figure 8.3, Table 8.1), where the 
injections were approximated as ellipsoids where the volume is given by the 
equation: 
𝑉 =  
4
3
𝜋(𝑎 ∗ 𝑏 ∗ 𝑐)           (eq. 8.1) 
The spacing between injections was determined to be 1.5 cm from center-to-
center, based on expected anatomical measures. Each injection was 0.3 mL, 
resulting in a total volume of 4.8 mL added to the model. To account for volumetric 
addition, the myocardial wall thickness throughout the injection regions was 
increased to 1.5 mm, thus preserving the total volume of myocardium. The 
longitudinal dimensions were unaltered, as was were dimensions in remote 
regions, away from the injection site.  
 
Figure 8.2. Depiction of finite element model geometry. (A) Finite element model of 
ovine LV with 16 hydrogel injections in the free wall. The injections were modeled as 
ellipsoids, which caused the LV wall to thicken. (B) Short axis view of LV wall. (C) Long 
axis view of LV wall. 
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Figure 8.3. Reconstruction of hydrogel geometry based on MRI data of injections 
embedded in myocardial wall. Note that the shape is approximately ellipsoidal and a 
volume of 0.298mL was directly determined from the reconstruction in ITK-Snap. 
 
Table 8.1. Ellipsoid dimensions of a 0.3 mL 






The material response of the myocardium was represented using a nearly 
incompressible, transversely isotopic, hyperelastic constitutive law, which was 
defined using the strain energy function: 












2 ) − 1) +  
𝜅
2
(𝐽 − 1)2   (eq. 8.2) 
where 𝐸𝑖𝑗 are the deviatoric components of the Green-Lagrange strain tensor 
relative to the myofiber coordinate system (f = fiber direction, s = cross-fiber in-
plane direction, n = transverse-fiber direction) and J is the determinant of the 
deformation gradient. The diastolic material parameters were assigned to be 𝐶 = 
0.51 kPa, 𝑏𝑓 = 22.84, 𝑏𝑡 = 3.45, and 𝑏𝑓𝑠 = 12, while the bulk modulus was 𝜅 = 1x10
3 
kPa.36 Since the model was intended to mimic the initial time frame after infarction, 
it was assumed that the properties would be unchanged during this timeframe.5. 
  232 
Hence, the model was created such that the myocardial material properties around 
the hydrogel injections were the same as in remote regions. The myofiber 
orientation was assigned to vary linearly from epicardium to endocardium using 
the angles of -37 degrees to 83 degrees, respectively. The material response of 
the hydrogel injections was represented using a nearly incompressible, isotopic, 
hyperelastic constitutive law, which was defined using the strain energy function: 
𝑊𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 =  
𝐸
2(1+𝜈)
 tr(𝐄𝟐)  + 
𝐸
6(1−2𝜈)
 ln (𝐽)2  (eq. 8.3) 
where E is the deviatoric Green-Lagrange strain tensor, tr() is the trace operator, 
and ln() is the natural log operator. The material parameters for Young’s modulus 
(E) were assigned based on the experimental measurements of the GH and DC 
hydrogels, while the Poison ratio (𝜈) was assigned a value of 0.499. A pressure of 
10 mmHg was assigned as a boundary condition on the endocardial wall in each 
of the FE models, simulating end-diastolic loading conditions and and 
corresponding regional examination of myofiber stress was performed.  
 
8.2.4 Ovine infarct model.  
All animals in this study were provided care in compliance with the National 
Institute of Health’s guidelines for the care and use of laboratory animals (NIH 
Publication 85-23, revised 1996) with protocol approval by the University of 
Pennsylvania’s Institutional Animal Care and Use Committee. Twenty-two adult 
male Dorset sheep, approximately 45 kg, were subject to infarction and study up 
to 8 weeks (Table 8.2).24 For MI induction, sheep were induced by ketamine (25 
mg/kg), intubated for mechanical ventilation, and maintained under anesthesia by 
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inhaled isoflurane (1.0-2.0%). A left thoracotomy was performed and a 
posterolateral infarct comprising approximately 20% of the LV was induced by 
selective ligation of the obtuse marginal (OM) branches (Figure 8.5A). Thirty 
minutes following ligation, sixteen injections (0.3 mL ea. via a 1/2cc syringe, with 
27G ½ in needle) were performed in the infarct region, which consisted of saline 
(MI control), GH hydrogel, or DC hydrogel (Figure 8.5B, C). The infarct was 
surrounded by MRI compatible markers sutured to the epicardium to aid in locating 
the infarct in MRI and post-mortem examination. The incision was closed in layers 
and the animal recovered under supervision with postoperative pain control by 
fentanyl (25-75 µg, transdermal).  
 
8.2.5 Echocardiography.  
MR was monitored throughout infarct induction, including baseline (pre-
ligation), 30 minutes post-ligation, immediately post-injection, and at the terminal 
timepoint of 8 weeks. For each timepoint, both real-time two-dimensional (2D) 
Doppler flow and three-dimensional (3D) and echocardiography of the mitral valve 
were performed.37 Severity of MR was graded using a standardized, semi-
quantitative scale based upon the area of the regurgitant jet observed in 2D 
Doppler flow echocardiography.38 Analysis of mitral valve geometry was performed 
by techniques previously described, where analysis was performed at mid-systole 
in Echo-View (TomTec Imaging Systems) through interactive segmentation of the 
valve.17,39  
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MI GH DC 
Animal Usage    
 Number Included 7 7 6 
 Weight (kg), Baseline 39.7 ± 1.1 44.4 ± 1.8 43.7 ± 2.0  
 Weight (kg), 2 WK 38.9 ± 0.8 42.0 ± 2.3 43.0 ± 1.9 
 Weight (kg), 8 WK 46.6 ± 1.0 51.4 ± 1.7 51.3 ± 1.3 
Heart Size, 8 WK    
 Heart Mass (g) 274.99 ± 16.20 306.42 ± 13.53 300.63 ± 18.43 
 RV Mass (g) 71.03 ± 14.01 58.20 ± 3.59 62.18 ± 4.64 
 LV Mass (g) 141.00 ± 18.78 166.84 ± 4.02 169.88 ± 9.02 
Infarct Geometry    
 Initial Infarct Area (% LV) 19.4 ± 0.6 18.6 ± 0.7 19.3 ± 0.7 
 Final LV Area (cm
2
) 19.35 ± 0.78 18.36 ± 1.22 17.25 ± 1.34 
 Final Infarct Area (cm
2
) 98.56 ± 5.96 98.85 ± 3.85 103.58 ± 4.41 
 Final Infarct Size (% LV) 19.31 ± 1.97 18.15 ± 1.43 17.93 ± 1.81 
Data provided as mean±SEM.  
No differences observed between groups (P > 0.05 by ANOVA).  
 
8.2.6 Magnetic resonance imaging and analysis.  
Image acquisition was performed at 3T (Tim Magnetom Trio Scanner; 
Siemens, Inc.). For visualization of the hydrogel distribution following in vivo 
injection, the explanted heart was submerged in saline and imaged via a T2 
weighted turbo spin echo pulse sequence (matrix size = 320 x 256 x 65, voxel size 
= 0.3125 x 0. 3125 x 1.0 mm3, repetition time = 1128 ms, echo time = 71 ms, 4 
signal averages). Examination of hydrogel distribution in explanted tissue was 
performed by 3D reconstruction of the hydrogel and myocardial segments (ITK-
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Snap40).For longitudinal analysis of myocardial geometry and function in vivo, 
imaging was performed at baseline (immediately prior to infarct), as well as at 2 
and 8 weeks post-infarct. Anesthesia was maintained throughout the procedure 
and cardiac gating was performed by placement of a pressure catheter (Millar 
Instruments, Inc.) into the LV. Two-dimensional TrueFISP CINE images were 
acquired for primary assessment of myocardial geometry (field of view = 
280x166.25 mm, acquisition matrix = 256 x 152 pixels, repetition time = 27.52 ms, 
echo time = 1.46 ms, BW = 930 Hz/pixel, slice thickness = 4 mm). Late gadolinium 
enhancement (LGE) imaging was performed approximately 15 minutes following 
bolus intravenous injection gadobenate dimeglumine (0.1mmol/kg; MultiHance; 
Bracco Diagnostics, Inc.) by a spoiled gradient echo sequence to confirm the size 
and location of fibrotic tissue (field of view = 218 x 350, acquisition matrix = 256 x 
160, repetition time = 5.50 ms, echo time = 2.42 ms, BW 244 Hz/pixel, slice 
thickness = 4 mm, 2 signal averages.).  
Longitudinal analysis of infarct thickness was performed from CINE MRI. Three 
consecutive short axis images were isolated at end-diastole from the infarcted 
region, immediately sub-papillary where possible. The infarct was confirmed from 
corresponding LGE images, and the location was maintained across all time 
points. For each image, 5 radial lines were drawn from epicardium to endocardium 
and measured (ImageJ; Figure. 8.4) and reported values represent the average of 
all 15 measurements for each animal. Analyses were repeated in the remote 
region along the contralateral LV wall. 
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Toward assessment of LV dilation and function, volumetric analysis was 
performed. CINE images were sorted and cropped using customized programming 
(MATLAB). Through all acquired planes and phases, semi-automated 
segmentation of the intraventricular space was performed with manual correction 
as necessary (ITK-Snap). Repartitioning of the images into the time-space and 
corresponding volumetric reconstruction enabled determination of the LV volume 
as a function of time, from which the minimum volume (LVESV), maximum volume 
(LVEDV), SV, and EF were determined.  
To allow assessment of MR volumes, planar magnitude and phase images 
were acquired orthogonal and immediately superior to the mitral valve (field of view 
= 300 x 243.75 mm, acquisition matrix = 192 x 117 pixels, slice thickness = 4 mm, 
repetition time = 41.35 ms, echo time = 3.41 ms, BW = 389 Hz/pixel, flip angle = 
25 degrees). Semi-automated contouring of the mitral valve as well as 
quantification of the net regurgitation volume was performed (Argus, Siemens).  
The long-axis dimension (LAD) and posterior chordae length (PCL) were 
evaluated from CINE data. End-systolic were isolated, rotated, and re-sliced 
(ImageJ) to provide long-axis sections through the posterior papillary, apex, and 
mitral valve. The LAD was measured as the length from the base (plane bisecting 
the LV-LA and Septal-RA junctions) to the endocardial wall of the apex. The PCL 
was measured and the length from the most prominent point of the posterior 
papillary (that affected by infarction) and the center of the mitral valve.  
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Figure 8.4. MRI based determination of myocardial thickness over time. Red and 
green arrows indicate infarct and remote thickness, respectively, as assessed for MI (left), 
GH (middle), and DC (right) treatment groups. Measurements were performed (3 slices, 
n = 5 measurements per slice) at baseline, 2 weeks, and 8 weeks, with delayed contrast 
enhancement (DCE) used to confirm measurements were made within the infarcted region 
(myocardial wall in white contrast). 
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8.2.7 Post-mortem analysis.  
Following evaluation at 8 weeks, animals were sacrificed, the hearts harvested, 
and long-axis sections were taken through the infarct region (adjacent to the 
posterior papillary) and from remote sections (adjacent to the anterior papillary).  
From these samples, myocardial thickness was directly measured and reported as 
the average of three measurements from the base, infarct (approximately 
equatorial), and apex for each animal. Subsequently, sections from these regions 
were fixed in formalin, paraffin embedded, and stained with Masson’s Trichrome 
and hematoxylin and eosin (H&E). To evaluate the distribution of the hydrogel in 
vivo, tissue was analyzed in one GH and one DC hydrogel injected animal within 
the first 24 hours post-MI. 
 
8.2.8 Percutaneous intramyocardial injection.  
GH hydrogels were evaluated for delivery to the myocardium via endocardial 
injection. Two healthy adult male Dorsey sheep were utilized, allowing 
investigation of two separate procedural approaches, both utilizing a delivery 
system comprised of an AgilisTM NxT steerable introducer, a BRKTM transseptal 
needle (4 Fr, 90 cm; St. Jude Medical) pre-loaded intraoperatively with sterile 
hydrogel, and a 1 mL syringe containing the desired injection volume (0.3 mL 
each). Injection position was monitored by fluoroscopy and directly visualized by 
simultaneous intracardiac echocardiography (ICE; AcuNav 8 Fr, Siemens). In the 
first approach, the introducer was inserted through the internal jugular and passed 
into the right ventricle (RV) over wire. The sheath was deflected to reach various 
locations and the needle advanced 4-5mm into the tissue for injection and 
subsequently retracted. Four injections were performed into the septal wall. In the 
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second approach, the introducer was similarly passed into the LV with access via 
the right carotid, and five injections were performed into the inferior and anterior 
walls. Following the procedure, injection was confirmed by MRI of the explanted 
tissue, as described above. 
 
8.2.9 Statistical analysis.  
Data is presented as mean ± standard deviation (SD, for in vitro data) or as 
mean ± standard error of the mean (SEM, for in vivo data). Statistical significance 
was determined by ANOVA, using repeated measures where appropriate, in 
conjunction with post hoc Student’s two-tailed t-tests with Bonferroni correction to 
account for multiple comparisons. Significance was determined at P = 0.05. For 
volumetric quantification, outliers were identified within groups by Grubb’s test (p 
< 0.05) and excluded from further analysis. 
 
8.3 Results 
8.3.1 Development of Injectable Hydrogels with Controlled Biophysical 
Properties.  
Guest-host (GH) hydrogel precursors were prepared with 25% of HA repeat 
units modified with either Ad or CD. Upon mixing solutions of Ad-HA with CD-HA, 
GH hydrogels (Figure 8.5B) rapidly formed through interactions between polymer 
chains. The elastic modulus (E) of GH hydrogels was estimated at 1.6 Hz 
(corresponding to a heart rate of 100 BPM) to be 799.2 Pa (Figure 8.6A). GH 
hydrogels are known to exhibit shear-thinning (during injection) and self-healing 
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(after injection into tissue) properties34,41,42 necessary for delivery into myocardial 
tissue (Figure. 8.5D); yet, shear-yielding was not observed at physiological 
myocardial strains (Figure 8.6B), indicating stability after reaching the tissue. 
 
Figure 8.5. MI model and therapeutic groups. (A) Infarct generation by selective obtuse 
marginal ligation and injection with saline (MI control), guest-host hydrogel (GH), or dual-
crosslinking hydrogel (DC) which were longitudinally assessed by MRI. (B) GH hydrogels 
were composed of adamantane modified hyaluronic acid (Ad-HA, blue) and cyclodextrin 
modified hyaluronic acid (CD-HA, red) which form physical associations (purple). (C) DC 
hydrogels were composed of thiolated Ad-HA (Ad-HA-SH) and methacrylated CD-HA 
(CD-MeHA), and resulted in additional covalent crosslinks (green). (D) Both GH and DC 
hydrogels were injected into the infarcted region. (E) DC hydrogel elastic moduli over time 
(mean ± SD; n = 6; *P < 0.01 relative to day 0). (F) Hydrogel degradation (mean ± SD; n 
= 5; *P < 0.05 relative to DC for all timepoints beyond day 1). 
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Figure 8.6. Rheological examination at physiological conditions. (A) Frequency 
sweep (1.0 % strain, 37○C) showing frequency dependence of GH hydrogel shear 
moduli (G’). Relevant moduli were estimated at 1.6 Hz, corresponding to a heart rate of 
approximately 100 BPM. Elastic moduli (E) estimated assuming an incompressible solid 
whereby E = 3*G’. (B) Strain sweep (1.0 Hz, 37○C) showing strain dependence of GH 
hydrogel shear moduli (G’). Shear-induced loss of GH mechanics and corresponding 
flow is not observed below strains of ~40%. Approximate physiological range (maximum 
strain of 10-15%)43,44 is indicated (shaded regions). 
 
Dual-crosslinking (DC) hydrogels were developed to introduce additional 
covalent crosslinks into the GH hydrogels to increase their mechanical properties 
(Fig. 1C). Thus, they are likewise injectable via shear-thinning but with increased 
mechanical strength. DC hydrogels possessed an elastic modulus of 41.4 ± 4.3 
kPa when measured at 48 hours after mixing. Subsequent softening, significant 
beyond 2 weeks, was observed due to hydrogel degradation (Figure 8.5E). GH 
and DC hydrogel degradation was monitored for 8 weeks under static conditions 
(Figure 8.5F). Rapid degradation of the GH hydrogel was observed (>50% 
cumulative erosion), in contrast to the DC hydrogel, which remained stable up to 
8 weeks (5.1 ± 0.2% degradation).  
In vivo examination of hydrogel retention was performed at 24 hours following 
infarct induction and intramyocardial injection. Both the GH and DC hydrogels were 
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well retained as solid, discrete hydrogels within the myocardium (Figure 8.7A,B). 
MRI of excised tissue for the DC hydrogel injection (Figure 8.7C) demonstrated 
dispersion of injections throughout the tissue with a measured volume of 5.1mL, in 
agreement with the estimated 4.8mL volume injected. Excised DC hydrogels 
exhibited moduli of 30.3 ± 2.6 kPa, coinciding with measured in vitro moduli at 
these times and demonstrating the ability for dual-crosslinking to occur in vivo.  
 
Figure 8.7. Material retention in vivo. Histological image of GH (A) and DC (B) hydrogels 
(indicated, *) within infarct tissue by H&E staining at 1 day post-MI. (C) MRI reconstruction 
of retained DC hydrogel (purple) within the myocardium (red) following initial injection in 
vivo.  
 
8.3.2 Finite Element Assessment of Myofiber Stress and LV Wall Deformation.  
Finite element simulations were conducted to evaluate anticipated myocardial 
bulking and altered distribution of end-diastolic myofiber stress throughout the LV 
wall at early time points post-MI. The average respective wall thickness within the 
injected regions at end-diastole for the control, GH, and DC cases were 1.0, 1.08, 
and 1.23 cm. The myofiber stress distributions throughout the LV were differentially 
altered by GH (Figure 8.8A) and DC (Figure 8.8B) hydrogel injections. The average 
myofiber stress in the myocardium surrounding the DC injection was 2.5 kPa (27% 
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reduction relative to control), while the stress around the GH injection was 3.4 kPa 
(Figure 8.8C). Through the transmural dimension, DC injection reduced the 
myofiber stress by 46% at the epicardium, 23% at mid-myocardium, and 51% at 
the endocardium compared to the control case (Figure 8.8D). Circumferentially, 
near the edge of the injection region, hydrogels reduced the myofiber stress 
(Figure 8.8E) by a maximum of 27% for GH and 60% for DC, relative to controls.  
 
Figure 8.8. Finite element analysis of hydrogel injection. End-diastolic myofiber stress 
distribution for an LV with either (A) GH hydrogel injection or (B) DC hydrogel injection. 
Note that only a portion of the model is shown in order to visualize the distribution within 
the myocardium. Myofiber stress in elements adjacent to the material (C), or distributed 
along a transmural (D) or circumferential (E) path in the edge of the injection region. 
Corresponding regions are indicated for the material region (i) or transmural (ii) and 
circumferential (iii) paths. 
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8.3.3 Assessment of Myocardial Thickness.  
Wall thickness was measured following excision at 8 weeks. Examination of 
myocardial long-axis segments (Figure 8.9A) clearly showed thinning of the infarct 
region after MI, relative to remote regions. Qualitatively, thinning was attenuated 
by hydrogel injection and remaining DC hydrogel was observed post-mortem in all 
cases, as indicated by black arrows. Histological examination at 8 weeks (Figure 
8.10) indicated integration of the DC hydrogel into the tissue, which was not 
apparent at early timepoints (Figure 8.7), with minimal chronic inflammation (i.e. 
foreign-body giant cell localization, fibrous encapsulation). Histologically, GH 
materials were not observed at the 8 week time point, consistent with the observed 
rapid erosion (Figure 8.5F) and prior in vivo examination.35 Quantitatively (Figure 
8.9B, Table 8.3), hydrogel injection demonstrated increased infarct thickness, 
significant for DC injection, as well as a tendency to increase adjacent basilar and 
apical thickness. Temporal assessment of end-diastolic thickness by CINE MRI 
(Figure 8.9C) revealed significant differences between infarct tissue thickness at 
both 2 and 8 weeks, with minimal differences observed in remote thicknesses 
(Table 8.4). Notably, DC hydrogel injection was observed to maintain wall 
thickness at 2 weeks, in contrast to the observed drastic thinning in both MI and 
GH groups.  
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Figure 8.9. Myocardial wall thickness. (A) Macroscopic images of remote or infarcted 
regions with hydrogel indicated (▼) for DC treatment. (B) Corresponding thickness 
quantification. (C) Temporal assessment of infarct thickness by CINE MRI. Measurements 
are normalized to the thickness of corresponding remote sections ( mean ± SEM; n≥6;  *P 




Figure 8.10. Histological examination 8 weeks post-MI. Myocardial sections from the 
infarct region in control (MI), guest-host (GH), and dual-crosslinking (DC) groups with 
remote section provided for reference. (A) H&E (top) and trichrome (bottom), with the 
expanded region indicated for DC injection. (B) Expanded view, with DC hydrogel visible 
by H&E staining (dark purple) and trichrome (light blue) integrated with viable tissue. Other 
groups demonstrate fibrosis (trichrome, dark blue) without indication of remaining 
hydrogel.  
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MI    
 Infarcted Region 11.11 ± 0.96  3.90 ± 0.48 8.49 ± 1.08 
 Remote Region 13.31 ± 1.04 12.39 ± 1.13 10.51 ± 0.49 
GH    
 Infarcted Region 11.25 ± 0.27 5.79 ± 0.96 8.66 ± 0.42  
 Remote Region 12.38 ± 0.85 11.13 ± 0.50 9.69 ± 0.74 
DC    
 Infarcted Region 11.92 ± 0.20 9.92 ± 0.24*,# 9.08 ± 0.84 
 Remote Region 11.75 ± 0.21 11.10 ± 0.25 9.82 ± 0.32 
 








MI   
 Baseline 9.44 ± 0.14 9.81 ± 0.28 
 2 Weeks 4.39 ± 0.43 9.94 ± 0.34  
 8 Weeks 3.56 ± 0.19 10.31 ± 0.22 
GH   
 Baseline 8.92 ± 0.24 9.32 ± 0.18 
 2 Weeks 6.98 ± 0.46* 9.76 ± 0.40 
 8 Weeks 5.51 ± 0.23* 9.70 ± 0.22 
DC   
 Baseline 10.90 ± 0.44*,# 10.79 ± 0.48 
 2 Weeks 11.39 ± 1.16*,# 10.78 ± 0.31 
 8 Weeks 10.02 ± 0.79*,# 11.21 ± 0.41* 
Data provided as mean±SEM.  
* P < 0.05 relative to MI 
# P < 0.05 relative to GH 
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8.3.4 LV Dilation and Functional Assessment.  
MRI was utilized to assess temporal changes in LV volume and function. The 
LV progressively dilated over time, as indicated by a greater than two-fold increase 
in LVEDV and LVESV in MI controls. At end-diastole (Figure 8.11A), hydrogel 
treatment reduced dilation at 8 weeks; however, significant differences were 
observed between DC and MI at 2 weeks, and between DC and both GH and MI 
groups at 8 weeks at end-systole (Figure 8.11B). While not significant, SV (Figure 
8.11C) was increased with DC hydrogel injection. EF (Figure 8.11D) showed a 
consistent, progressive loss of function following MI, which was moderately 
attenuated by GH injection and significantly attenuated by DC hydrogel injection 
at both 2 and 8 weeks. Additional significance was noted for DC relative to GH 
hydrogels at 2 weeks. 
 
Figure 8.11. MRI assessment of cardiac geometry and function. CINE MRI 
determination of LVEDV (A), LVESV (B), SV (C), and EF (D) (mean ± SEM; n≥6;  *P < 
0.05 relative to MI; #P < 0.05 relative to GH).  
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8.3.5 Mitral Regurgitation Severity. 
Both echocardiography and MRI were used to assess progression and severity 
of MR. 2D Doppler echocardiography demonstrated MR (Figure 8.12A). At the time 
of infarct induction, there was no significant difference in MR grade between 
treatment groups, including at baseline, post-MI, or post injection (Figure 8.12B), 
and no significant change in MR occurred within groups between these points in 
the procedure (Figure 8.12C,D). There was significant reduction in MR between 
MI and DC groups at 8 weeks (Figure 8.12B). At 8 weeks, four animals in the MI 
group developed 2+ MR and one developed 3+ MR; two animals in the GH 
treatment group developed 2+ MR and one developed 3+ MR; in the DC treatment 
group, three animals exhibited 1+ MR (two of which were 1+ as baseline) and 
remaining animals had no detectable MR. MR progressed from infarct induction to 
the 8 week timepoint in MI controls (Figure 8.12E). Severity of the progression was 
reduced by hydrogel treatments, significant of DC treatment (p = 0.013).  
Retrograde flow in the left atrium (LA) was detected by flow velocity magnitude 
scans superior to the mitral valve (Figure 8.12F). The lateral location of the MR jet 
(indicated) was consistent across animals in which MR was observed by these 
methods and was consistent with that expected for posterolateral infarct. 
Quantification of the cumulative regurgitation volume per cardiac cycle (Figure 
8.12G) showed increased prevalence of high volumes (>5 mL) in the MI group (2 
of 7 cases, compared to 1 in the GH and 0 in the DC treatment groups). 
Regurgitation volumes were as high as 17.3 mL. Differences between group 
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means were not significant, likely due to variation in the location of the acquired 
plane resulting in false negative measurements.     
 
Figure 8.12. Assessment of mitral regurgitation severity. (A) Representative 2D 
Doppler echocardiography at 8 weeks post-infarct for an MI control (MR jet indicated in 
red) and corresponding graded MR quantification (B). Change in MR resultant from MI 
(C), injection (D), and progression of LV remodeling post-MI to 8 weeks (E). (F) 
Representative short axis magnitude scan transecting the LA superior to the mitral valve; 
regurgitation jet indicated (▼). (G) Corresponding regurgitation volume quantification. *P 
< 0.05 relative to MI. Indicated in images: left ventricle (LV), left atrium (LA), aorta (Ao), 
and pulmonary artery (PA).  
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8.3.6 Geometric Remodeling of the Mitral Valve and Subvalvular Apparatus.  
Direct assessment subvalvular apparatus was performed by CINE MRI, where 
long-axis views of the LV at end-systole allowed direct quantification of the LAD 
and PCL (Figure 8.13A,D). Ventricular dilation resulted in progressive increase in 
LAD (Fig 8.13B), which was a correlated with an increase in PCL (𝛥𝑃𝐶𝐿 =
0.64(𝛥𝐿𝐴𝐷) +  0.89; 𝑅2 = 0.63). Change in the LAD and PCL dimensions were 
attenuated by hydrogel treatments, significant for DC at 8 weeks (ΔLAD) and 2 and 
8 weeks (ΔPCL). At 8 weeks, both assessments of ventricular elongation were 
correlated with the observed MR grade (R2 > 0.71), with treatment dependent 
clustering (indicated, Figure 8.13C,F). 
Direct assessment the mitral valve geometry was performed by 3D 
echocardiography. Deviation from the baseline geometry was observed; annular 
height (AH), commissural width (CW), and their ratio (AHCWR) all increased in MI 
controls, with changes attenuated by hydrogel treatment (not significant, Figure 
8.13H). Assessment of tethering of the anterior (A1, A2, A3) and posterior (P1, P2, 
P3)  leaflets was performed (Figure 8.13I) and strongly indicated tethering of the 
posterior leaflet in MI controls—moderately reduced in GH and significantly 
reduced (P1) or absent in DC treatments. The location of strongest tethering in MI 
controls (P2, P3) is consistent with the observed location of the MR jet via flow 
velocity magnitude scans (Figure 8.12F) and indicative of asymmetric ischemic 
MR. Notably, increase in the circumference of the posterior leaflet, leaflet length, 
and coaptation area were observed in the MI group with relative reduction by 
hydrogel treatments (Table 8.5), though not significant.   
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Figure 8.13. Valve-associated Geometric Changes due to LV remodeling. Long axis 
dimension (LAD, A) and posterior chord length (PCL, D) were determined from CINE MRI. 
(B,E) Corresponding quantification for change (∆,relative to baseline measurement for 
each case) in LAD and PCL, separated by treatment groups. (C,F) MR grade (8 WK) 
dependence on ∆LAD and ∆PCL, where treatment group clustering is indicated (MI: black, 
solid; GH: purple, dashed; DC: green, dotted line). (H) Saddle shape geometry was 
assessed by geometric change in annular height (AH), commissural width (CW), and the 
annular height to commissural width ratio (AHCWR). (I) Leaflet angle (α), indicative of 
tethering, was regionally assessed within the anterior and posterior leaflet. *P < 0.05 
relative to MI unless otherwise indicated. Indicated in images: right atrium (RA), left 




  252 















MI Post-MI 60.71 ± 1.50 
44.06 ± 3.74  
/ 49.07 ± 4.71 
138.62 ± 19.20 
 Terminal 67.53 ± 2.85 
53.86 ± 5.73  
/ 58.15 ± 5.33 
219.98 ± 51.54 
 Change 6.82 ± 2.75 
9.80 ± 4.27  
/ 9.07 ± 4.43 
81.36 ± 47.87 
GH Post-MI 63.68 ± 2.09 
58.07 ± 5.65  
/ 57.14 ± 3.91 
129.09 ± 13.38 
 Terminal 68.59 ± 2.12 
64.19 ± 7.33  
/ 63.96 ± 6.84 
197.46 ± 44.15 
 Change 4.91 ± 1.98 
6.12 ± 7.63  
/ 6.82 ± 5.81 
68.37 ± 43.19 
DC Post-MI 65.81 ± 2.58 
40.86 ± 1.24  
/ 43.11 ± 1.53 
122.23 ± 7.73 
 Terminal 69.43 ± 1.84 
41.62 ± 1.03  
/ 45.82 ± 0.61 
147.52 ± 13.01 
 Change 1.87 ± 1.57 
  0.95 ± 1.60  
/ 1.18 ± 0.22   
25.23 ± 11.24 
Data provided as mean±SEM.  
* No difference between groups determined by ANOVA 
 
8.3.5 Percutaneous Hydrogel Delivery.  
The potential for percutaneous injection of the shear-thinning GH hydrogel was 
examined using equipment and methods amenable to adaptation in the majority of 
interventional cardiology units. Hydrogels were prepared as described, and the 
injection volume (0.3 mL) was loaded into 1 mL Luer-Lock syringes. The desired 
injection location (i.e., septal for RV approach, anterior and posterior wall for LV 
approach) were positively identified by fluoroscopy, the introduction sheath 
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positioned accordingly, and ICE used to allow visualization of the needle location 
(Figure 8.14A,D). The injection catheter was filled with hydrogel prior to insertion 
into the introduced sheath and injections were performed by insertion of needle 
into the LV wall, as visualized by ICE (Figure 8.14A, inset). Following sacrifice and 
excision of the heart, hydrogel injections were visualized by MRI. As with direct 
injection via left thoracotomy, discrete hydrogel injections were located along the 
long axis (Figure 8.14B,E) and short axis (Figure 8.14C,F) of the myocardium. 
 
Figure 8.14. Percutaneous hydrogel injection. (A) Internal jugular approach toward RV 
injection, with alignment of the steerable introducer (i), intracardiac echocardiograph 
probe (ICE, ii), and deployment of needle assembly (iii). Inset: corresponding ICE view of 
deployed needle (indicated, white arrow) entering the myocardial wall (indicated, dashed 
red line). (B-C) Long axis (B) and short axis (C) images of hydrogel injection (indicated, 
white arrows). (D) Right carotid approach toward LV injection, including steerable 
introducer (i), ICE (ii), and deployment of needle assembly (iii) into the midwall of the LV. 
(E-F) Long axis (E) and short axis (F) images of hydrogel (indicated, white arrows). 
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8.4 Discussion 
Toward abating the LV remodeling process post-MI, epicardial placement of 
devices, including both mechanical restraints25 and therapeutic-containing 
patches45,46 have demonstrated great efficacy in pre-clinical studies. However, the 
clinical application of such therapies will most likely be limited due to their inherent 
requirement for open surgical approaches. To address this important 
consideration, therapeutics that may be delivered via catheter have been 
investigated (i.e., cell therapy).47 In addition to such approaches, our group and 
others have utilized a combination of experimental and computational tactics to 
explore the capacity for injectable hydrogels to directly alter the mechanical 
environment both in and around the infarcted region.11,28,29,36,48  
The ability of material injection to reduce myofiber stress within the infarct 
region and its borderzone is critical, as rapid geometric changes within the infarct 
(i.e. infarct expansion) and progressive dysfunction of the borderzone myocardium 
have been repeatedly implicated in progression of LV remodeling, as previously 
discussed. GH and DC hydrogels are both shear-thinning and self-healing to 
permit hydrogel localization in the myocardium (Figure 8.7); however, the DC 
hydrogel exhibits stiffening (>40-fold change) to increase the delivered hydrogel 
mechanical properties. FE modeling of the LV was utilized to examine the potential 
for the two distinct material systems to reduce potentially damaging stresses in the 
myocardium. At representative end-diastolic conditions, DC injection showed the 
greatest reduction in myofiber stress relative to MI controls. Stress reduction was 
driven by the preservation of LV shape in the case of DC injections; the increased 
  255 
material stiffness allowed the LV wall to maintain a near normal thickness, which 
reduced myofiber stress. In contrast, GH injections deformed under loading, 
elongating circumferentially (Figure 8.8A). Although only an initial snapshot into 
this mechanism, these results indicate that the hydrogel stiffness is important 
because it enables reduction in fiber stress through stiffness-induced bulking of 
the myocardium. While progressive DC degradation results in moduli decline and 
hydrogel integration with the host tissue, the therapy is intended to intercept the 
remodeling process by reducing myofiber stress to prevent early infarct expansion 
and thinning within a temporal window where remodeling proceeds rapidly — prior 
to endogenous infarct stiffening which occurs in progressive remodeling due to 
collagen deposition.49 
Myocardial bulking predicted by FE modeling was consistent with in vivo 
observations, as the thickness of the myocardium was better maintained with 
hydrogel injection. Notably, DC injection maintained baseline measurements at 2 
and 8 weeks, with thickness at 2 weeks consistent with FE model predictions. 
Importantly, recent analyses have highlighted myocardial thinning as a dominant 
feature of LV remodeling, consistent across species, making it an attractive 
therapeutic target.50  In addition to bulking, the FE model predicted alterations in 
myocardial loading which translated to attenuation of LV remodeling events in vivo, 
with DC treatment resulting in significant reduction in LVESV and improvement in 
EF at both 2 and 8 weeks. Moreover, the hydrogel treatments demonstrated the 
capacity to reduce progression and severity of MR as a result of attenuated 
remodeling. These metrics have been shown to be valuable clinical predictors for 
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survival post-MI.51,52 While decreased LV volume, resulting from tissue 
displacement by hydrogel, may contribute minimally to changes in EF, the injection 
volumes alone (4.8 mL) cannot account for the disparity in LV volumes between 
control and treatment cases (44 mL at end-systole, 8 wk) and consistent 
improvement in SV was demonstrated, indicating genuine preservation of both 
ventricular geometry and function.  
To enable formation of injectable hydrogels in vivo, both physical and covalent 
crosslinking have been individually leveraged, and a myriad of such hydrogels 
have been injected into the myocardium after MI.27 Yet, exceedingly few have 
demonstrated feasibility for percutaneous delivery, largely owing to procedural 
complications that place restrictions upon the material system.53 To date, only soft 
physically crosslinked hydrogels have been delivered percutaneously via 
catheters. Specifically, alginate has been delivered via intracoronary infusion,30 
decellularized extracellular matrix has been delivered via intramyocardial 
injection,31,54 and pH responsive assembly of poly(ethylene glycol) hydrogels in 
situ has been demonstrated via intramyocardial injection as a vehicle for local 
growth factor delivery.55 For such physically assembling systems, the range of 
attainable elastic moduli limit their applicability toward mechanical restraint.56 Yet, 
positive results have been demonstrated in porcine models, possibly attributable 
to biological effects,57 and these material systems have advanced to clinical trials 
(AUGMENT-HF, VentriGel) with outcomes pending.  
While physically assembling systems have demonstrated percutaneous 
delivery with some positive effects on LV remodeling, they have failed to exploit 
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mechanical stabilization in their mechanism of action. As an alternative, covalent 
crosslinking of hydrogels has been utilized to achieve mechanical restraint of the 
infarcted region, with factors such as increasing stiffness and prolonged 
degradation correlated with improved functional outcomes.28,29 However, gelation 
of these systems relies on the mixing of several components, which can be 
challenging with a catheter where rapid gelation can clog the catheter and slow 
gelation can lead to material dispersion in the tissue, compromising hydrogel 
formation.35,58 This challenge has prevented covalently crosslinking hydrogels 
from being delivered in a percutaneous approach.  
To address these limitations, we have leveraged physical interactions (i.e., 
formation of complexes between guest and host molecules) to enable formation of 
a soft hydrogel which exhibited fluid-like behavior within the needle or catheter to 
allow injection. Importantly, the guest-host system allowed rapid re-assembly 
within the tissue and thus high local retention. Secondary covalent crosslinking, 
via thiol-ene addition reaction, has been tuned to provide crosslinking on the order 
of hours under controlled conditions (i.e., pH 5), to enable ease of use in a clinical 
setting.35 The resulting DC hydrogel mechanics were sufficient to provide tissue 
bulking to thicken the myocardium, reduce myofiber stress, and attenuate LV 
remodeling processes. Similar to the previously mentioned soft materials (e.g., 
alginate, decellularized extracellular matrix), there was some positive outcome 
even with the soft GH hydrogel. This is likely due to the biological effect of injection 
a foreign material into the myocardium, which can lead to changes in collagen 
production and thus preservation of tissue thickness. Taken together, we have 
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demonstrated, for the first time, the development of a catheter-deliverable material 
system with the ability to mitigate LV remodeling through mechanical restraint. 
The present study has demonstrated that hydrogels can effectively assuage LV 
remodeling after MI without the need for added biological therapeutics (i.e. cells, 
drugs) through modulation of the myocardial stresses. The study also 
demonstrates the feasibility of delivering these materials via catheter-based 
techniques, owing to the independently designed mechanisms for material 
retention and stiffening. Such materials will facilitate the development of clinically 
relevant approaches, owing to the relative ease of preparation and potential for 
minimally invasive delivery.25,27,59 Moreover, the primary constituents (i.e., HA and 
CD) have been certified as generally recognized as safe (GRAS) by the US Food 
and Drug Administration, and many of their chemically modified forms are 
industrially well represented, including in the pharmaceutical and medical device 
industries.60-62 The defined material formulations therefore constitute a medical 
device that holds potential to rapidly progress toward clinical use. 
 
8.5 Conclusion 
For the first time, we have developed shear-thinning hydrogels with 
therapeutically relevant properties for delivery via percutaneous intramyocardial 
injection. Such shear-thinning delivery enabled local hydrogel retention, while 
secondary covalent crosslinking enhanced mechanically advantageous bulking of 
the infarct tissue. Importantly, the stiffening reaction occurred autonomously in situ 
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on clinically relevant timescales and further enhanced treatment efficacy through 
bulking and mechanical stabilization of the infarct. The dual-crosslinking hydrogel 
system represents the first engineered material designed to specifically and 
simultaneously address the needs of localized retention, mechanical stabilization, 
and percutaneous delivery for treatment of MI. The present study establishes the 
efficacy of the material system as a therapeutic approach toward moderating LV 
remodeling.  
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CHAPTER 9 
 
Injectable and Cytocompatible Tough Double-Network 
Hydrogels Through Tandem Supramolecular and Covalent 
Crosslinking 
 
Adapted from: C.B. Rodell, N.N. Dusaj, C.B. Highley, J.A. Burdick. Injectable and 
Cytocompatible Tough Double-Network Hydrogels Through Tandem 
Supramolecular and Covalent Crosslinking. (In Review). 
 
9.1 Introduction 
Hydrogels are an invaluable class of materials for biomedical applications, 
owing to their utility as structural, bioinstructive, and cell-laden implants1,2. Despite 
their many positive attributes, covalently crosslinked hydrogels are typically brittle, 
and supramolecular assemblies often exhibit pseudoplastic deformation with low 
resistance to loading. Thus, each individually fails to recapitulate biological tissue’s 
resilience toward repeated loading. Addressing these limitations, double network 
(DN) hydrogels3, a subset of specifically structured interpenetrating networks that 
exhibit resistance to mechanical failure, have evolved to produce desirable 
mechanical properties for biomedical applications4-6. Canonically, the primary 
network (formed first) is highly crosslinked and brittle to dissipate energy and 
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protect the ductile secondary network from rupture.7,8 Remarkably, this mechanism 
has recently enabled the formation of hydrogels with strengths approaching those 
of synthetic rubbers and connective tissues5,6,8-10.  
Despite their improved mechanical properties, DNs are susceptible to the 
Mullins effect11,12, a loss of mechanical strength upon loading, due to permanent 
rupture of covalent bonds. Physical networks, including those based on ionic 
crosslinking (e.g., polyampholytes13, alginate14,15, and chitin16) as well as hydrogen 
bonding17, have been introduced to attain recoverable primary networks within DN 
hydrogels. However, recovery remains poor, requiring long timeframes (>30min) 
or excessive heating (>50○C) to approach initial properties. Moreover, the 
processing techniques common to the fabrication of DN hydrogels require lengthy 
sequential polymerizations where often toxic secondary network components are 
swollen into the first network3 or secondary ionic crosslinking is similarly 
induced13,16,17. Some efforts have been taken to overcome these limitations and 
encapsulate viable cells within IPN‘s, such as by orthogonal click reactions18 or 




9.2.1 Material Synthesis. 
Hyaluronic acid (HA, Lifecore) was converted to methacrylated HA (MeHA) by 
esterification (Figure 9.1) with methacrylic anhydride (MA)24. HA with 25% 
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(Me25HA) or 100% (Me100HA) of disaccharides modified were prepared by reaction 
with 6 eq MA (pH 8.0-8.5, 3 hr) or 25 eq MA (pH 9-10, 4 hr; repeated without 
purification), respectively. To enable anhydrous reaction in DMSO, HA and a 
portion of Me25HA were converted to their respective tetrabutylammonium salts 
(HA-TBA and Me25HA-TBA) by exchange against Dowex-100 (3.0 g per 1.0 g HA) 
and neutralization by tetrabutylammonium hydroxide. Adamantane modified HA 
(Ad-HA) and β-cyclodextrin (CD) modified HA (CD-HA) were formed by methods 
previously reported (Figure 9.2)25, having respective modifications of 33% and 
31% of disaccharide repeats. Briefly, HA-TBA (1 eq) was dissolved in anhydrous 
DMSO (2 wt%) and modified by esterification with 1-adamantane acetic acid (3.0 
eq) via Boc2O (0.67 eq)/DMAP (0.5 eq) catalysis or separate amidation with 
aminated CD (0.8 eq) by reaction with BOP (0.8 eq). Methacrylated Ad-HA (Ad-
MeHA) and CD-HA (CD-MeHA) were identically prepared (Figure 9.3), starting 
with Me25HA-TBA (1 eq). Modification by Ad and CD were determined to be 33% 
and 30%, respectively. All final gel precursors were purified by extensive dialysis, 
recovered by lyophilization, and modifications determined by 1H NMR (Bruker, 
DMX 360 MHz). 
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Figure 9.1. Methacrylate modifications. (A) Preparation of methacrylated hyaluronic 
acid (MeHA) with both high and low modifications, designated Me100HA (y = ~1.0) and 
Me25HA (B, y = 0.26). Methacrylate modification was determined by integration of the vinyl 
singlets (1H ea., shaded green) relative to the sugar ring of HA (10H, shaded gray). 
 
Figure 9.2. Guest-host polymer modifications. (A) Preparation of guest-host polymers, 
including hyaluronic acid (HA) with pendant modification by adamantane (Ad-HA; x = 0.33) 
or β-cyclodextrin (CD-HA; z = 0.30). (B) Modification of Ad-HA was determined from 1H 
NMR spectra by integration of the ethyl multiplet (12H, shaded blue) of adamantane 
relative to the sugar ring of HA (10H, shaded gray). (C) Modification of CD-HA was likewise 
determined from 1H NMR spectra by integration of the hexane linker (12H, shaded yellow) 
of 6-(6-aminohexyl)amino-6-deoxy-β-cyclodextrin relative to the N-acetyl singlet of HA 
(3H, shaded gray). 
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Figure 9.3. Methacrylated guest-host polymer modifications. (A) Preparation of 
methacrylated guest-host polymers, including hyaluronic acid (HA) with pendant 
modification by adamantane and methacrylate (Ad-MeHA; x = 0.33 y = 0.26) as well as β-
cyclodextrin and methacrylate (CD-MeHA; z = 0.30, y = 0.26). Reaction proceeded as for 
Ad-HA and CD-HA modifications, with prior methacrylation to product Me25HA (Scheme 
2). (B) Modification of Ad-MeHA was determined from 1H NMR spectra as described for 
both MeHA and Ad-HA polymers. (C) Due to considerable spectral overlap of pendant 
modifications with both the sugar ring and N-acetyl group of HA, modification of CD-MeHA 
was determined from 1H NMR spectra by assuming the methacrylate modification to be 
conserved throughout the reaction (25%, vinyl protons 1H ea., shaded green) with 
integration of the hexane linker (12H, shaded yellow) of 6-(6-aminohexyl)amino-6-deoxy-
β-cyclodextrin. 
 
9.2.2 Hydrogel Formation. 
For single networks composed of guest-host networks alone (GH), Ad-HA and 
CD-HA were dissolved in equal volumes of PBS such that their combination 
resulted in the combined overall concentration desired (5.0 wt%, unless otherwise 
specified). For single networks composed of covalent crosslinks alone (MeHA), 
Me100HA was dissolved in triethanolamine buffer (TEOA buffer: PBS, 
supplemented with 50 mM TEOA, pH 8.5). Dithiothrietol (DTT) was added at 20x 
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concentration, such that the ratio of thiol/methacrylate (ΧDTT) was that specified 
and the overall weight percent of Me100HA in solution was 3.0 wt%, unless 
otherwise specified. For guest-host double networks (GH DNs), hydrogels were 
formed as stated for single network formation, using TEOA buffer. CD-HA and 
Me100HA were dissolved together, and DTT thoroughly mixed with Ad-HA 
immediately before hydrogel formation. For methacrylated guest-host double 
networks (MethGH DNs), hydrogels were prepared as described for GH DNs, with 
substitution of Ad-MeHA and CD-MeHA.  
 
9.2.3 Mechanical Testing: Shear Rheology. 
Hydrogels were cast between the geometry (1○ cone angle, 20 mm diameter) 
and Peltier plate (37○C) of a stress controlled rheometer (TA Instruments, 
AR2000); examination was performed by oscillatory frequency sweeps (0.01-100 
Hz, 0.5% strain), time sweeps (1.0 Hz, 0.5% strain), and strain sweeps (1.0 Hz, 
0.5-500% strain). For hydrogels undergoing covalent crosslinking, crosslinking 
was observed in situ via time sweeps (1.0 Hz, 0.5% strain). Analyses were 
performed in a minimum of duplicate and results are reported as representative 
samples. 
 
9.2.4 Mechanical Testing: Compressive Dynamic Mechanical Analysis. 
Immediately following the mixing of hydrogel components, 50 µL of hydrogel 
was cast into 5 mm diameter cylinders, sealed to prevent dehydration, and 
crosslinked at 37○C overnight prior to compression testing (TA Instruments, Q800). 
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Samples (n ≥ 3) were secured via a preload (0.01 N) and compression performed 
(0.5 N min-1) for determination of elastic moduli (slope from 10-20% strain), failure 
strain, and failure stress. Additionally, moduli were determined for a single sample 
at 5, 10, 100, and 500 % strain min-1 to demonstrate strain rate dependence. 
Hysteresis testing was performed at 0.5 N min-1 with repeated loading and 
unloading cycles to 70% or 80% strain. Similar cyclic testing, with maximum strain 
progressively increased by 10% per cycle was also performed. For all repeated 
loading, a minimum of 5% strain was utilized to maintain sample contact with the 
instrument. Stress-strain profiles were integrated by geometric approximation 
(MATLAB) to determine hydrogel toughness, strain energy, and relaxation energy. 
 
9.2.5 Mechanical Testing: Tensile Analysis. 
Utilizing similar fabrication methods to compression samples, hydrogels (n ≥ 4) 
were cast using PDMS molds into dog-bone shaped samples (3.0 mm thickness, 
5.0 mm width at center). Samples were secured in custom clamps, pre-tension 
applied (0.01 N), and subjected to extension at 5.0 mm sec-1 (Instron, 5848, 10 N 
load cell). Elastic moduli (slope from 40-50% strain), failure strain, and failure 
stress were measured. Toughness was determined by methods analogous to 
compressive testing. 
 
9.2.6 Cell Encapsulation and Viability. 
Human mesenchymal stem cells (hMSCs, Lonza) were expanded under 
standard culture conditions in MSC growth media (α-MEM, 16.7% FBS, 1% L-
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glutamine, penicillin streptomycin) and encapsulated between passage 3 and 7 at 
a density of 5x106 cells per mL, maintained in culture for 24 hours (day 0) or an 
additional 14 days, and stained for live/dead following manufacturer’s instructions 
(Molecular Probes). For encapsulation, hydrogels were prepared as described, 
with 10% of the total volume reserved to account for addition of a concentrated cell 
suspension to the components immediately before onset of gelation. For all cases, 
crosslinking was performed in Media 199 (Gibco) supplemented with 2.5 mM 
TCEP, 25 mM HEPES, and with the pH adjusted such that final gelation occurred 
at pH 8-8.5 under culture conditions. Images were acquired (Olympus, BX51) at 
10x magnification using epifluorescent filters for both live (calcein AM labeled) and 
dead (ethidium homodimer labeled) cells. Viability is reported as the percentage 
of cells with positive calcein staining, n ≥ 3 per group. To examine hMSC 
distribution within the hydrogels, representative images were obtained by confocal 
microscopy (Zeiss, LSM 510, 10x objective) with maximum projections and 3D 
rendering performed (ImageJ). To assess metabolic activity, hMSCs were 
encapsulated and serially examined at set timepoints by incubation with Alamar 
blue (Fisher; 1:10 dilution with growth media, 4 hr incubation) and quantified by 
fluorescence (Tecan, Infinite M200, λabs/em=530/590 nm), which was normalized to 
baseline for each sample (n = 4). 
 
9.2.7 Injection. 
Hydrogels were prepared using supplemented Media 199. Ex vivo injections 
were performed subcutaneously (rat, 300 µL ea.) and intramyocardially (ovine left 
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ventricle, 200 µL ea.). Articular cartilage defects (bovine tibia, 5 mm) were filled by 
injection of hydrogels, contacted with the meniscus throughout crosslinking, and 
subsequently washed. All were incubated (37○C, 2 hrs) prior to excision and/or 
imaging. For subcutaneous injection, samples were collected (n ≥ 4, 4 mm 
diameter) and subjected to compressive analysis. 
 
9.2.8 Statistical Analysis. 
All data are reported as mean ± standard deviation (SD). Statistical significance 
was determined by ANOVA with post hoc Tukey HSD to compare between groups 
unless otherwise stated. In all cases, significance was determined at P ≤ 0.05.  
 
9.3 Results and Discussion 
9.3.1 Hydrogel Design and Network Properties. 
To simultaneously address the need for rapid self-healing, injectable delivery, 
and cytocompatibility, we have established a novel and generalizable methodology 
for formation of DN hydrogels by tandem supramolecular interactions and 
secondarily formed covalent crosslinks. Supramolecular guest-host assembly26,27 
was utilized  to develop a rapidly self-healing primary network, where β-
cyclodextrin (CD, host) was chosen as the host macrocycle due to its 
demonstrated biocompatibility, ease of chemical modification28, and high affinity 
guest-host complexation (Keq ~ 105 M-1)29 with adamantane (Ad, guest). Standard 
anhydrous esterification and amidation reactions (Figure 9.2) were utilized to 
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couple 1-adamantane acetic acid and aminated CD to hyaluronic acid (HA), used 
due to its long history of use in biomedical applications and potential for functional 
modification30. Upon mixing of the separate polymer solutions (5.0 wt% overall), a 
guest-host (GH) hydrogel formed (Figure 9.4A) that exhibited expected frequency 
dependent moduli due to the dynamic bond structure (Figure 9.4B) and yielded at 
high strain (>75% reduction in G‘) with recovery (>95%) within 6 seconds of 
removal of high strain conditions (Figure 9.4C). Thus, GH complexation was 
successfully leveraged in construction of a primary network that formed upon 
simple mixing, was shear-yielding, and underwent rapid self-healing.  
The secondary network was formed through an orthogonal covalent 
crosslinking reaction. Specifically, methacrylated HA (3.0 wt% Me100HA, Figure 
9.1) was reacted with dithiothreitol (DTT) to form a covalently crosslinked hydrogel 
under basic conditions (50 mM TEOA, pH 8) via Michael addition between 
methacrylates and thiols (Figure 9.4D). Addition crosslinking enabled facile 
changes in the covalent crosslink density by adjusting the ratio of thiol to 
methacrylate (ΧDTT), resulting in a network with tunable properties. Failure strains 
and elastic moduli were achieved ranging from 45.5±0.5 to 86.5±7.6 % and 2.2±0.2 
to 85.7±4.5 kPa, respectively (Figure 9.4E,F). All subsequent analyses utilized 
ΧDTT = 20%, due to requisite ductility of the secondary network.  
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Figure 9.4. Properties of single network hydrogels and schematics of hydrogels 
examined. (A) Schematic of adamantane (Ad-HA, blue) and β-cyclodextrin (CD-HA, 
yellow) modified hyaluronic acid crosslinked through guest-host (GH) complexation. (B-
C) GH hydrogels (5.0 wt%) were examined by frequency sweeps (B; 0.01-100 Hz, 0.5% 
strain) and strain sweeps (C; 1.0 Hz, 0.5-500% strain) with yield point indicated (▼, 64% 
strain) and subsequent rapid recovery (shaded; 1.0 Hz, 0.5% strain). (D-F) Schematic of 
Michael addition crosslinking (D) of methacrylated hyaluronic acid (MeHA) by dithiothreitol 
(DTT, red), where crosslink density was controlled through the thiol:methacrylate ratio 
(ΧDTT) and altered failure strains (E) and compressive elastic moduli (F). (p < 0.05, except 
where no difference (n.d.) is indicated). (G) Network architectures examined included a 
guest-host (GH) hydrogel, covalently crosslinked (MeHA) hydrogel, guest-host double 
network (GH DN), and methacrylated guest-host double network (MethGH DN). Local 
stress under loading (red) dissipated through reversible GH complex rupture (i) within the 
primary GH network; increased stress led to covalent bond rupture (ii) within the 
secondary covalent network, whereas energy dissipation from the GH network reversibly 
protected the secondary MeHA network from bond rupture within the double networks (iii), 
a mechanism which was enhanced through network tethering to enable stress 
transference (iv). 
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The combination of supramolecular and covalent chemistries enabled the 
engineering and investigation of DN hydrogels with unique and desirable 
properties (Figure 9.4G), including injectability and self-healing (due to reversible 
guest-host crosslinking) and easily tunable properties (due to covalent 
crosslinking). The guest-host double network (GH DN) was readily formed upon 
one-pot mixing of the polymer solutions, owing to simultaneous and orthogonal 
crosslinking mechanisms, with interpenetration of the two networks resulting in 
stress transference primarily through network entanglement31.  Since network 
tethering may enhance overall network properties32, the polymers were modified 
(Figure 9.3) to incorporate methacrylates into the GH network (MethGH DN), 
enabling coupling of the two interpenetrating networks.  
 
9.3.2 Double Network Mechanical Characterization 
Under compressive loading (Figure 9.5A) MeHA hydrogel controls with only 
covalent crosslinking exhibited dramatic and sudden failure, attributed to 
unhindered propagation of covalent rupture points11,33; GH DN hydrogels exhibited 
ductile and unrecoverable failure, attributed to covalent bond rupture and 
subsequent sliding of entanglement points and GH complexes12; MethGH DN 
hydrogels demonstrated exceptional recovery with only minor and localized 
defects observed, likely arising from imperfections created during sample 
preparation. Due to the pseudoplastic behavior of GH single networks, they were 
not suitable for testing. 
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Compressive stress-strain relationships (Figure 9.5C) illustrated increased 
moduli for DNs (inset), as well as substantially increased failure stresses for 
MethGH DN hydrogels. While properties were investigated at a nominal rate (0.5N 
min-1), compressive strain rate dependence was observed (Figure 9.6) due to 
stochastic and forcefully induced GH complex yielding27,34, indicating shock 
absorbing capacity reminiscent of many load bearing tissues. Elastic moduli were 
dependent on polymer concentration of the GH network (Figure 9.5E). Since no 
significant improvements were observed with GH polymer concentrations greater 
than 5.0 wt%, this concentration was used in subsequent analyses. Hydrogel 
properties were highly tunable through modulation of covalent crosslink density 
(Figure 9.5F). MethGH DN moduli exhibited approximately a fivefold and threefold 
amplification at ΧDTT = 20% and 100%, respectively, far exceeding summation of 
network properties where the elastic moduli of GH and MethGH single network 
hydrogels were <1kPa (1.0 Hz, 0.5% strain, where 𝐸 =  3(𝐺’)). Enhancement of 
MethGH DN moduli resulted in greater failure stresses and toughness, despite 
similar failure strains (Figure 9.7). Enhanced mechanical properties required an 
interpenetrating structure, but did not result from entanglement alone, as indicated 
by controls with perturbed polymer composition (Figure 9.8).  
Under tensile loading (Figure 9.5B,D) all hydrogels exhibited substantial elastic 
elongation with high failure strains (>150%, Figure 9.9). Elastic moduli increased 
with GH DN formation and further improved with tethering in the MethGH DN 
(Figure 9.5D). For both DNs, failure stresses were also significantly improved over 
MeHA controls. As a result of these changes, both DNs exhibited drastic increases 
in toughness (Figure 9.5G, > 8.5 fold increase for MethGH DN). 
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Figure 9.5. Dependence of double network properties on structure and composition. 
(A) Differing modes of compressive failure were observed between the hydrogels following 
compression to 90% strain (unconfined, 0.5 N min-1): brittle (MeHA: 3.0 wt% Me100HA, 
ΧDTT = 20%; left), ductile (GH DN: 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% GH, middle), 
and recoverable (MethGH DN: 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH, right). 
Scale bar: 5.0 mm. (B) Tensile testing of identically composed samples demonstrated a 
high degree of elasticity, where starting position of the top member is indicated (dotted 
line). Scale bar: 1.0 cm. (C-D) Corresponding compressive (C, 0.5 N min-1) and tensile (D, 
5 mm sec-1) stress-strain relationships. (E-G) Networks demonstrated tunable properties. 
(E) Compressive elastic moduli with varied supramolecular guest-host density (3.0 wt% 
Me100HA, ΧDTT = 20%, 0-7.5 wt% GH), where MeHA groups contained soluble HA to 
account for contributions by polymer entanglement. (p < 0.01, within and between groups 
for both DNs except where no difference (n.d.) is indicated). (F) Compressive elastic 
moduli with varied covalent crosslink density modulated by the ratio of thiol to methacrylate 
(3.0 wt% Me100HA, ΧDTT = 20-100%, 5.0 wt% GH). (p < 0.01, for all comparisons except 
where indicated: *, p < 0.05; n.d., no difference). (G) Tensile toughness for DNs and MeHA 
controls (*, p < 0.05; ***, p < 0.005,).  
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Figure 9.6. Dependence of compressive elastic moduli on strain rate. Moduli were 
examined at various strain rates (0.5-500% strain min-1 compression as shown: inset, left) 
for MeHA (A, 3.0 wt% Me100HA, ΧDTT = 20%), GH DN (B, 3.0 wt% Me100HA, ΧDTT = 20%, 
5.0 wt% GH) and MethGH DN (C, 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH) 
hydrogels, which demonstrated moduli dependence on strain rate only for networks 
containing supramolecular crosslinks.  
 
 
Figure 9.7. Dependence of compressive hydrogel properties on covalent crosslink 
density. Failure strain (A), failure stress (B), and corresponding hydrogel toughness (C) 
were investigated as a function of covalent crosslink density (ΧDTT = 20-100%), including 
for MeHA (3.0 wt% Me100HA), GH DN (3.0 wt% Me100HA, 5.0 wt% GH) and MethGH DN 
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Figure 9.8. Dependence of compressive mechanical properties on double network 
composition and architecture. Investigated groups include 3.0 wt% Me100HA (MeHA), 
3.0 wt% Me100HA + 5.0 wt% HA (MeHA + HA), 3.0 wt% Me100HA + 5.0 wt% GH (MeHA + 
GH), 3.0 wt% Me100HA + 5.0 wt% MethGH (MeHA + MethGH), 3.0 wt% Me100HA + 5.0 
wt% Me25HA (MeHA + MeHA (25%)) and 5.0 wt% MethGH alone (MethGH). In all cases, 
ΧDTT = 20% and loading was performed at a strain rate of 0.5 N min-1 to determine 
compressive elastic modulus (A), failure stress (B), and failure strain (C). (ǂYield point not 
observed due to ductile failure. Significance relative to MeHA shown: *, p < 0.05; **, p < 
0.01, ANOVA with post hoc HSD). Results demonstrate the inability of entanglement with 
or without tethering (MeHA + HA and MeHA + MeHA (25%), respectively) to account for 
changes in hydrogel mechanics. Moreover, the necessity of a double network, utilizing two 
separate polymers rather than covalent stabilization of MethGH alone, is demonstrated by 
the failure of MethGH only to recapitulate the high failure mechanics of the MethGH DN. 
 
 
Figure 9.9. Dependence of tensile hydrogel properties on network structure. 
Dependence of tensile (5.0 mm sec-1 elongation) failure strain (A), elastic modulus (B), 
and failure stress (C) on hydrogel network structure, including for MeHA (3.0 wt% 
Me100HA, ΧDTT = 20%), GH DN (3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% GH) and MethGH 
DN (3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH) hydrogels. (*, p < 0.05; ***, p < 
0.001, ANOVA with post hoc HSD). 
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9.3.3 Supramolecular Self-Healing 
In addition to enhancing mechanical strength, a distinctive and advantageous 
feature of supramolecular interactions is their ability to undergo repeated 
association to endow macrostructural and microstructural (i.e., internal) self-
healing (Figure 9.10). Cut hydrogel fragments exhibited cohesion in aqueous 
conditions, which was disturbed only for MeHA hydrogels following mechanical 
agitation (Figure 9.10A). Cohesion likewise occurred between GH DN and MethGH 
DN hydrogel fragments, due to their identical guest-host composition. Notably, 
binding occurred rapidly (~1 sec), allowing near-immediate resistance to 
separation by repeated mechanical loading. 
To quantitatively investigate internal self-healing of DNs, repetitive loading was 
examined. Stress-strain profiles under ramped cyclic compressive strain (20-70%, 
Figure 9.10B, Figure 9.11) demonstrated synchronization of the loading curves 
with no appreciable change in moduli between loading cycles, indicating elastic 
recovery below critical strains. An appreciable increase in the strain energy (i.e., 
the energy required to induce deformation) was observed for MethGH DN 
hydrogels (Figure 9.10C) with successive cycles. Moreover, the hysteresis energy 
(i.e., the energy consumed due to internal bond failure11) demonstrated a notable 
increase for MethGH DN hydrogels, relative to MeHA and GH DN groups, 
indicating energy dissipation due to forcefully induced GH complex failure. With 
repeated application of 80% maximum strain, Mullins-type softening (i.e., loss of 
moduli and strain energy) was observed in MeHA and GH DN hydrogels, which 
was not observed at subcritical (<70%) strains (Figure 9.12) or in MethGH DNs 
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(Figure 9.10D,E). Thus, MethGH DNs effectively leverage the primary 
supramolecular network to prevent internal rupture of covalent bonds and maintain 
their moduli, even without lengthy recovery times that are needed with other types 
of crosslinking (e.g., ionic DNs)13,15,16. Taken together, results indicate that 
supramolecular bonds within DNs immediately self-heal between loading cycles 
and contribute substantially to energy consumption throughout loading, enabling 
supramolecular DNs to undergo repetitive loading in rapid succession, such as that 
which occurs in biological tissues. 
 
Figure 9.10. Supramolecular self-healing at macroscopic and molecular scales. (A) 
Macroscopic images of self-healing between fragments of MeHA (blue, 3.0 wt% Me100HA, 
ΧDTT = 20%), GH DN (green, 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% GH), and MethGH 
DN (orange, 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH) hydrogels before (top) and 
after (bottom) mechanical agitation, which demonstrated a lack of self-healing between 
MeHA samples only. Scale bar: 1.0 cm. (B-C) Compressive stress-strain profiles (B) for 
ramped loading (8 cycles at 0.5 N min-1 as shown, inset) of MethGH DN and strain energy 
of all groups (C). (D-E) Compressive stress-strain profiles for repeated loading to 80% 
strain (5 cycles at 0.5 N min-1 as shown, inset) of  MethGH DN (D) and normalized strain 
energy of all groups (E). 
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Figure 9.11. Evaluation of network energy throughout loading and unloading cycles. 
Ramped strain loading (20-70% strain at 0.5 N min-1 compression as shown, inset) for 
MeHA (A, 3.0 wt% Me100HA, ΧDTT = 20%), GH DN (B, 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 
wt% GH) and MethGH DN (C, 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH) hydrogels 
with determination of strain energy during loading (D), relaxation energy during unloading 
(E), and the hysteresis energy as the difference in strain and relaxation energy (F).  
 
 
Figure 9.12. Evaluation of network recovery from cyclic compressive loading. 
Loading (5 cycles at 0.5 N min-1 compression) was maintained below the yield strain, 
including to 70% strain (A-C) and 80% strain (D-F) for MeHA (A, D; 3.0 wt% Me100HA, 
ΧDTT = 20%), GH DN (B, E; 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% GH), and MethGH DN 
(C, F; 3.0wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH) hydrogels with determination of 
compressive moduli for successive cycles (insets, right). Hydrogels exhibited elastic 
recovery at 70% strain, but successive Mullins-type losses in moduli at 80% strain for 
MeHA and GH DN samples, not observed for MethGH DNs. 
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9.3.4 Double Network Cytocompatibility 
For biomedical applications, the encapsulation or delivery of cells is often 
desirable; however, these processes remain challenging with many types of 
crosslinking. Towards this, we developed cytocompatible crosslinking conditions 
(< 20 min, pH 8.5, 37○C) that supported tandem DN formation (Figure 9.13), using 
a phosphine Michael addition catalyst (TCEP: tris(2-carboxyethyl)phosphine, 
2.5mM). These conditions were informed by previous reports that showed TCEP 
to be a water soluble and highly efficient Michael addition catalyst under mildly 
basic conditions35, as well as recent utilization of Media 199 in nucleophilic 
addition36. These crosslinking conditions and cell inclusion did not impact hydrogel 
mechanics (Figure 9.14).  
 
Figure 9.13. Development of cytocompatible crosslinking conditions. Real-time 
rheological examination of MeHA crosslinking kinetics (A-C, 1.0 Hz, 0.5% strain. MeHA: 
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Me100HA, ΧDTT = 20%) and metabolic assay (D) Alamar blue) were used to identify 
conditions suitable for rapid Michael addition catalysis while maintaining cell viability. Upon 
probing relevant catalytic conditions in Media 199, the speed of crosslinking was observed 
to be greatly dependent on pH variations (A, pH 8.0 – 9.5, 25 mM TCEP, 37 ○C), nearly 
independent of variations in TCEP concentration (B, pH 8.5, 2.5 mM – 25 mM TCEP, 37 
○C), and highly dependent on temperature (C, 2.5 mM TCEP, pH 8.5, 4 – 37 ○C), where 
no increase in moduli was observed at 4○C within 1 hour. (D) Alamar blue assay was 
conducted according to manufacturer’s instructions following exposure of MSCs (seeded 
25x103 cells/well, 24 well plate) to conditions which replicated hydrogel encapsulation, 
including exposure to the prescribed buffer conditions (100 µL/well) for 30 min followed 
be dilution with 1.5 mL MSC growth media and overnight culture. Buffers included MSC 
growth media (Media), MSC growth media adjusted to pH 8 by NaOH (Media pH 8), 50 
mM TEOA in MSC growth media at pH 8 (TEOA, pH 8), Media 199 supplemented with 
TCEP (TCEP 2.5-125 mM, pH 7.5), and Media 199 supplemented with TCEP at various 
pH (TCEP 2.5 mM, pH 7.5-9.0).  Significant differences relative to standard media 
conditions are designated (*, p < 0.01, ANOVA with post hoc HSD). We observed a 
notable decrease in metabolic activity in the presence of TEOA (TEOA, pH 8), which likely 
resulted in part from TEOA toxicity rather than pH alone, as Media pH 8 showed a lesser 
effect. Toxicity of TCEP was observed only at concentrations greater than 2.5 mM. At a 
concentration of 2.5 mM TCEP, no differences were observed in metabolic activity from 
pH 7.5 – 9.0. Based on these observations, suitable crosslinking conditions for cell 
encapsulation were determined by be 2.5 mM TCEP, 37 ○C, pH 8.5 where serum free 
Media 199 was utilized and pH was maintained in the CO2 environment by addition of 25 
mM HEPES.  
 
 
Figure 9.14. Mechanical characterization of cell laden double network hydrogels. To 
examine the capacity for cytocompatible crosslinking conditions to fully crosslink materials 
without detriment to established mechanical properties, including in the presence of cells, 
mechanical characterization was performed in TEOA buffer (TEOA), Media 199 
supplemented with 2.5 mM TCEP, 25 mM HEPES, pH 8.5 (M199), and in the presence of 
MSCs (5x106 cells per mL, M199 + MSC). Regardless of catalysis conditions or cell 
presence, similar trends were observed between groups in elastic compressive moduli 
(A), failure stress (B), and failure strain (C). No significant differences were observed 
between TEOA and M199 + MSC conditions with the exception of moderate reductions in 
failure strain (*, p < 0.05).  
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At 24 hours following hydrogel formation (day 0), all hydrogels exhibited 
homogenous cell distributions, assessed by confocal microscopy (Figure 9.15A, 
Figure 9.16) and high viability (>95%, Figure 9.15B). Throughout 14 days in 
culture, metabolic activity (Figure 9.15C) remained similar between all hydrogel 
groups (p > 0.67, ANOVA) and increased over time, significant for GH DN beyond 
7 days and for MethGH DN beyond 3 days, relative to group baseline. 
Corresponding temporal examination of hydrogel moduli, swelling, and 
degradation (Figure 9.17) revealed that MethGH DN moduli were higher than that 
of the MeHA and GH DN hydrogels throughout the study and that DN groups 
exhibited reduced degradation. All hydrogels exhibited a nearly four-fold increase 
in mass due to swelling by day 1, which was maintained thereafter; such high water 
content (> 97%) likely helped overcome diffusive limitations that hindered long-
term viability in other tough IPN and DN hydrogels19-21,23. At day 14, high viability 
(> 98%) and uniform cell distribution was maintained (Figure 9.16). 
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Figure 9.15. Cell encapsulation, distribution, and long-term viability. (A) Confocal 
microscopy maximum projections of encapsulated mesenchymal stem cells (MSCs; 
calcein & ethidium staining) 24 hours after encapsulation within single (GH: 5.0 wt%; 
MeHA: 3.0 wt% Me100HA, ΧDTT = 20%) and double network (GH DN: 3.0 wt% Me100HA, 
ΧDTT = 20%, 5.0 wt% GH; MethGH DN: 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH) 
hydrogels. Of note, GH hydrogels exhibited a high degree of swelling, which reduced MSC 
density. Scale bar: 200 µm. (B) High viability (> 95%) was observed for all hydrogels 24 
hours after encapsulation (day 0), determined via quantification of epifluorescent images, 
and did not vary between groups (p > 0.95). (C) Metabolic activity was similar across 
groups at all timepoints (p > 0.69) and increased over 14 days of culture (*p < 0.05 relative 
to baseline, repeated measures ANOVA with post hoc Student’s t-test). GH hydrogels are 
not included, as they were not maintained in long-term culture.  
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Figure 9.16. Cell distribution within single and double network hydrogels. Oblique 
perspectives of confocal microscopy images of cell laden hydrogels at day 0 (A) and day 
14 (B). GH hydrogels demonstrated apparent reductions in density at day 0 due to the 
relatively high degree of swelling and could not be maintained in culture through day 14. 
Covalently crosslinked hydrogels, including MeHA, GH DN, and MethGH DN exhibited 
relatively homogenous cell distributions throughout the culture period. Oblique projections 
through the hydrogel edge (not shown) did not show proliferation on the gel surface at day 
14. Scale bar: 200 µm.  
 
 
Figure 9.17. Temporal characterization of material properties. To understand the bulk 
properties and behavior of the hydrogels over the time-course of cell culture, 
characterization of compressive elastic moduli (A), hydrogel degradation (B), and swelling 
(C) was performed for MeHA (3.0 wt% Me100HA, ΧDTT = 20%), GH DN (3.0 wt% Me100HA, 
ΧDTT = 20%, 5.0 wt% GH), and MethGH DN (3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% 
MethGH) hydrogels in the absence of cell inclusion. All hydrogels showed a high degree 
of swelling within the first 24 hours, moderate loss of moduli, and concurrent hydrogel 
degradation and HA release. 
 
  
  290 
9.3.5 Double Network Injectability 
In addition to endowing DNs with the ability to withstand repeated loading, rapid 
self-healing of supramolecular bonds enabled hydrogel injection, which is crucial 
for minimally invasive delivery in biomedical applications. As demonstrated 
rheologically (Figure 9.4C), GH complexation enabled yielding and flow of GH 
single network hydrogels under application of high strain with subsequent rapid 
recovery. This unique quality was harnessed to enable injection, where upon 
injection into aqueous media (TEOA buffer; Figure 9.18A) GH DN and MethGH 
DN hydrogels exhibited near-instantaneous supramolecular re-assembly following 
injection, resulting in retention of the interpenetrating MeHA polymer which 
subsequently crosslinked to form a highly elastic DN (Figure 9.18B). Conversely, 
MeHA single networks rapidly diffused prior to crosslinking.  
Translation toward gelation in situ, such as for therapeutic in vivo injection, was 
evaluated through injection into various tissues post-mortem (Figure 9.18C). In all 
cases, including subcutaneous injection in rats, intramyocardial injection in ovine 
tissue, and filling of cartilaginous defects, MeHA hydrogels were notably absent 
from the delivery location as a result of slow crosslinking kinetics; however, DN 
hydrogels were successfully retained at the injection locations. The mechanical 
properties of DNs following injection and in situ crosslinking were evaluated after 
harvesting of subcutaneous implants. GH DN and MethGH DN samples exhibited 
moduli of 5.83 ± 0.95 kPa and 11.17 ± 3.21, respectively, that were similar (p > 
0.79) when compared to in vitro controls. Likewise, failure mechanics of MethGH 
DN samples were similar to in vitro controls, including failure stress (264.00 ± 48.38 
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kPa, p = 0.08), failure strain (86.63 ± 4.05% strain, p = 0.51), and toughness 
(311.33 ± 54.00 kJ/m3, p = 0.41). Thus, developed supramolecular DN hydrogels 
retained desirable mechanical properties, including after injection and in situ 
crosslinking within tissue.  
 
Figure 9.18. Hydrogel injectability. (A-B) Macroscopic images of hydrogels following 
injection into TEOA buffer (A), demonstrating diffusion of MeHA (3.0 wt% Me100HA, 
ΧDTT = 20%) prior to crosslinking and rapid supramolecular re-assembly of double 
network formulations (GH DN: 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% GH; MethGH 
DN: 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH), which maintained elasticity (B, 
GH DN) following covalent crosslinking. (C) Hydrogel placement within tissues including 
subcutaneous (i) and intramyocardial (ii) injection, where approximate injection locations 
are indicated (▼), and filling of articular cartilage defects (iii, control empty defect shown 
at bottom left). GH DN and MethGH DN hydrogels formed highly localized implants, 
encircled by dashed lines, while MeHA alone rapidly diffused from the sites prior to 
hydrogel formation. Scale bars: 5 mm.  
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9.4 Conclusions 
Supramolecular interactions, including ionic13,15,16,37, and hydrogen 
bonding17,38, and engineered binary associations39-41, are essential in the 
development of tough materials. Yet, these methods have failed to deliver 
hydrogels that rapidly self-heal to enable sequential repetitive loading. We have 
harnessed the rapid association of supramolecular macrocycles to enable near-
immediate internal self-healing of DN hydrogels, where concurrent and substantial 
amplification of the hydrogel toughness and elastic moduli were simultaneously 
achieved through tethering of the single networks to enable stress transfer during 
loading. In contrast to conventional DN formation, hydrogels were composed of 
orthogonal supramolecular and covalent bonding schemes, which enabled single 
step (one-pot) preparation without detriment to encapsulated cells and enabled 
maintenance of high cell viability in culture — features not observed in other DNs. 
Autonomy of the reactions, in combination with shear-yielding behavior of the 
supramolecular bonds, enabled injectability with in situ DN formation. Due to their 
unique load-bearing, injectable, and cytocompatible properties, hybrid 
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CHAPTER 10 
 
Summary, Limitations, and Future Directions 
 
10.1 Overview  
The work presented in this dissertation has illustrated the development, 
characterization, and utility of hydrogels formed through guest-host (GH) directed 
assembly. Specifically, supramolecular hyaluronic acid (HA) hydrogels were 
developed that undergo dynamic assembly, directed by the GH complexation of β-
cyclodextrin (CD) and adamantane (Ad). Owing to the dynamic nature of these 
bonds, GH hydrogels underwent shear-thinning and re-assembly — desirable 
properties for injectable materials. Through extensive in vitro and in vivo 
characterization, an understanding of the material properties was developed, 
including the mechanical properties, dynamic rearrangement into supramolecular 
microstructures, and degradation behaviors, which were altered through both 
hydrogel composition and external triggers (e.g., enzymatic degradation). The 
hydrogel development and characterization served as a basis of understanding 
towards their utility in biomedical applications.   
Subsequent studies focused on altering the material properties of these 
physical hydrogels through additional covalent crosslinking, to improve their 
mechanical properties toward specific or general biomedical application. In the first 
approach, GH hydrogels were modified to undergo secondary covalent 
  298 
crosslinking (of the same polymer) in order to improve their mechanical strength. 
These dual-crosslinking (DC) hydrogel systems were applied to both small and 
large animal models, where they demonstrated promise as an injectable 
therapeutic to assuage maladaptive left-ventricular (LV) remodeling precipitated 
by myocardial infarction (MI). Toward development of tough hydrogels, secondary 
covalent crosslinking was introduced through interpenetrating double networks 
(DNs) with the GH hydrogel. These hydrogels were injectable, self-healing, and 
cytocompatible — properties that are useful for widespread biomedical 
applications. The remainder of this chapter summarizes primary conclusions and 
limitations of each specific aim, as well as future directions. 
   
10.2 Specific Conclusions, Limitations, and Future Directions 
Specific Aim 1: Develop and characterize guest-host (GH) hydrogels capable 
of injection. 
Conclusions: Through anhydrous esterification and amidation reactions, host 
(CD-HA) and guest (Ad-HA) polymers were prepared. Polymer conjugation did not 
impact the guest or host affinity, relative to unconjugated controls (Ka ≈ 500 M-1). 
Individual components were non-viscous solutions, which resulted in physical GH 
hydrogels when mixed with tunable moduli (G’ ≈ 200 Pa – 20 kPa at 1.0 Hz, 1.0% 
strain) and bulk relaxation behaviors (τ ≈ 0.1 – 100 sec) through modulation of 
polymer concentration, adamantane:cyclodextrin ratio, and modification of Ad-HA. 
Moreover, GH hydrogels were shear-thinning with rapid subsequent recovery 
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(>80% G’ within 1.33 sec). GH hydrogels were therefore concluded to be a 
mechanically tunable physical hydrogel system with desirable properties for use 
as an injectable hydrogel. 
GH hydrogels were stable is aqueous environments (20-80% mass loss at 60 
days, dependent on formulation) and permitted sustained diffusive protein release 
(bovine serum albumin, >60 days). Further modification of this system 
incorporated an enzymatically degradable peptide linker between HA and Ad, 
which enabled accelerated hydrogel degradation either through collagenase or 
matrix metalloproteinases (MMP-2) in vitro. Hydrogel erosion was likewise 
accelerated in vivo, relative to non-degradable controls. The GH hydrogel system 
is therefore a promising drug delivery system, enabling injectable delivery of 
therapeutic reservoirs which can be made responsive to native biological signals. 
Dynamic supramolecular assembly of GH hydrogels also resulted in a 
hierarchical structure in vitro. Visible turbidity arose following GH hydrogel 
formation and incubation, indicative of light diffraction due to microscale 
heterogeneity. The porous structure was observed by microscopic methods in the 
hydrated state and evolved temporally with void fractions (~8.5 - 94%) and pore 
diameters (~2.1 – 1025 µm) that were tunable through polymer concentration and 
Ad-HA modification. Micromechanical analysis via atomic force microscopy and 
microparticle tracking analysis revealed the evolution of hollow pores. Thus, a 
tunable microstructure was achieved through guest-host directed polymer 
assembly.  
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Limitations & Future Directions: Taken together, the extensive synthesis and 
characterization employed resulted in diverse hydrogel features; though, several 
experimental variables remain unexplored. Toward tailoring of the GH hydrogels 
at the polymeric level, only pendant modification of hyaluronic acid was explored. 
Additional polymers may be of interest, including cationic or neutral polymers as 
well as those with star, dendrimeric, or branched structures. Moreover, only β-
cyclodextrin and adamantane were examined as the guest-host pair. As discussed 
in Chapter 3, an array of possible host macrocycles and corresponding guest 
moieties are available, which enable alterations in binding constants and even 
stimuli-responsive behaviors. These variations in hydrogel composition may 
enable further implementation of the GH hydrogel for cell and drug delivery or use 
as model cell culture substrates.  
Toward the utilization of these materials as bioerodible hydrogels for delivery 
of therapeutic cargo, we have demonstrated here the long-term stability of these 
hydrogels as well as concurrent release of an inert model protein (albumin). The 
investigation of therapeutic delivery has not been observed in vivo through the 
studies presented herein. Though, continuing work beyond the scope of this 
dissertation has utilized these materials for localized peptide and protein delivery, 
including for applications in kidney1,2 (IL-10 and anti-TGF β delivery) and 
myocardial disease (SDF-1α and cathelicidin-related antimicrobial peptide), both 
with positive outcomes. Longitudinal analysis of release behavior and related 
activity in vivo, rather than in vitro examination alone, would improve upon such 
studies. Moreover, supramolecular interactions also perpetuate controlled delivery 
  301 
though the guest-host interaction of CD with small molecule therapeutics or 
polymer charge interactions to electrostatically control release of charged 
therapeutics (i.e., proteins, RNA). These mechanisms have not been explored 
here, but remain a focus of continuing efforts. 
While a microscale structure was shown to evolve in this hydrogel system, it 
has not yet been generalized to include the assembly of alternative binding pairs. 
Likely, the choice of binding pair will greatly alter the timescale for evolution and 
feature size. Additionally, alterations to the polymer may result in interesting 
changes, including by reduction in electrostatic repulsion for neutral polymers that 
would enable polymer condensation with greater density (i.e., higher moduli). The 
modulus of the hydrogel phase was not determined in the absence of secondary 
photopolymerization, and it therefore remains ambiguous if hydrogel stiffening 
occurred (due to polymer compaction) or if swelling in the surrounding aqueous 
environment resulted in softening. These questions warrant further investigation, 
as they are relevant toward the development of these and related adaptable 
materials as three-dimensional cell-culture substrates,3 and may greatly influence 
hydrogel permeability relevant to drug delivery applications.    
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Specific Aim 2: Develop dual-crosslinking (DC) hydrogels capable of both 
guest-host assembly and secondary covalent crosslinking in situ on 
clinically relevant timescales. 
Conclusions: Separate thiolation of Ad-HA (Ad-HA-SH) and methacrylation of 
CD-HA (CD-MeHA) resulted in a dual-crosslinking (DC) hydrogel that was 
injectable prior to covalent crosslinking. Onset of secondary covalent crosslinking 
occurred with sufficient time (>2 hours) for clinical application. Elastic moduli (~25 
kPa) were increased over GH hydrogels and hydrogel erosion was significantly 
reduced over time both in vitro and in vivo. When GH and DC hydrogels were 
delivered to the heart through multiple injections in the infarct border zone in rats, 
mechanically-dependent alterations in left-ventricular (LV) geometry and function 
were observed. Both GH and DC hydrogels improved LV wall thickness, LV inner 
diameter, and fractional shortening, relative to MI controls. Though, only the end-
systolic pressure volume relationship, ejection fraction, and cardiac output were 
significantly improved by DC treatment. Geometric and functional outcomes were 
typically improved by DC treatment, relative to GH treatment. We conclude that 
the guest-host crosslinking mechanism enabled hydrogel injectability with 
retention at the target site, while secondary covalent crosslinking mechanisms 
stiffened the hydrogels in vivo to improve attenuation of adverse LV remodeling in 
a rat model of MI.    
Limitations & Future Directions: While the materials concept presented provided 
immediate development towards cardiac applications, efforts focused only on 
optimization of secondary crosslinking on clinically useful timescales and 
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achieving moduli of > 20 kPa. No efforts were made to explore additional 
crosslinking mechanisms, such as dynamic covalent chemistries, which may 
confer additional advantages such as self-healing capacity. Moreover, materials 
were not yet optimized to produce catheter-deliverable formulations — as 
formulations had high viscosity that prevented their flow through conventional 
catheter tubing. These issues were later addressed in Aim 3 through the use of a 
non-conventional injection catheter coupled with formulations which exhibited 
properties (i.e., lower viscosity, injection force) more amenable to catheter 
injection.   
Additionally, the animal model provided strong proof-of-concept that the 
materials system had desirable features and efficacy for myocardial application, 
though the methodology was limited by technical aspects and experimental design. 
First, it is noted that injections were performed immediately following infarct due to 
challenges in a second thoracotomy for two surgical procedures. These timescales 
of delivery would likely not be clinically feasible, and further discussion toward this 
point is provided in the following section. Secondly, neither longitudinal evaluation 
of function or myocardial mechanical properties were assessed. With hydrogel 
therapy to restrict expansion, DC hydrogels were necessarily stiffer than the 
myocardium, which may have imposed diastolic dysfunction (i.e., ventricular 
under-filling due to restriction of wall motion). While the end-diastolic pressure 
volume relationship (a measure of myocardial elasticity) showed no change with 
hydrogel injection, further investigation (e.g., evaluation of diastolic myocardial 
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properties and wall motion by finite element analysis of SPAMM tagged MRI) is of 
general interest toward injectable materials as infarct restraints.  
 
Specific Aim 3: Assess the therapeutic potential of guest-host and dual-
crosslinking hydrogels to attenuate LV remodeling in an ovine infarct model. 
Conclusions: GH and DC hydrogels of similar formulation to Aim 2 were 
employed in an ovine model of MI, where the GH hydrogels (<1 kPa moduli) 
enabled injection and localized retention with subsequent stiffening (41.4±4.3 kPa 
moduli) after injection for the DC system. Finite element modeling, predictive of 
early myocardial stress distributions, projected myofiber stress reduction within the 
infarct region for DC but not GH hydrogel treatments. Infarct thickness, LV end 
systolic volume, and ejection fraction were improved with both GH and DC 
hydrogels, with results graded according to material stiffness — consistent with 
results from Aim 2 and with predicted myocardial stress reductions. Furthermore, 
ischemic mitral regurgitation (MR) was attenuated by hydrogel therapies, with no 
significant increase in MR grade observed at 8 weeks. Across all treatment groups, 
MR grade was correlated (R2 > 0.71) with increases in the LV long-axis dimension 
as well as posterior chord length. Echocardiographic analysis revealed significant 
posterior leaflet tethering, which was attenuated in the DC treatment arm. 
Percutaneous delivery of GH hydrogels was accomplished through endocardial 
injection, using fluoroscopic and echocardiographic guidance. Successful delivery 
was visualized by MRI. We conclude that a percutaneous delivered hydrogel 
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system was developed, and hydrogels with increased stiffness were most effective 
in ameliorating LV remodeling, preserving LV function, and attenuating MR.  
Limitations & Future Directions: While the mechanical analysis of hydrogels 
conducted herein demonstrated that DC hydrogel moduli following in vivo injection 
were comparable to those measured in vitro, mechanical analysis of GH hydrogels 
could not be performed as a result of hydrogel dispersion throughout the tissue, 
and temporal analysis of GH hydrogel mechanics was not performed due to the 
inability to accurately assess these hydrogels rheologically following swelling. For 
both GH and DC hydrogel injection, the spatiotemporal mechanical properties of 
the hydrogel-tissue composite are an important consideration and their 
understanding would enable further development of the finite element analysis 
techniques employed. Indeed, improving upon these mechanical analyses is a 
point of consideration already being explored. Measurement of the mechanical 
properties would be improved through examination of the hydrogel-tissue 
composite (rather than hydrogel alone) coupled with the ability to discern both 
compressive, tensile, and shear loading conditions that better representing the 
mechanical complexity of the myocardial environment. Such analysis may be 
accomplished through multipoint triaxial loading, and collaborative efforts to 
explore these avenues are being initiated. 
Toward development of injectable material systems as a clinically translatable 
methodology, further scrutiny of two primary safety considerations is necessary. 
First, it is recognized that percutaneous endocardial injection is accompanied by 
the risk of embolism—either through leaking of the material or thrombotic response 
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within the ventricle.4 It is anticipated that shear-thinning of hydrogels within the 
circulation may prevent embolism, but direct investigation (such as by ventricular 
lumen injection) is needed to substantiate such claims. While HA is inherently non-
thrombogenic, examination of the synthetically modified forms used here is worthy 
of further investigation. Secondly, the injection of discrete hydrogel regions into the 
myocardium has the potential to impair electrophysiological conductivity, resulting 
in increased risk of arrhythmia. While hydrogel therapies would be performed 
through injection tissue that is already minimally conductive (scar tissue or tissue 
that will transition into a scar), systematic investigation of conductivity following 
injection and prevalence of arrhythmia may be warranted. 
Intervention with hydrogel injection was performed at the time of infarct 
induction. Such timing is likely not achievable clinically, with intervention in the 3 
to 7 day range or later being more feasible.5 The results of this study therefore 
demonstrate the capacity for the material systems developed to act as a 
preventative therapy to alter LV remodeling, as well as introduce a delivery 
approach that could expand the feasibility of injection at later times. While efficacy 
of material injection at later time points has been demonstrated in some small 
animal,6-8 large animal,4,9 and clinical studies10, the optimization of injection time 
for both clinical applicability and efficacy remains an important issue in need of 
direct examination and likely the optimal material formulation will be dependent on 
this treatment time. Indeed, these efforts are already initiated through the 
development of ischemia/reperfusion MI models that do not require a thoracotomy 
and then injection through minimally invasive approaches.  These efforts may be 
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aided by percutaneous injection procedures that are accompanied by necessary 
myocardial and infarct mapping. Lastly, animals were only studied out to 8 weeks 
post-MI; longer studies will be required to assess the durability of the therapeutic 
response at time points beyond the in vivo lifetime of the DC materials. Ultimate 
clinical translation of the materials described here will be dependent on future 
studies that will be focused on timing, dosing, and addressing essential safety 
concerns. 
 
Specific Aim 4: Develop injectable, cytocompatible, and tough 
supramolecular double network (DN) hydrogels through tandem guest-host 
and covalent crosslinking reactions. 
Conclusions: In order to form interpenetrating double networks (DNs) of 
supramolecular and covalently crosslinked polymers, GH hydrogels were used in 
conjunction with highly methacrylated HA (MeHA, 100% modification). Guest-host 
double networks (GH DNs) were formed with interpenetration of MeHA, 
crosslinked through Michael addition with dithiothreitol (DTT). Additionally, the two 
networks were tethered by methacrylation (25%) of Ad-HA and CD-HA, yielding 
methacrylated guest-host double networks (MethGH DNs). Compressive and 
tensile mechanical analyses demonstrated toughening (> eightfold increase) and 
high strength (~0.25 MPa moduli) when compared to covalent networks alone. 
Guest-host interactions exhibited rapid self-healing (<6 sec, observed 
rheologically), which allowed hydrogel injection prior to covalent crosslinking as 
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well as immediate recovery of DNs between repeated loading cycles. Mild 
crosslinking conditions were developed which permitted the encapsulation of 
viable cells (>95% viability at day 0 and day 14), as well as DN formation following 
injection into tissue — both without loss of mechanical properties. We conclude 
that the novel combination of guest-host and covalent crosslinking (on separate 
polymers) results in a material system that balances injectability, cytocompatibility, 
and tough mechanical properties.  
Limitations & Future Directions: The material preparations examined here 
enabled drastic increases in moduli and toughness relative to covalently 
crosslinked hydrogels alone. Yet, neither of these yet attain the properties of soft 
connective tissues (e.g., cartilage and tendon). While compressive moduli 
approached 0.25 MPa moduli, these remain marginally below that of native 
cartilage (~1 MPa). To improve upon these properties, further alteration of the 
materials system may be explored—including increasing the concentration of 
MeHA, therefore increasing the covalent crosslink density above that achieved 
here. These changes, however, are likely to over-emphasize the covalent hydrogel 
characteristics and thereby remove self-healing properties and yield more brittle 
materials. Alternatively, it has been demonstrated that the properties also depend 
upon supramolecular crosslink density (through guest-host polymer 
concentration). As increases beyond 5.0 wt% yielded little change, other 
modifications to the supramolecular crosslinking may prove useful. These may 
include deviation from the cyclodextrin macrocycles (as previously discussed) to 
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leverage the improved binding affinity of other guest-host complexation or 
increases in the guest and host polymer modification may be explored.  
A promising avenue for continued exploration is the development of mechanical 
properties through stimulation of cells encapsulated within the gel to produce their 
own extracellular matrix (ECM). It is realized that hydrogels do not have to initially 
match the exact mechanical properties of native tissues. Rather, encapsulated 
cells (e.g., chondrocytes, mesenchymal stem cells) may be encouraged to produce 
ECM through mechanical or cytokine (e.g., TGF-β) stimulation, resulting in 
improved mechanical performance of the ECM-hydrogel composite. Owing to high 
viability in long-term culture and the ability to undergo repetitive loading without 
detriment to mechanical properties, it is envisioned that these unique DNs have 
the capacity to undergo such examination. Injectability and in vivo formation of 
these systems perpetuate a regenerative medicine approach to engineering of 
mechanically durable tissues.   
 
10.3 Conclusions 
The body of work presented throughout this dissertation builds-up a class of 
material systems centered upon the design, synthesis, and characterization of a 
supramolecular hydrogel uniquely designed and optimized for injection. In 
particular, this base system has been well characterized to develop an 
understanding of its native characteristics, including mechanical properties, 
microstructure, erosion, and molecule release behaviors. Through engineered 
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modification of this base material, either through changes in formulation or varied 
synthetic modifications, adaptations toward enzymatic response as well as 
mechanical reinforcement have been demonstrated. Such material systems are 
highly relevant as biomedical scaffolds for therapeutic use, as they enable ease of 
application in a clinical setting through simple injection. Such utility has been 
demonstrated in specific application toward treatment of myocardial infarct, though 
these same principles apply toward the application of these hydrogel systems as 
general biomedical materials, where highly localized delivery of mechanically 
robust materials is desired or where hydrogels may be used for their capacity as 
therapeutic (i.e., cell, drug) delivery vehicles. Collectively, these materials hold 
promise as adaptable biomaterials for widespread use in conventional therapeutic 
and regenerative medicine approaches.  
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